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Statement to my Thesis 
 My thesis is written in a cumulative format. It consists of a synopsis about 
a topic related to my work (Apoptosis and its modulation by bacterial pathogens), 
followed by chapters, each presenting a manuscript with a short summary. Finally, I 
resume the major findings of my thesis in the section concluding remarks. 
 
 
  
i 
Table of Contents 
Table of Contents 
   
 Apoptosis and its modulation by bacterial pathogens……………………………………… A-1 
  General introduction………………………………………………………………… A-1 
   Molecular mechanisms of apoptosis……………………………………………… A-1 
   Modulation of apoptosis by bacterial pathogens…………………………………. A-5 
   References…………………………………………………………………………… A-17 
   
  Chapter 1:  Bartonella henselae induces NFκB-dependent upregulation of  
                    adhesion molecules in cultured human endothelial cells: possible  
   roles of outer membrane proteins as pathogenic factors………………….. B-1 
   Manuscript……………………………………………………………………………. B-4 
 
 Chapter 2:  The VirB type IV secretion system of Bartonella henselae  
   mediates invasion, proinflammatory activation, and  
   antiapoptotic protection of endothelial cells…………………………………. C-1 
  Manuscript……………………………………………………………………………. C-3 
   
 Chapter 3:  A bipartite signal mediates the transfer of type IV secretion  
                    substrates of Bartonella henselae into human cells……………………….. D-1 
   Manuscript…………………………………………………………………………… D-3 
 
 Chapter 4:  A translocted protein of the vascular tumor-inducing pathogen  
  Bartonella protects human vascular endothelial cells from apoptosis… E-1 
   Abstract……………………………………………………………………………..…E-4 
   Introduction………………………………………………………………………..…. E-5 
   Results………………………………………………………………………………... E-8 
   Discussion……………………………………………………………………………. E-16 
   Materials and methods……………………………………………………………… E-22 
   Acknowledgements…………………………………………………………………. E-29 
   References…………………………………………………………………………... E-30 
   Figures legends……………………………………………………………………… E-37 
   Figures……………………………………………………………………………….. E-41 
   Supplemental Material…………………………………………………………….... E-49 
   
  Concluding remarks……………………………………………………………………………….. F-1 
   References…………………………………………………………………………... F-6 
   
 Acknowledgements………………………………………………………………………………… G-1 
  
 Curriculum vitae…………………………………………………………………………………….. H-1 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Synopsis 
Molecular mechanisms of apoptosis 
Apoptosis and its modulation by bacterial pathogens 
 
General introduction 
 The term apoptosis was introduced in 1972 by John Kerr and is derived from the 
Greek meaning “falling off”. It describes a distinct form of cell death whereby cells die 
in a tightly regulated fashion. In contrast to apoptosis, also known as programmed 
cell death, necrosis is a degenerative process in which cells swell and lyse after 
irreversible tissue injury (Hengartner, 2000). Apoptosis is characterized by changes 
including nuclear and cytoplasmic condensation, membrane budding, 
internucleosomal DNA fragmentation and the formation of apoptotic bodies (Kerr et 
al., 1972). Apoptosis acts as a homeostatic mechanism for controlling cell 
proliferation, because excessive death may lead to compromised development or 
degenerative disease, while the lack of cell death could result in proliferative 
disorders (Reed, 2003). In this synopsis, I will concentrate on bacterial pathogens 
that employ different strategies to modulate the programmed cell death of the 
infected host cell. In general, the specific modulation of the host cell fate enhances 
bacterial spreading and enables bacterial survival in the infected host.  
The first part of this synopsis introduces the basic and relevant molecular 
mechanisms of apoptosis. The second part discusses the mechanisms by which 
bacterial pathogens induce and/or block apoptosis, and the implications of these 
modulations on pathogenesis and diseases. 
 
 
Molecular mechanisms of apoptosis 
 
Caspases:  the central executioners 
The central component of the apoptotic machinery is a family of cysteine 
proteases. These proteases called caspases (cysteine aspartyl-specific proteases) 
(Thornberry, 1998) belong to a family of intracellular enzymes that cleave their 
substrate at aspartic acid (Asp) residues. Caspases are often categorized as either 
upstream “initiator” or downstream “effector” caspases (Salvesen and Dixit, 1997). 
Upon induction of apoptosis, initiator caspases are activated. The active initiator 
caspases trigger then the activation of the effector caspases resulting in a caspase 
cascade (Salvesen and Dixit, 1999). The targets of activated effector caspases 
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appear to be crucial in maintaining the cell architecture, in RNA splicing, and in DNA 
repair (Table 1).  
Human caspase-1, -4, and -5 are classified in a different subgroup, the so 
called inflammatory caspases. Although there is evidence that these caspases are 
involved in apoptosis, their primary function is the regulation of inflammatory 
processes. They mediate the processing of pro-inflammatory cytokines, particularly 
pro-Interleukin-1β (pro-IL-1β) and pro-IL-18 (Martinon and Tschopp, 2004). 
 
. Table 1. Classification of the caspases 
Death
for transduction of the apoptotic signal. 
tive the initiator caspases (Ashkenazi, 
 
 
 
 
 
 
 
 
 
 
 receptors 
Two major pathways have been described to induce apoptosis, an extrinsic 
and an intrinsic mechanism (Figure 1, pA-3). Both result in the activation of 
caspases. The extrinsic pathway is initiated by an extrinsic signal and mediates the 
activation of the tumor necrosis factor receptors (TNFR) superfamily , also known as 
the death receptors. Two well-characterized death receptors are Fas and the tumor 
necrosis factor receptor 1 (TNFR1). In their cytoplasmic tails, they carry the so-called 
“death domains” (DD) (Ashkenazi, 2002). Upon ligand binding to the extracellular 
domain, the DDs interact with adapter proteins like Fas-associated DD (FADD) 
protein and TNFR-associated DD (TRADD) 
These adapter proteins then interact and ac
2002). 
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 the Bcl-2 family are involved in this process 
himizu et al., 1999) (Figure 1, pA-3).  
The B
ondrial control of cell death 
The intrinsic pathway to induce apoptosis is controlled by the mitochondrium. 
The mitochondrium is able to release a potent cocktail of pro-apoptotic proteins into 
the cytoplasm of the cell. The main player among these proteins is cytochrome c. 
Once cytochrome c is released from the mitochondrium to the cytosol, it associates 
with Apaf-1 (apoptotic protease activating factor 1) and pro-caspase-9 to form a 
complex known as the Apoptosome (Li et al., 1997). The exact mechanism, how 
cytochrome c manages to cross the mitochondrial outer membrane is not yet known. 
Nevertheless, it is proposed that pore-forming proteins like the voltage-dependent 
anion channel (VDAC) and members of
(S
 
cl-2 family 
The Bcl-2 family consists of pro-apoptotic and anti-apoptotic Bcl-2 proteins 
controlling the release of cytochrome c from the mitochondrium (Figure 2, pA-4). The 
pro-apoptotic proteins like Bax and Bak might operate as pore formers or ion 
channels and induce the release of cytochrome c through the outer mitochondrial 
membrane, whereas the anti-apoptotic proteins Bcl-2 and Bcl-XL suppress this 
release (Kuwana and Newmeyer, 2003). The Bcl-2-family proteins share defined 
homology between each other. This homology is found in one to four regions 
designated the Bcl-2 homology (BH) domains BH1-4. Some pro-apoptotic family 
members, such as Bad, Bid, and Bim, contain only one homology domain, the BH3 
region. This group is also defined as BH3-only proteins. Several BH3-only proteins 
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can inactivate anti-apoptotic Bcl-2 fam poptosis ily members and thereby induce a
(Kelekar and Thompson, 1998).  
  
Figure 2.  Balance of apoptosis. The amount of 
pro- and anti-apoptotic Bcl-2 family members 
controls the permeabilization of the outer 
itochondrial membrane and the release of m
cytochrome c.  
 
oteins prevent initiation of apoptosis by 
hibiting the sequestering of pro-apoptotic signals from the mitochondrium, IAPs are 
able to inhibit already activated caspases. 
 
The “inhibitor of apoptosis” gene family 
The inhibitor of apoptosis (IAP) proteins family was initially identified in the 
baculoviral genome. They all contain baculovirus IAP repeat (BIR) domains, which 
are essential for the anti-apoptotic properties (Fesik, 2000). Although IAP-family 
members like XIAP, cIAP1, cIAP2, and survivin possess other functions, most of 
them bind and potentially inhibit activated caspases. Usually the effector caspase-3 
and -7, and/or the initiator caspase-9 are inhibited by IAPs (Deveraux and Reed, 
1999). This inhibition of caspases by IAP differs from the Bcl-2 family related 
apoptotic suppressors. Whereas Bcl-2 pr
in
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Bacterial control of apoptosis 
Bacterial pathogens have developed different strategies to modulate the 
apoptotic pathway of their host cell (Dockrell, 2001; Hueffer and Galan, 2004; 
Zychlinsky and Sansonetti, 1997). Pathogen-induced activation of the host cell-death 
pathway may serve to eliminate key immune cells or evade host defenses. Several 
bacterial pathogens induce apoptosis by inducing caspase activation, which also can 
be involved in inflammation. The elicited accompanied inflammation process at the 
place of infection leads to disruption of the surrounding tissue barriers. This might 
facilitate the initiation of infection and secures an efficient microbial spread in the 
host. In contrast, inhibition of apoptosis might be essential for intracellular pathogens 
to protect their invaded host cells from collapsing. Thereby they facilitate their 
replication and persistence in the infected host. Activation and inhibition of apoptosis 
by bacterial pathogens thus plays an important role in a variety of infectious 
diseases. 
 
Induction of apoptosis by bacterial pathogens 
To induce apoptosis, a number of pathogens possess virulence factors, which 
can activate the death pathway of the host cell or interfere with survival pathways 
(Navarre and Zychlinsky, 2000; Weinrauch and Zychlinsky, 1999). These bacterial 
virulence factors induce apoptosis by a variety of mechanisms such as (i) pore-
forming toxins, which interact with the host cell membrane and permit the leakage of 
cellular components, (ii) toxins inhibiting host-cell protein synthesis, (iii) direct 
injection of effector proteins into the host-cell cytoplasm via a type III secretion 
system, (iv) effectors of the type IV secretion system, (v) superantigens targeting 
immune cells, and (vi) other effectors. 
 
(i) Pore-forming toxins 
Staphylococcus aureus is a Gram-positive coccus that causes a number of 
diseases, including carbuncles, wound infections, toxic shock syndrome, and food 
poisoning (gastroenteritis) (Manders, 1998). S. aureus mediates apoptosis either by a 
pore-forming α-toxin or by superantigens as discussed later. The α-toxin  
(or α-hemolysin) of S. aureus belongs to the channel-forming toxins and is active 
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against erythrocytes as well as a range of other cells including epithelial cells and 
endothelial cells (Menzies and Kourteva, 2000; Wesson et al., 2000). Two 
mechanisms are proposed for the induction of apoptosis by α-toxin. The first one 
suggests that secretion of α-toxin at low levels results in its association to the 
eukaryotic cell membrane and the formation of small ion-permeable pores which 
initiate cell death (Jonas et al., 1994). The second one suggests that intracellular  
S. aureus uses α-toxin to escape from the phagosome into the cytoplasm. Upon 
evasion of the phagosome apoptosis is induced by targeting the pore-forming α-toxin 
to the mitochondrial membrane, resulting in the release of cytochrome c (Figure 3, p. 
A-14) (Bantel et al., 2001; Essmann et al., 2003) 
Pore-forming toxins are also found in Listeria monocytogenes, a Gram-
positive rod. L. monocytogenes is an opportunistic food-borne human and animal 
pathogen responsible for serious infections predominantly in immunocompromised 
individuals, pregnant women, and neonates (Portnoy et al., 1992). After 
internalization, L. monocytogenes lyses the phagosomal membrane and escapes into 
the cytoplasm. This process is mediated by listeriolysin O (LlyO), a bacterial secreted 
pore-forming toxin (Guzman et al., 1996).  Intracellular L. monocytogenes can induce 
apoptosis in a variety of cells in vivo and in vitro, but a bacterial escape of the 
phagosome is required. It is thought that the cytoplasmic LlyO permeabilizes 
mitochondrial membranes in a similar way as the α-toxin from S. aureus resulting in 
cytochrome c release (Figure 3, p. A-14) (Rogers et al., 1996). 
Another bacterial pore-forming toxin, which was described to induce 
apoptosis, is the outer membrane protein PorB of Neisseria gonorrhoeae.  
N. gonorrhoeae is a Gram-negative, human-specific intracellular bacterial pathogen 
that colonizes the genital or rectal mucosa, causing the sexually transmitted disease 
gonorrhea (Naumann et al., 1999). It is thought that apoptosis of mucosal epithelial 
cells supports the access of the gonococci to deeper tissues during infection. It has 
been proposed that PorB translocates by a yet undefined mechanism from the outer 
bacterial membrane to the mitochondrium, where it forms a pore in the membrane. 
These pores lead to an efflux of cytochrome c from the mitochondrium into the 
cytosol resulting in the induction of the intrinsic apoptotic pathway (Figure 3, p. A-14) 
(Muller et al., 2000). PorB shares structural and functional homology with the 
mitochondrial VDAC, suggesting that it may represent an analogue or precursor of 
this putative central regulator of apoptosis (Muller et al., 2002). The same authors 
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have previously shown that PorB also translocates to the cytoplasmic cell membrane, 
leading to an influx of calcium, and then calpain and caspase-3 activation (Muller et 
al., 1999). Importantly, PorB of N. meningitidis was also described as an anti-
apoptotic factor, contradicting observations in N. gonorrhoeae. This will be discussed 
in more detail in the section “inhibition of apoptosis by bacterial pathogens”.  
The Gram-negative pathogenic bacterium Helicobacter pylori is the causing 
agent of chronic gastritis, which may develop to a lymphoma of the stomach. Beside 
the Cag pathogenicity island (Cag-PAI), encoding a type IV secretion system (T4SS), 
the vacuolating cytotoxin VacA has been reported to be an important pathogenic 
factor, although its precise role in H. pylori virulence is still unknown (Monack et al., 
2004; Reyrat et al., 1999). VacA is a secreted protein that, among other functions, 
induces cellular vacuolization in epithelial cells. Ectopic expression of VacA as well 
as external application of VacA to human tumor cell lines induces apoptosis. VacA is 
targeted to the mitochondrium, where it initiates the release of cytochrome c. This 
effect can be inhibited by co-expressing Bcl-2, a known inhibitor of mitochondrial 
membrane permeabilization (Galmiche et al., 2000). Induction of apoptosis by VacA 
in vivo is based on the disruption of the epithelial barrier and the leakage of nutrients 
into the place of H. pylori infection (Monack et al., 2004). 
 
(ii) Protein synthesis inhibitors 
The diphtheria toxin (DT) produced by Corynebacterium diphtheriae, a 
Gram-positive extracellular pathogen, is the causative agent of the respiratory 
disease diphtheria (Popovic et al., 2000). DT can induce apoptosis in several 
epithelial and myeloid cell lines (Morimoto and Bonavida, 1992). Expression of DT by 
C. diphtheriae requires an integrated bacteriophage genome encoding the toxin gene 
(Cianciotto and Groman, 1997). DT belongs to the family of secreted A-B toxins. The 
B subunit mediates attachment to the cell through a host receptor and facilitates the 
delivery of the catalytic A subunit to the cytoplasm. The A subunit of DT causes ADP-
ribosylation of the elongation factor 2 (EF2), an essential co-factor of the protein 
synthesis machinery. ADP-ribosylation of EF2 blocks the protein synthesis of the 
eukaryotic cell and leads to cell death (Chang et al., 1989; Holmes, 2000). Other 
studies indicate that DT-mediated apoptosis involves additionally a cellular apoptosis 
susceptibility protein (CAS) (Brinkmann et al., 1995).  
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Other bacterial pathogens inducing apoptosis by protein synthesis inhibitors 
are Shigella dysenteriae and enterohemorrhagic Escherichia coli (EHEC), the 
etiological agents of dysenteric syndromes. These bacteria produce similar  
A-B toxins, called Shiga toxin (ST) and Shiga-like toxin (SLT) (Karmali, 2004). The 
catalytic A subunit cleaves eukaryotic rRNA and thereby disrupts eukaryotic 
ribosome function and protein synthesis. The B subunit, mediating the internalization 
of the A subunit into the host cell, binds to a host cell receptor specifically expressed 
on cells from the kidney and in the central nerve system (CNS). Significantly, 
macrophages do not express this receptor and are not susceptible to ST or STL 
cytotoxicity (Herold et al., 2004). 
 
(iii) Type III secreted proteins 
Type III secretion systems (T3SS) are specialized organelles of Gram-
negative bacterial pathogens that deliver proteins to host cell membranes and the 
cytosol (Hueck, 1998). The T3SS apparatus is a needle-like structure which spans 
the inner and outer membranes of the bacterial envelope and secretes translocon 
and effector proteins. The structure of the needle is similar to that of the flagellar 
basal body. Translocon proteins mediate pore formation in the host cell membrane 
and translocated effector proteins subvert different aspects of host cell physiology, 
thereby promoting bacterial virulence (Waterman and Holden, 2003). 
Shigella spp. are the causative agents of bacillary dysentery and bloody 
diarrhea (Jennison and Verma, 2004). Induction of apoptosis of macrophages by 
Shigella is mediated by the plasmid-encoded invasion plasmid antigen B (IpaB)  
(Hilbi et al., 1998). Upon phagocytosis by the macrophage, Shigella escapes from the 
phagosome into the cytoplasm. There, Shigella injects the pro-apoptotic IpaB effector 
protein into the cytoplasm of the macrophage by its T3SS.  After translocation, IpaB 
binds to and activates caspase-1, resulting in macrophage apoptosis (Figure 3, p. A-
14) (Zychlinsky et al., 1992). Caspase-1 activation and apoptotic death of Shigella-
infected macrophages causes the release of mature IL-1β, which results in an 
inflammatory response. This leads to the recruitment of leukocytes, which 
compromises the integrity of the epithelial barrier during transmigration. The induction 
of an inflammatory response might be essential for the spreading of the bacteria into 
the deeper epithelium of the intestine (Dockrell, 2001; Zychlinsky and Sansonetti, 
1997). 
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Salmonella spp. cause a variety of clinical syndromes, including a self-limiting 
gastroenteritis in humans (Galan, 2001; House et al., 2001). Salmonella induces 
rapidly apoptosis of macrophages during its logarithmic-growth phase depending on 
the T3SS that is encoded by the Salmonella pathogenicity island 1 (SPI-1). Upon 
phagocytosis by the macrophage, Salmonella resides and replicates within an 
acidified phagosome. Once Salmonella has escaped from this phagosome, it 
secretes the Salmonella invasive protein B (SipB) into the cytoplasm of the host cell 
by using its T3SS. SipB is a homologue of IpaB and binds directly to and activates 
caspase-1 (Figure 3, p. A-14) (Hersh et al., 1999; Hueffer and Galan, 2004). 
However, Salmonella can also induce macrophage cell death that occurs in a 
delayed manner. In that situation Salmonella uses a different T3SS that is encoded 
by a second pathogenicity island, SPI-2 (van der Velden et al., 2000). Besides the 
DNA fragmentation reported in this study, additional biochemical events are still 
unknown. 
Yersinia spp. harbors a T3SS like Shigella and Salmonella and is able to 
induce apoptosis in macrophages. Y. pestis is the causative agent of bubonic plague, 
Y. pseudotuberculosis and Y. enterocolitica can cause gastrointestinal symptoms and 
septicemia (Cornelis, 2000). In contrast to Shigella and Salmonella, which both 
induce apoptosis of macrophages after invasion, Yersinia is able to induce apoptosis 
without being internalized by the macrophage. Upon adherence, Yersinia injects by 
its T3SS Yersinia effector proteins (Yop) across the bacterial and host cell membrane 
into the cytoplasm of the macrophage (Mills et al., 1997). Apoptosis is caused by the 
effector YopP/J and is accompanied by the activation of the pro-apoptotic Bcl-2 
family protein BID, the release of cytochrome c, and the activation of caspase -3/-7 
(Denecker et al., 2001) (Figure 3, p. A-14). In the cytoplasm, YopP/J represses the 
activation of transcription factor NFκB (Schesser et al., 1998). NFκB is known to 
induce the expression of genes which are involved in a pro-inflammatory response 
and in the inhibition of apoptosis.  This defines the NFκB pathway also as a survival 
pathway of the cell (Karin and Lin, 2002). In addition YopP/J interferes with the 
mitogen-activated protein kinase (MAPK) signaling pathway by binding to multiple 
MAPK kinases (MAPKKs) (Orth et al., 1999).  It was also shown that YopP/J can act 
as an ubiquitin-like protein (SUMO-1) protease, thereby deregulating post-
translational protein modification (Orth et al., 2000). Apoptosis induced by YopP/J 
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might thus be a result of the activation of a death mechanism and/or due to the 
inhibition of the survival pathway NF-κB (Cornelis, 2002; Ruckdeschel et al., 2001). 
 
(iv) Type IV secreted proteins 
Similar to the previously described T3SS, the T4 secretion machineries allow 
the translocation of bacterial macromolecules across bacterial and host cell 
membranes. T4SS are evolutionary related to the conjugal transfer system. Bacterial 
pathogen use T4SS to deliver effector molecules to eukaryotic target cells during 
infection. Upon translocation, bacterial effector proteins subvert the host cell function 
and they can contribute in different ways to the infection process (Cascales and 
Christie, 2003).  
Legionella pneumophila is a Gram-negative facultative intracellular 
bacterium. It is the causative agent of Legionnaire’s disease, and invades and 
replicates within alveolar macrophages, monocytes, and possibly alveolar epithelial 
cells (Bitar et al., 2004). Inside the cell, L. pneumophila resides within a specialized 
phagosome that does not acidify and fails to fuse with the lysosomes. Induction of 
apoptosis of these cells is mediated by the activation of the executioner caspase-3. 
The expression of apoptosis-inducing factor(s) by L. pneumophila might be regulated 
by the Dot/Icm T4SS, as several secretion deficient dot/icm mutants fail to induce 
apoptosis (Gao and Abu Kwaik, 1999). Other reports indicate that Legionella-induced 
cytotoxicity may be caused by osmotic lysis upon pore formation in the macrophage 
cytoplasmic membrane (Bitar et al., 2004; Kirby and Isberg, 1998) or by the activation 
of the intrinsic mitochondrial death pathway (Neumeister et al., 2002). As factors 
encoded by the dot/icm gene cluster of Legionella spp. are essential for altering 
phagosome properties and are as well required for pore formation, it can be 
speculated that Legionella-induced apoptosis might be due to pore formation upon 
translocation of unknown pro-apoptotic effector proteins through the Dot/Icm 
secretion system. 
 
 (v) Superantigens 
Beside the already described pore-forming α-toxin, Staphylococcus aureus 
harbors as additional virulence factors superantigens (Manders, 1998). Bacterial 
superantigens are proteins that interact with immune cells and stimulate potent 
immune responses. Superantigens activate T cells by directly binding to major 
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histocompatibility complex (MHC) class II molecules on antigen-presenting cells and 
to the T-cell receptor (TCR) on T cells. Activation of the TCR through superantigens 
like staphylococcal exotoxin (SE) A and B induces apoptosis in T cells. The precise 
pathway how this activation results in apoptosis is not yet known (Baker and 
Acharya, 2004; Goodyear and Silverman, 2004). A possible mechanism for SEB 
mediated cell death is that SEB induces the expression of the death receptor Fas on 
normal human T lymphocytes which results in Fas-ligand-triggered apoptosis 
(Ettinger et al., 1995; Sohn et al., 2003). 
 
(vi) Other effectors 
Mycobacterium tuberculosis is the etiologic agent of the tuberculosis. 
Macrophages infected with M. tuberculosis undergo increased rates of apoptosis 
which is accompanied by the release of the cytokines TNF-α and IL-10 (Rojas et al., 
1999). The production of TNF-α by macrophages and the induction of apoptosis can 
be mediated by binding of bacterial cell wall components and/or lipoproteins to the 
Toll-like receptor-2 (TLR-2) (Quesniaux et al., 2004). A putative pro-apoptotic 
candidate is a cell-associated and secreted 19-kDa glycoprotein which is able to 
induce apoptosis dependent on TLR-2 (Lopez et al., 2003). In addition to the 
pathway described above, downregulation of expression of the anti-apoptotic protein 
Bcl-2 has also been shown in M. tuberculosis-infected macrophages (Figure 3, p. A-
14) (Klingler et al., 1997). Paradoxically, M. tuberculosis can also protect cells 
against apoptosis through a TLR-2-dependent mechanism, as discussed in the 
following section. 
Chlamydia spp. is also a bacterial genus that is able to modulate the 
apoptotic pathways of its host cell in two opposing directions (Fischer et al., 2004; 
Perfettini et al., 2002). Chlamydia are obligate intracellular pathogens causing a 
broad range of diseases in humans, including trachoma, sexually transmitted 
diseases, and pneumonia (Byrne and Ojcius, 2004). The pro- and anti-apoptotic 
effect of Chlamydia is thought to be dependent on (i) the stage of the infection, (ii) the 
infected host cell, and (iii) the different biovars (Byrne and Ojcius, 2004). It is 
proposed that induction of apoptosis during the late state of infection facilitates 
bacterial spread and re-infection.  
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Inhibition of apoptosis by bacterial pathogens 
Many bacteria live within the cytoplasm or the endocytotic compartment of the 
cell. Inside the cytoplasm, the pathogenic bacteria have unlimited access to the host 
cell metabolites, which serves as nutritional source. In addition, hidden inside the 
host cell, the bacterial pathogens are protected from the immune system. Bacterial 
pathogens use different strategies to inhibit cell death of their host cell: (i) hijacking a 
pro-survival pathway of the host cell, (ii) secretion of anti-apoptotic effector proteins 
through a T4SS, and (iii) other mechanisms.  
Several bacteria described for their abilities to induce apoptosis in the previous 
section will appear in this section again, because they are also able to inhibit 
apoptosis at a different stage of infection.  
 
(i) Hijacking a pro-survival pathway 
The pathogen M. tuberculosis, capable of inducing apoptosis in 
macrophages, was in few reports described to also inhibit apoptotic cell death in 
macrophages by two different pathways. Firstly, through enhancement of the 
production of a soluble death receptor sTNFR2. The sTNFR2 binds surrounding 
TNF-α, which leads to the neutralization of the pro-apoptotic activity of TNF-α 
(Balcewicz-Sablinska et al., 1998). The release of sTNFR2 by infected macrophages 
is regulated by the cytokine IL-10. Secondly, bacterial lipoproteins binding to TLR-2 
might activate the transcription factor NF-κB and thereby induce the NF-κB survival 
pathway (Figure 3, p. A-14) (Means et al., 2001; Toossi et al., 1997). 
A second bacterial pathogen that shows modulation of pro-survival and pro-
apoptotic host cell signals is Chlamydia (Byrne and Ojcius, 2004). The anti-apoptotic 
activity of Chlamydia spp. is believed to be important during the initial stage of 
invasion where it relies on the host cell integrity and metabolism for its restricted 
intracellular lifestyle. Chlamydia-infected host cells are resistant to a variety of pro-
apoptotic stimuli. It has been shown that the activation of NF-κB during  
C. pneumoniae infection is associated with the protection of macrophages against 
apoptosis (Wahl et al., 2001). A recent study revealed a additional protection 
mechanism by which C. pneumoniae inhibits host cell apoptosis by the degradation 
of pro-apoptotic BH3-only proteins (Figure 3, p. A-14) (Fischer et al., 2004). 
Interestingly, genes encoding a T3SS have been identified in Chlamydia spp. (Hsia 
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et al., 1997). Whether the bacteria use this putative secretion system to mediate their 
anti- and pro-apoptotic effects remains to be elucidated.  
Rickettsia rickettsii is an obligate intracellular bacterium that causes Rocky 
Mountain spotted fever. During in vivo infection, the vascular endothelial cell is the 
primary target cell for R. rickettsii invasion and replication (Silverman and Bond, 
1984). In vitro, R. rickettsii protects endothelial cells from apoptotic cell death by 
activating the NFκB pro-survival signaling pathway (Figure 3, p. A-14) (Clifton et al., 
1998; Joshi et al., 2004). NFκB-mediated inhibition of apoptosis and enhanced host 
cell survival during the course of infection likely facilitates the growth and 
multiplication of the intracellular rickettsiae. 
 
(ii) Type IV secreted proteins 
Bartonella henselae is a Gram-negative zoonotic pathogen, capable of 
infecting humans as incidental hosts. B. henselae is the causing agent of cat-scratch 
disease in immunocompetent patients (Dehio, 2004). In immunocompromised 
patients, B. henselae has the property to induce vascular tumor formation, described 
as bacillary angiomatosis (Dehio, 2003). B. henselae-infected endothelial cells are 
protected from apoptotic cell death (Kirby and Nekorchuk, 2002). It is proposed, that 
inhibition of apoptosis by B. henselae contributes to the observed vascular tumor 
formation (Kirby, 2004; Kirby and Nekorchuk, 2002). As described in chapter 2  
(p. C-3), inhibition of apoptotic cell death by B. henselae requires a functional 
VirB/VirD4 T4SS (Schmid et al., 2004). The identification of Bartonella effector 
proteins (Bep), translocated into the host cell via the VirB/VirD4 T4SS, is reported in 
chapter 3 (p. D-3). In chapter 4 (p. E-3), we identified the Bartonella effector protein A 
(BepA) mediating the anti-apoptotic activity during endothelial cell infection. During 
HUVEC-infection, BepA induces an increased intracellular cAMP level in the host cell 
and a transcriptional activation of cAMP-responsive genes. In HUVEC, it is known 
that an elevated cAMP level can protect the cells from apoptotic cell death 
(Hippenstiel et al., 2002). Hence, we propose a model, in which BepA protects 
endothelial cells from apoptosis by increasing the cAMP level in the host cell (Figure 
3, p. A-14). 
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(iii) Other Mechanisms 
In contrast to PorB from Neisseria gonorhoeae, which induces apoptosis, PorB 
from N. meningitidis was described to act as anti-apoptotic factor. Although both 
molecules share a similar structure and are both targeted to the mitochondrium, the 
outcome of this interaction seems to be oppositional and is a matter of debate 
(Massari et al., 2000; Muller et al., 2000).  
The anti-apoptotic effect of PorB is thought to be mediated through protein-
protein interactions with the voltage-dependent anion channel (VDAC) of the 
mitochondrium. PorB is assumed to lead to closure of the VADC is closed and 
thereby inhibiting the release of cytochrome c (Figure 3, p. A-14) (Massari et al., 
2000).  
 
 Figure 3. The modulation of host cell apoptosis by bacterial pathogens. Details of the various 
mechanisms are given in the text. Adapted from “Bacterial Disease Mechanism”, Cambridge. A-14 
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Conclusions 
Numerous pathogens were shown to modulate apoptosis. The mechanisms to 
interfere with the apoptotic machinery differ between different pathogens. This 
includes (i) the alteration of the host cytoplasmic- or mitochondrial membrane by pore 
forming toxins (Neisseria, Listeria, Staphylococcus, Helicobacter) (ii) inhibition of 
protein synthesis (Corynebacterium) (iii) injection of pro- or anti-apoptotic effector 
molecules into the host cell via secretion systems (Shigella, Salmonella, Yersinia, 
Bartonella) (iv) activation or inhibition of the NFκB survival pathway (Rickettsia, 
Chlamydia) and (v) unbalancing pro- and anti-apoptotic effectors in the host 
(Chlamydia, Mycobactrium). It is difficult to draw a sharp line between the classified 
mechanisms, which often overlap. In addition, several bacterial pathogens use more 
than one strategy to modulate host cell apoptosis. Such modulation can lead to 
elimination of key defense cells that are necessary to eradicate the pathogen, or can 
facilitate intracellular trafficking of the bacteria, enhance intracellular bacterial 
replication, release intracellular bacteria after termination of replication, and facilitate 
bacterial spread. The majority of the here-described pathogens have facultative 
intracellular life cycles. They are highly adapted to infect a distinct part of the host, 
including mucosal layers, the endothelium, Peyer’s-patches, and the stomach. To 
survive and replicate in the host, they depend on the preservation of their niche. The 
interference with host cell apoptosis must therefore be fine-tuned to ensure 
transmission to new hosts.  
Although the subversion of the host cell fate by interfering with the apoptotic 
pathway is an important virulence factor for bacterial pathogens, only a few 
mechanisms are understood on the molecular level. The best-characterized 
mechanisms are the one of Shigella and Salmonella, where the bacterial factor as 
well as the eukaryotic response is identified. In these species, induction of apoptosis 
is a major process during the physiological infection course. In other bacteria, either 
the bacterial factor or the eukaryotic effector molecules are known. Like in the case of 
Yersinia-induced apoptosis, where the bacterial effector protein, its translocation, and 
its interaction with the host cell machinery is well established, the apoptosis inducing 
mechanism still needs further investigation. In contrast, in Chlamydia-inhibited 
apoptosis, where the cell death protection mechanism of the eukaryotic cell has 
recently been elucidated, the bacterial factors are still unknown.  
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In our work with Bartonella, we identified the anti-apoptotic bacterial factor 
BepA, which is translocated into the host cell by a T4SS. Furthermore, we propose a 
putative protection mechanism through which the host cell circumvents apoptosis. 
Based on our studies, we are able to introduce a second anti-apoptotic bacterial 
factor to the already controversially described PorB of Neisseria. Thereby BepA 
represents the first T4SS substrate modulating the apoptotic pathway of the host cell.  
In summary, modulation of apoptosis reveals further insights into the complex 
relationship between hosts and bacterial pathogens and is a challenging topic in the 
field of bacterial pathogen-host interaction. A better understanding of the molecular 
mechanisms of the pro- and anti-apoptotic activities may help to prevent and cure 
bacterial infections. 
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Bartonella henselae induces NFκB-dependent upregulation of 
adhesion molecules in cultured human endothelial cells: possible 
role of outer membrane proteins as pathogenic factors 
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Bartonella are unique among bacterial pathogens in stimulating endothelial 
cell proliferation, which results in the formation of vascular tumors (Dehio, 1999). In 
these vascular tumors, called vasoproliferative lesions, B. henselae localizes around, 
and within endothelial cells, indicating that the vascular endothelium represents a 
target tissue for extra- and intracellular colonization in vivo. The vasoproliferative 
lesions are typically infiltrated by polymorphonuclear neutrophiles (PMN) and 
monocytes, which is indicative of an inflammatory response (Manders, 1996). The 
pro-inflammatory response is mediated by endothelial cells, which upon activation 
induce expression of adhesion molecules and release of cytokines. These events 
promote binding and extravasation of PMN, respectively. 
Here we report the invasion and pro-inflammatory activation of human 
umbilical vein endothelial cells (HUVEC) upon infection with the B. henselae strain 
Berlin-1, which was isolated from a bacillary angiomatosis lesion of an 
immunodeficient patient. First, we investigated the ability of Berlin-1 to colonize and 
invade endothelial cells. We infected HUVEC and monitored the invasion process of 
the bacteria by immunocytochemistry. As previously shown for other B. henselae 
isolates, the Berlin-1 strain was able to invade HUVEC by two distinct routes (Dehio 
et al., 1997): (i) by the classical endocytotic pathway, whereby intracellular bacteria 
localize after invasion in a peri-nuclear endosomal compartment and (ii) by the 
formation of bacterial aggregates, which are internalized by a unique cellular 
structure, termed as invasome. Next, we tested whether Berlin-1 infection of HUVEC 
results in the activation of a pro-inflammatory response. The pro-inflammatory 
activation was determined by monitoring the rolling and adherence of PMN on the 
HUVEC surface in a flow chamber. After 8 h of infection, HUVEC showed enhanced 
rolling and adhesion of PMN. During a pro-inflammatory response, the rolling and 
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adhesion of PMN is mediated by the adhesion molecules E-selectin and ICAM-1 
(Cook-Mills and Deem, 2005). To test whether the observed enhanced rolling and 
adhesion of PMN upon Berlin-1 infection is also dependent on these adhesion 
molecules, we applied different antibodies to block receptor-bacteria interaction. By 
blocking the E-selectin adhesion molecules, we abolished PMN rolling and 
adherence. This indicates that E-selectin is central for PMN-endothelium interaction. 
In contrast, blocking of the adhesion molecules ICAM-1 and VCAM-1 did not inhibit 
PMN–HUVEC interaction at 8 h post-infection. Next, we used ELISA to analyze the 
expression of adherence molecules in the course of bacterial infection. During the 
first 12 h of bacteria-host cell interaction, E-selectin expression was strongly 
increased, whereas at later time points (around 24 h) the expression of ICAM-1 was 
elevated. These increased expression of E-selectin and ICAM-1 correlated with 
transcriptional upregulation at the according time points, as shown by Northern-blot 
analysis. 
Adhesion molecules involved in a pro-inflammatory response are 
transcriptionally regulated by nuclear factor κB (NFκB) (Karin and Lin, 2002). To 
determine the activation of NFκB upon Berlin-1 infection, we used a bandshift assay. 
Infection of HUVEC resulted in the activation of NFκB, which was independent of the 
viability of the bacteria and independent of bacterial LPS. Inhibition of NFκB during 
Berlin-1 infection abolished the increased expression of E-selectin and ICAM-1, 
indicating that NFκB mediates the pro-inflammatory response triggered by Berlin-1 
during HUVEC infection. 
To identify putative Bartonella effectors mediating the activation of 
endothelium, the outer membrane protein (OMP) fraction of Berlin-1 was purified. 
These OMPs were sufficient to activate endothelial cells in a dose-dependent manner 
as monitored by ICAM-1 and E-selectin expression. 
 
Statement of the own participation 
  I contributed to this publication by the following data: To demonstrate that the 
B. henselae strain Berlin-1 adheres to and invades human endothelial cells, I 
performed HUVEC-infection assays followed by immunocytochemical analyses  
(Fig. 1).  
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The endothelium is a specific target for Bartonella henselae, and endothelial cell infection represents an
important step in the pathogenesis of cat scratch disease and bacillary angiomatosis. Mechanisms of Bar-
tonella-endothelial cell interaction as well as signaling pathways involved in target cell activation were ana-
lyzed. B. henselae strain Berlin-1, isolated from bacillary angiomatosis lesions of a human immunodeficiency
virus-infected patient, potently stimulated human umbilical cord vein endothelial cells (HUVEC), as deter-
mined by NF-kB activation and enhanced adhesion molecule expression. These effects were accompanied by
increased PMN rolling on and adhesion to infected endothelial cell monolayers, as measured in a parallel-plate
flow chamber assay. Monoclonal antibodies against E-selectin significantly reduced PMN rolling and adhesion.
In our hands, B. henselae Berlin-1 was substantially more active than the typing strain B. henselae ATCC 49882.
E-selectin and ICAM-1 upregulation occurred for up to 9 days, as verified by Northern blotting and cell surface
enzyme-linked immunosorbent assay. Induction of adhesion molecules was mediated via NF-kB activation and
could be blocked by a specific NF-kB inhibitor. Additional studies indicated that B. henselae-induced effects did
not require living bacteria or Bartonella lipopolysaccharides. Exposure of HUVEC to purified B. henselae outer
membrane proteins (OMPs), however, reproduced all aspects of endothelial cell activation. In conclusion, B.
henselae, the causative agent of cat scratch disease and bacillary angiomatosis, infects and activates endothelial
cells. B. henselae OMPs are sufficient to induce NF-kB activation and adhesion molecule expression followed
by enhanced rolling and adhesion of leukocytes. These observations identify important new properties of B.
henselae, demonstrating its capacity to initiate a cascade of events culminating in a proinflammatory phenotype
of infected endothelial cells.
Bartonella henselae, a gram-negative, fastidious, rod-shaped
bacterium, can cause several human diseases, the most prom-
inent being cat scratch disease, a persistent, necrotizing lymph-
adenitis (2, 4, 38). The domestic cat is the main reservoir of B.
henselae, and the cat flea, Ctenocephalides felis, has been es-
tablished as the vector in cat-to-cat transmission (15). An in-
creasing number of other clinical manifestations such as endo-
carditis, osteolytic lesions, pulmonary nodules, neuroretinitis,
and fever of unknown origin have been documented (1, 7, 11,
24, 43). In immunocompromised patients B. henselae infection
can result in bacillary peliosis hepatitis (BPH). Another typical
Bartonella-related disease is bacillary angiomatosis (BA),
which is characterized by lesions resembling those produced by
Kaposi’s sarcoma (27–29).
Judged from the histology of BPH and BA lesions bacteria
are in direct contact with the endothelium, probably promoting
endothelial cell proliferation and angiogenesis. Therefore, en-
dothelial cells appear to be a specific and unique target of the
genus Bartonella (17). A detailed analysis of bacteria-endothe-
lial cell interaction is vital for understanding the pathophysi-
ology of these Bartonella-induced emerging diseases.
Exposure of endothelial cells to the bacterium has been
shown to result in aggregation, engulfment, and subsequent
internalization of the rods, forming a singular and well-defined
host cellular structure, the invasome (18; for a review see
reference 19), but uptake by phagocytosis has also been de-
scribed (8, 18). B. henselae-related virulence factors and the
target cell reaction upon infection are poorly defined (5, 9, 39).
Rolling and adhesion of circulating polymorphonuclear leu-
kocytes (PMN) to endothelial cells, an early step in an acute
inflammatory reaction, are governed by several adhesion mol-
ecules such as selectins and intercellular adhesion molecule 1
(ICAM-1) (12, 32). Multiple receptor-ligand pairs act sequen-
tially and in an overlapping manner to effect initial attachment,
rolling, firm adhesion, and transmigration of leukocytes. Sev-
eral receptor-ligand interactions are involved in PMN adhe-
sion to activated endothelial cells: interactions between E-
selectin and sialyl Lewis carbohydrate-containing molecules
* Corresponding author. Mailing address: Medizinische Klinik m.S.
Infektiologie, Charite´, Campus Virchow-Klinikum, Humboldt-Univer-
sita¨t, Augustenburger Platz 1, 13353 Berlin, Germany. Phone: 49-30-
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(34, 47), P-selectin and P-selectin glycoprotein ligand 1, and
ICAM-1 and b2-integrins (23).
A prerequisite for expression of E-selectin and other proin-
flammatory mediators is activation and subsequent transloca-
tion of NF-kB, which is involved in the transcription of genes
associated with the immune response (33, 45, 50).
The main objective of this study was to assess the ability of
B. henselae to infect and to activate cultured human endothe-
lial cells. For this purpose we used the first European B.
henselae isolate obtained from BA lesions of a human immu-
nodeficiency virus (HIV)-infected patient (Berlin-1) (3). We
compared this isolate with highly passaged phenotypically and
genotypically indiscernible typing strain ATCC 49882 (Hous-
ton-1). We focused on endothelial signal transduction resulting
in enhanced adhesion molecule expression and PMN-endothe-
lial cell interaction. To further characterize effects induced by
B. henselae (Berlin-1), we also made use of enriched outer
membrane protein (OMP) preparations.
The data presented indicate that B. henselae bacteria as well
as B. henselae-derived OMPs induce an NF-kB-dependent up-
regulation of E-selectin and ICAM-1 in endothelial cells,
which in turn results in enhanced PMN rolling and adhesion.
(This work was done in partial fulfillment of the require-
ments for a Ph.D. by O. Fuhrmann.)
MATERIALS AND METHODS
Materials. Tissue culture plastic ware was obtained from Becton Dickinson
(Heidelberg, Germany) and Nunc (Wiesbaden, Germany). MCDB 131 medium,
Hanks balanced salt solution, phosphate-buffered salt solution (PBS), trypsin-
EDTA solution, HEPES, and fetal calf serum (FCS) were from GIBCO
(Karlsruhe, Germany). Collagenase (CLS type II) was purchased from Worth-
ington Biochemical Corp. (Freehold, N.J.). Specific inhibitor of NF-kB translo-
cation caffeic acid phenethyl ester (CAPE) (40) was obtained from Biomol
(Hamburg, Germany). Tumor necrosis factor alpha (TNF-a) was from R&D
Biosystems (Wiesbaden, Germany). Lipopolysaccharide (LPS) from Salmonella
enterica serovar Abortus equi was a kind gift from C. Galanos, Freiburg, Ger-
many. All other reagents were purchased from Sigma Chemical Co. (Munich,
Germany).
Abs. Purified freeze-dried monoclonal antibodies (MAbs) directed against
E-selectin (1.2B6), vascular cell adhesion molecule 1 (VCAM-1) (1G11), and
ICAM-1 (15.2) were from Dianova (Hamburg, Germany), and horseradish per-
oxidase-conjugated polyclonal sheep anti-mouse immunoglobulin G (IgG) anti-
bodies (Abs) were from Amersham Pharmacia (Freiburg, Germany). All Abs
used were azide free.
Rabbits were inoculated with 3.5 3 107 CFU of heat-inactivated B. henselae
Houston-1 (ATCC 49882) in 1 ml of saline intravenously. Blood was collected 4
weeks postinoculation (p.i.), and serum samples were prepared according to
standard protocols. The titer of Bartonella-specific IgG Abs was measured by
indirect immunofluorescence test of the preinoculation and p.i. serum samples
and found to be ,100 (detection limit) and 10,000, respectively. The hyperim-
mune serum did not show any cross-reaction at a dilution of 1:100 with other
bacterial species tested.
Preparation of HUVEC. Cells were isolated from umbilical cord veins and
identified according to the method of Jaffe et al. (25). Briefly, cells obtained from
collagenase digestion were washed, resuspended, and cultivated in MCDB 131–
10% FCS and seeded into flasks. Confluent monolayers were split once, and
first-passage human umbilical cord vein endothelial cells (HUVEC) were used.
Isolation of human PMN. Heparinized human donor blood was centrifuged in
a discontinuous Percoll gradient to yield a PMN fraction of .97% purity as
previously described (31).
Bacterial strains and growth media. B. henselae strain Berlin-1, isolated from
bacillary angiomatosis lesions of an HIV-infected patient in Germany, has been
characterized previously (3). Low-passage bacteria were grown to logarithmic
phase in brucella broth supplemented with 7% Fildes (Unipath Ltd., Basing-
stoke, United Kingdom) and 250 mg of hemin (EGA-Chemie, Steinhausen,
Germany)/ml.
B. henselae strains ATCC 49882 and ATCC 49793 were obtained from the
American Type Culture Collection (ATCC; Manassas, Va.). They had originally
been isolated from blood of HIV-infected patients. All ATCC Bartonella strains
were grown on Columbia agar (Difco Laboratories, Detroit, Mich.) supple-
mented with 7% defibrinated sheep blood (Oxoid, Wesel, Germany) in a hu-
midified atmosphere at 37°C and 5% CO2.
B. henselae OMP preparation. OMPs were enriched by sarcosyl treatment of
total-membrane preparations (20, 49). Bacteria were grown in supplemented
brucella broth and harvested during the logarithmic phase by 30 min of centrif-
ugation at 3,000 3 g at 4°C. After being washed twice with ice-cold PBS, bacteria
were resuspended in 30 ml of PBS. DNase and RNase (1 mg each) were added
to the solution, followed by sonication (15 cycles at 2 min each; Branson Sonifier;
duty cycle, 50%; output, 5) on ice. To remove residual bacteria, the suspension
was centrifuged for 15 min at 3,000 3 g, followed by additional centrifugation of
the clarified supernatant at 20,000 3 g for 30 min at 4°C (Beckman; J2–21, JA 20
rotor). The pellet was then resuspended in 1 ml of PBS. After that, the suspen-
sion was mixed on ice with 1 ml of sarcosyl (2% in PBS)/ml of pellet. Incubation
for 1 h on ice was followed by centrifugation at 20,000 3 g for 30 min (Beckman;
J2–21, JA 20 rotor). The final membrane pellet, containing enriched OMPs, was
then resuspended in 1 ml of PBS and stored in aliquots at 270°C. Protein
concentration was determined using the Bradford protein assay (6). Ten micro-
grams of protein in an equal volume of sample buffer was heated at 95°C for 3
min and analyzed using sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (SDS-PAGE).
Bartonella infection assay. Prior to infection with B. henselae, HUVEC (pas-
sage 1) were washed three times with MCDB 131 medium without supplements
or antibiotics. Bacterial concentrations were adjusted to 108 bacteria/ml, and
appropriate dilutions were prepared. For infection, bacteria were added in a
bacteria-to-eukaryotic-cell ratio of 50:1 and centrifuged on a HUVEC monolayer
at 1,500 3 g for 5 min. After 2 h plates were washed extensively with plain
medium and subsequently incubated in MCDB 131–2% FCS. Medium was
replaced every 24 h. At times indicated in the figure legends cells were processed
for NF-kB electrophoretic mobility shift assay (EMSA), Northern blotting for
E-selectin and ICAM-1, cell surface enzyme-linked immunosorbent assay
(ELISA), and neutrophil rolling and adhesion assays under defined flow condi-
tions. Where indicated in the figure legends, NF-kB-specific inhibitor CAPE was
added 1 h before bacterial infection. In some experiments, inactivation of B.
henselae was achieved by heating (65°C for 30 min). LPS was inactivated by
addition of 50 mg of polymyxin B/ml immediately before exposure to HUVEC.
Immunofluorescence analysis of B. henselae infection. After stimulation of
HUVEC grown on glass chamber slides (Falcon CultureSlide; Becton Dickinson,
Rutherford, N.J.) with 50 bacteria/endothelial cell for the appropriate time, cells
were fixed with 4% paraformaldehyde for 15 min. Permeabilization of the cell
membrane was achieved by addition of 0.1% Triton X-100 in PBS for 5 min. The
primary polyclonal rabbit anti-B. henselae Ab (1:200) was added for 30 min.
Thereafter cells were washed three times with PBS and exposed to an ALEXA488-
conjugated goat anti-rabbit Ig Ab and/or ALEXA568-phalloidin-conjugated anti-
human F-actin Ig Ab (Molecular Probes, Eugene, Oreg.) for 15 min. After the cells
were washed three times with PBS, coverslips were sealed and examined in an IMT-2
fluorescence microscope (Olympus Optical; equipped with an Olympus OM-4 cam-
era) with an Olympus 603 objective.
Confocal laser scanning microscopy. Confocal laser scanning microscopy was
performed as described by Dehio et al. (18). The samples stained for immuno-
fluorescence were viewed with a TCS NT confocal laser scanning microscope
(Leica Lasertechnik, Heidelberg, Germany) equipped with an argon-krypton
mixed-gas laser. In triple stainings, the three channels were recorded simulta-
neously. The corresponding images were digitally processed with Photoshop,
version 5.0 (Adobe Systems, Mountain View, Calif.).
Preparation of nuclear extracts and EMSA. Nuclear proteins were extracted
as described by Jonat et al. (26). For the NF-kB EMSA, nuclear proteins (1 mg)
were incubated with a 32P-labeled double-stranded consensus oligonucleotide
probe 59-AGT TGA GGG GAC TTT CCC AGGC-39 (sense strand). Briefly,
0.07 pmol of NF-kB consensus oligonucleotides in 10 mM HEPES (pH 7.9)–50
mM KCl–0.2 mM EDTA–2.5 mM dithiothreitol–50 pmol of salmon sperm
DNA–10% glycerol–0.05% NP-40 was incubated with 1 mg of soluble HUVEC
nuclear proteins. The binding reaction was performed for 30 min at room
temperature. Protein-DNA complexes were resolved on 7% native acrylamide
gels run in 5 mM Tris (pH 8.3)–38 mM glycine before vacuum drying and
autoradiography. Specificity was shown by addition of a 20-fold excess of unla-
beled competitor consensus oligonucleotides.
Northern blot analysis. RNA was extracted using the guanidinium isothiocya-
nate method described by Chomczynski and Sacchi (14). Total RNA was quan-
tified by measuring absorbance at 260 nm with a Uvikon 860 spectrophotometer
(Kontron, Neufahrn, Germany). RNA samples (10 mg/lane) were electropho-
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resed on denaturing 1% formaldehyde-agarose gels and transferred onto a
Magna nylon membrane (MSI, Westborough, Mass.) and fixed by exposure to
UV radiation using a Hoefer UVC 500 cross-linker.
cDNA probes were labeled with [a-32P]dCTP (.3,000 Ci/mmol) by random
priming (Rediprime DNA labeling system; Amersham Pharmacia) and added to
the prehybridization chambers at 106 cpm/ml and incubated for 12 to 16 h at
42°C. The E-selectin cDNA probe was a kind gift from D. Simmons (Institute of
Molecular Medicine, Oxford, United Kingdom). The ICAM-1 cDNA probe was
prepared by reverse transcription-PCR with custom-designed primer pair 59-A
AAGGATGGCACTTTCCCAC-39 and 59-TTCCCCTCTCATCAGGCTAGA
C-39 (Amersham Pharmacia). The 598-bp cDNA fragment of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was obtained as previously described (22).
Following hybridization, the filters were washed to a stringency of 0.13 SSC (13
SSC is 0.15 M NaCl plus 0.015 M sodium citrate)–0.1% SDS for 30 min at 55°C.
Membranes were autoradiographed overnight at 270°C by exposure to Hyper-
film MP (Amersham Pharmacia). After exposure, blots were stripped in 50%
formamide–10 mM NaH2PO4 for 1 h at 70°C before subsequent rehybridization.
To account for a difference in loading or transfer of the RNA, hybridization was
performed with a 32P-labeled GAPDH cDNA probe.
Cell surface ELISA for E-selectin and ICAM-1 expression. E-selectin and
ICAM-1 expression on endothelial cells preincubated with B. henselae was de-
termined by cell surface ELISA (46). Confluent pretreated HUVEC monolayers
in 96-well flat-bottom microtiter plates were washed and finally fixed with 4%
paraformaldehyde for 15 min. Human Ig was used to reduce nonspecific binding,
and primary Abs were added for 30 min. Thereafter, cells were washed three
times and exposed to a horseradish peroxidase-conjugated rabbit anti-mouse Ig
Ab for 30 min. After the cells were washed, o-phenylenediamine was added for
5 min. Data are indicated as optical densities at 492 nm.
Neutrophil rolling and adhesion assay under flow conditions. Leukocyte roll-
ing and adhesion were determined using a parallel-plate flow chamber as de-
scribed by Lawrence and Springer (32) and were evaluated as described previ-
ously (30). Confluent endothelial monolayers grown on coverslips (Thermanox;
22 by 60 mm; Nunc) were preincubated with live B. henselae as described above.
A suspension of 3 3 106 leukocytes/ml was perfused through the chamber at a
constant wall shear stress of 1.0 dyne/cm2 (syringe pump sp100i; WPI, Sarasota,
Fla.). The field of observation was chosen randomly, and interactions were
visualized using a phase-contrast video microscope (with a KP-C551 charge-
coupled device color camera; Hitachi, Rodgau, Germany) and videotaped (HR-
S7000EG; JVC, Friedberg, Germany) during the entire time period of leukocyte
perfusion. Images were recorded in real time and played back at six- or ninefold-
slower speed. The tape was paused to mark the locations of cells, and the
displacements of the centers of individual cells were measured 2 to 4 s later.
Rolling was expressed as the number of rolling cells/high-power field during a
3-min observation period (47). Leukocytes were considered to be adherent after
30 s of stable contact with the monolayer. Adhesion was determined after 5 min
of perfusion by analysis of 10 to 12 high-power (403) fields from videotape (32).
Statistical methods. Depending on the number of groups and number of
different time points studied, data were analyzed by a two-way analysis of vari-
ance. Main effects were then compared by an F probability test. A P value of
,0.05 was considered significant.
RESULTS
Infection of HUVEC by B. henselae. During BA, bacteria are
in contact with the endothelium, apparently promoting endo-
thelial cell proliferation and angiogenesis. We exposed
HUVEC to recently described B. henselae strain Berlin-1 (3).
This isolate is phenotypically and genotypically indiscernible
from typing strain ATCC 49882 but differs with respect to its
low passage number and growth conditions. Exposure of
HUVEC to B. henselae Berlin-1 resulted in bacterial adhesion
and internalization. Singular bacteria appeared to be internal-
ized by phagocytosis within 2 h (Fig. 1a). After 24 h of expo-
sure, perinuclear formation of internalized bacteria was ob-
served (Fig. 1b). By 7 days p.i., the internalized bacteria form
a dense area around the nucleus (Fig. 1c), clearly demonstrat-
ing the ability of B. henselae to replicate within endothelial
cells, whereas lysis of cells was not observed. Confocal laser
scanning microscopy (Fig. 1d) clearly demonstrated the intra-
cellular localization of the bacteria and, furthermore, gave
evidence for the internalization of B. henselae Berlin-1 by an
invasome-like mechanism, as described for B. henselae ATCC
49882 and ATCC 49793 (18).
B. henselae induced rolling and adhesion of PMN on
HUVEC. Exposure of HUVEC to B. henselae resulted in a
profound cell activation with subsequently enhanced PMN
rolling and adhesion at 8 h p.i. as determined under flow at a
shear rate of 1 dyne/cm2. B. henselae turned out to be almost as
potent as TNF-a (20 ng/ml), which was used as a positive
control (Fig. 2). In the presence of an anti-E-selectin MAb,
PMN rolling and adhesion on B. henselae-stimulated cells were
reduced by 90%, suggesting that this endothelial adhesion mol-
ecule is central for PMN-endothelium interaction in the early
phase of B. henselae infection. Experiments with anti-ICAM-1
and anti-VCAM-1 antibodies indicated no decrease of rolling
and adhesion of PMN upon blockade of ICAM-1 or VCAM,
underscoring the important role of E-selectin at 8 h p.i.
Bartonella strains ATCC 49882 and ATCC 49793 which have
been passaged frequently induced only a marginal endothelial
cell activation. Similarly, B. henselae Berlin-1 in passage 20 was
only 30 to 40% as active as its low-passage-number parents
(data not shown), suggesting that a high passage number is
accompanied by loss of rolling- and adhesion-inducing prop-
erties. Therefore, low-passage-number B. henselae Berlin-1
was used in the following experiments.
B. henselae increased E-selectin and ICAM-1 expression in
HUVEC. Enhanced rolling and adhesion of PMN on B.
henselae-infected HUVEC were accompanied by an increased
expression of adhesion molecules on the cell surface (Fig. 3a).
E-selectin expression on B. henselae-exposed HUVEC in-
creased at 6 h p.i., peaked at 7 to 12 h, and declined to baseline
after 20 to 24 h. Significant ICAM-1 expression occurred at 20
to 26 h p.i. and persisted for up to at least 6 days after initial
contact with the bacteria. In contrast, control cells showed no
increase in adhesion molecule expression.
Northern blot analysis was performed to study mRNA up-
regulation for E-selectin and ICAM-1 (Fig. 3b). E-selectin
mRNA peaked at 4 to 5 h after B. henselae stimulation, de-
clined to almost baseline after 10 h, and was detectable again
after 36 h. ICAM-1 mRNA increased by 4 h p.i. and remained
elevated for as long as 216 h (9 days).
B. henselae induced NF-kB-dependent adhesion molecule
expression in HUVEC. NF-kB is important for regulation of
the transcriptional activities of E-selectin and ICAM-1, and
multiple NF-kB binding sites have been located in the promot-
ers of the genes for both (21, 36). NF-kB activation and trans-
location were demonstrated by bandshift assays, which indi-
cated the enhanced capacity of NF-kB to bind to the
corresponding consensus oligonucleotides (Fig. 4a). TNF-a
was used as a positive control. Exposure of HUVEC to B.
henselae resulted in NF-kB activation and translocation within
10 min. This signal transiently peaked at 40 min p.i. and re-
mained elevated for at least 72 h (Fig. 4b). Interestingly,
HUVEC stimulated with heat-inactivated bacteria in the pres-
ence of polymyxin B displayed undiminished NF-kB activation,
suggesting that live bacteria and Bartonella LPS are not central
for NF-kB activation in HUVEC (Fig. 4a). Control experi-
ments with a 2- to 20-fold molar excess of cold NF-kB consen-
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FIG. 1. Infection of HUVEC by B. henselae Berlin-1 is shown in double-immunofluorescence experiments. HUVEC were grown on glass
chamber slides and exposed to B. henselae in a bacteria/cell ratio of 50:1. After the appropriate time, cells were fixed with paraformaldehyde and
permeabilized with 0.1% Triton X-100 in PBS. Anti-human F-actin MAbs and anti-B. henselae Abs were added; this was followed by incubation
with fluorescein isothiocyanate (FITC)- or rhodamine-conjugated secondary Abs. At 2 h p.i., singular bacteria were phagocytosed (a). At 24 h p.i.
perinuclear localization of internalized bacteria was evident (b). At 7 days p.i. dense areas of bacteria were visible (c). Representative pictures from
five independent experiments are shown. Magnification, 3540. Specimens were immunocytochemically stained for extracellular bacteria, intra-
cellular bacteria, and the actin cytoskeleton and analyzed by confocal laser scanning microscopy (d). Prior to the permeabilization of the host cell
membranes, extracellular bacteria were labeled with anti-B. henselae antiserum and Texas red-conjugated secondary Abs (II; blue). Following
permeabilization, all bacteria were labeled with anti-B. henselae antiserum and Cy5-conjugated secondary Abs (III; red). The actin cytoskeleton
was stained with FITC-labeled phalloidin to indicate the location of cellular structures (I; green). IV, overlay of all three channels. Intracellular
bacteria appear red due to the absence of a signal in the blue channel. In contrast, extracellular bacteria appear purple as a result of the
superimposition of signals in both the red and blue channels. Arrow, perinuclear localized bacteria; arrowhead, bacterial aggregate within the
invasome. Bar, 10 mm.
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sus oligonucleotide demonstrated the specificity of the shift
(Fig. 4c).
Preincubation of HUVEC with NF-kB-specific inhibitor
CAPE dose dependently reduced E-selectin mRNA and pro-
tein expression in B. henselae-exposed cells (Fig. 4d). The E-
selectin protein level in cells preincubated with CAPE (5 and
25 mM) for 1 h was reduced dose dependently. Similar results
were obtained for ICAM-1, demonstrating that NF-kB is also
a pivotal transcription factor in adhesion molecule expression
in B. henselae-exposed endothelial cells.
Preparation of B. henselae OMPs. The immediate endothe-
lial cell activation by B. henselae, even by dead bacteria, as well
as the data obtained with polymyxin B pointed to OMPs of
Bartonella as key initiators of target cell stimulation.
OMPs of B. henselae Berlin-1 were purified according to a
method described by Welch et al. (49). The sarcosyl fraction
and a total-membrane preparation were analyzed by SDS-
PAGE. Prominent bands of 92, 43, 32, 30, 28, and 23 kDa were
identified (Fig. 5). These OMPs compared very well with those
purified by Burgess and Anderson (9). These authors also
demonstrated specific binding of B. henselae OMPs of 43, 32,
and 28 kDa to endothelial cells, suggesting that these OMPs
represent B. henselae adhesins.
B. henselae OMPs activate endothelial cells. B. henselae Ber-
lin-1 OMPs in the range of 10 pg/ml to 1 mg/ml activated
HUVEC dose dependently, as shown by increased E-selectin
and ICAM-1 protein expression (Fig. 6a). Data on OMP-in-
duced PMN rolling and adhesion resembled the data obtained
for live bacteria (data not shown). OMPs in a concentration of
500 ng/ml were as potent as living B. henselae (compare Fig. 6
and 3) and almost as effective as TNF-a, clearly indicating that
OMPs are a potent stimulus and that intracellular infection of
HUVEC by B. henselae is not required for induction of adhe-
sion molecule expression. Effects of B. henselae OMPs were
not due to LPS, as indicated by Northern blot experiments and
cell surface ELISAs, because polymyxin B was very efficient in
blocking LPS- but not OMP-induced adhesion molecule ex-
pression (Fig. 7a). Furthermore, OMP-related endothelial cell
activation was dose dependently reduced by CAPE, suggesting
that OMPs also acted via NF-kB (Fig. 7a). Bandshift assays
clearly indicate that OMP (500 ng/ml) induced NF-kB activa-
tion and translocation, while LPS (S. enterica serovar Abortus
equi LPS; 50 mg/ml) had only a minor effect. In these experi-
ments TNF-a (20 ng/ml) was used as a positive control (Fig.
7b).
DISCUSSION
This study demonstrates that B. henselae infects and acti-
vates human endothelial cells. B. henselae strain Berlin-1, iso-
lated from a BA lesion of an HIV-infected patient, was used
and was shown to upregulate, via NF-kB translocation, endo-
thelial adhesion molecule expression, followed by increased
rolling and adhesion of human PMN. Endothelial cell activa-
tion was reproduced by exposure to enriched B. henselae
OMPs. These observations identify important new properties
of this pathogen, demonstrating its capacity to initiate a cas-
cade of events culminating in the proinflammatory phenotype
of infected endothelial cells.
B. henselae strain Berlin-1 has previously been characterized
extensively (3). Infection of HUVEC resulted in internaliza-
tion by phagocytosis and subsequent perinuclear localization of
B. henselae. Bacteria seem to slowly replicate within their host
cells, forming a dense area around the nucleus. Lysis of the
endothelial cells could never be observed, even at 7 days p.i. In
addition to phagocytosis of bacteria, we observed invasome-
mediated mechanisms of B. henselae Berlin-1 uptake, as dem-
onstrated by confocal laser scanning microscopy (18). With
respect to endothelial cell infection, Berlin-1 grown in supple-
mented brucella broth turned out to be substantially more
effective in our hands than plated subcultures or typing strains
ATCC 49882 and 49793 on agar plates (data not shown).
Avoidance of high passage number and of growth on solid
media, which may be responsible for potential loss of patho-
genicity, contributed to the high efficiency of B. henselae Ber-
lin-1. In addition, centrifugation of bacteria on HUVEC mono-
layers turned out to be necessary, since exposure without prior
centrifugation stimulated adhesion molecule expression by
only 30%. Moreover, strict use of first-passage human endo-
thelial cells contributed to a reproducible infection and acti-
vation of HUVEC.
FIG. 2. PMN rolling and adhesion on Bartonella-exposed HUVEC
under flow at a shear rate of 1 dyne/cm2. Bacteria were centrifuged on
endothelial cells in four-well plates containing rectangular coverslips.
After 8 h coverslips were processed for a laminar-flow adhesion assay.
PMN (3 3 10 6 per ml) were injected into the flow system and perfused
over endothelial cell monolayers for 5 min using a high-precision
syringe pump. When indicated, cells were preincubated with Abs
against E-selectin, ICAM-1, or VCAM-1 120 min before measure-
ment. TNF-a (20 ng/ml) was used as a positive control. Rolling PMN
(for a definition see Materials and Methods) were counted over a
3-min observation period. Adherent PMN were determined by count-
ing 10 to 12 random high-power fields (see Materials and Methods). B.
henselae Berlin-1 was almost as effective as TNF-a. Note that PMN
rolling and adhesion were almost completely blocked by an anti-E-
selectin MAb. Data are means 6 standard errors of the means of three
separate experiments.
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PMN are known to be important for the control of the early
phase of a bacterial infection. Hence, it is conceivable that
PMN also contribute to the nonspecific resistance to Bar-
tonella, although no studies of Bartonella-infected PMN-de-
pleted animals have been published.
We analyzed the PMN-endothelial cell interaction at a de-
fined shear rate of 1 dyne/cm2 using a parallel-plate flow cham-
ber. This approach allowed the study of PMN rolling and
adhesion under physiological conditions (23, 47). At least two
separate receptor-ligand pairs appear to be involved in the
PMN interaction with infected endothelial cells (23, 34). E-
selectin and ICAM-1 on the endothelium bind to E-selectin
ligand 1 and leukocyte b2-integrins, respectively. These adhe-
sion molecules act sequentially and in an overlapping manner
to effect leukocyte attachment and adhesion (12). At 8 h after
B. henselae infection the PMN-HUVEC interaction was dom-
inated by E-selectin, as shown by E-selectin upregulation and
by anti-E-selectin MAb studies (Fig. 2). No significant de-
crease of rolling and adhesion of PMN was observed upon
blockade of ICAM-1 or VCAM-1. In the later phase of infec-
tion, an indirect PMN stimulation by Bartonella-exposed en-
dothelial cells via E-selectin binding and subsequent upregu-
lation of b2-integrin, which in turn binds to ICAM-1, is
conceivable. This aspect requires further study as does the
question of whether B. henselae directly stimulates PMN.
Moreover, B. henselae-exposed endothelial cells likely support
adhesion of other circulating leukocytes (lymphocytes and
monocytes) which contribute to the specific host defense. Ad-
ditional studies to address the role of VCAM-1 and different
interleukins in the leukocyte-endothelial cell interaction are
required.
B. henselae virulence factors leading to activation and reor-
ganization of the endothelial cells are of major interest, but
unfortunately knowledge about the pathogenic role of Bar-
FIG. 3. (a) Enhanced expression of E-selectin and ICAM-1 in B. henselae-infected HUVEC. Bacteria were added to HUVEC monolayers in
96-well plates by centrifugation at 1,500 3 g in a bacteria-to-cell ratio of 50:1. After 2 h plates were washed three times with fresh medium. After
incubation for another 2 to 144 h, cells were processed for E-selectin or ICAM-1 cell surface ELISA. Note that E-selectin expression peaked at
7 to 12 h, while ICAM-1 increased up to 144 h. Data are means 6 standard errors of the means of four separate experiments. (b) Northern blot
showing increase of E-selectin and ICAM-1 mRNA in B. henselae-infected HUVEC. Total endothelial RNA was isolated, and levels of E-selectin-,
ICAM-1, and GAPDH mRNA were quantitated. Note different time patterns of mRNA expression after B. henselae infection for E-selectin and
ICAM-1 and the remarkably long upregulation of ICAM-1. A representative gel (of four independent experiments) is shown.
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tonella-specific endotoxin, exotoxins, and pili is very fragmen-
tary (5, 39). Conley et al. (17) localized a stimulus for endo-
thelial cell proliferation in the particulate fraction of B.
henselae lysates. In contrast, Maeno et al. (36) suggested a
FIG. 4. (a) B. henselae-induced translocation of transcription factor
NF-kB in HUVEC. An EMSA using a 32P-labeled double-stranded
NF-kB consensus oligonucleotide was performed. Nuclear proteins
were extracted 10 to 180 min p.i. TNF-a was used as a positive control.
Note biphasic NF-kB translocation in B. henselae-exposed HUVEC.
Moreover, note the undiminished NF-kB signal in HUVEC treated
with heat-inactivated polymyxin B (50 mg/ml)-exposed bacteria (right
lane), suggesting that living bacteria and LPS are not central to NF-
kB-translocation. A representative gel (of five independent experi-
ments) is shown. (b) NF-kB upregulation was detected even at 72 h p.i.
(c) Control experiments with a 2- to 20-fold molar excess of an NF-kB
consensus oligonucleotide clearly demonstrate the specificity of the
shift. (d) B. henselae-induced E-selectin and ICAM-1 expression was
dose dependently reduced by NF-kB-specific inhibitor CAPE, as dem-
onstrated by cell surface ELISA. Data are means 6 standard errors of
the means of three separate experiments.
FIG. 5. OMP fractions of B. henselae were characterized by SDS–
10% PAGE and silver staining. Lane 1, sarcosyl-insoluble outer mem-
brane fraction of B. henselae; lane 2, total protein fraction of B.
henselae.
FIG. 6. (a) B. henselae Berlin-1 OMPs in the range of 10 pg/ml to
1 mg/ml dose dependently enhanced E-selectin and ICAM-1 expres-
sion in HUVEC. OMPs were added to cell monolayers in 96-well
plates by centrifugation at 1,500 3 g. After 8 (E-selectin) or 48 h
(ICAM-1) cells were processed for cell surface ELISA. Data are
means 6 standard errors of the means of three separate experiments.
(b) Northern blot showing increase of E-selectin and ICAM-1 mRNA
in HUVEC exposed to OMP, TNF-a (10 ng/ml), and LPS (100 ng/ml)
after 5 h of stimulation. OMPs were added in a concentration of 500
ng/ml. When indicated, polymyxin B (50 mg/ml) was added 5 min prior
to exposure to OMPs or LPS. A representative blot (from one of three
independent experiments) is shown.
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soluble B. henselae-derived growth factor. Garcia et al. (21)
reported on a heat-labile (56°C, 30 min) mitogenic factor of
Bartonella bacilliformis extract.
Burgess et al. (10) demonstrated a 43-kDa OMP to be the
major B. henselae-derived adhesin that specifically interacts
with HUVEC.
Our observation that heat-inactivated B. henselae in the
presence or absence of polymyxin B was still able to induce
NF-kB activation and adhesion molecule expression in
HUVEC suggested the sufficiency of dead B. henselae and the
requirement for a component other than LPS. This study dem-
onstrates for the first time that a purified and enriched outer
membrane fraction of B. henselae can mimic the effects of live
bacteria, indicating a prominent role for OMPs as a pathogenic
factor in B. henselae-induced endothelial cell activation.
At least nine proteins (28, 30, 35, 43, 58, 61, 79, 92, and 171
kDa) were reported to occur in the sarcosyl-insoluble fraction
of B. henselae lysates (9). Five of them (28, 32, 43, 52, and 58
kDa) have been shown to attach to HUVEC, with the 43-kDa
OMP being the predominant adhesin (18). Very recent se-
quence analysis of the 43-kDa OMP by Burgess et al. (10)
revealed a 38% identity to Brucella spp. OMP2b porin.
Sarcosyl fractionation of B. henselae Berlin-1 resulted in the
resolution of proteins with similar molecular masses (23, 28,
30, 43, and 92 kDa). The differences observed are possibly due
to different purification protocols and/or to Bartonella-specific
aspects with regard to piliation, strain, passage number, and
growth and culture conditions. Further studies to characterize
the biological effects of the B. henselae Berlin-1 43-kDa OMP
and the role of pili in activation of endothelial cells are in
progress.
Colonization of host tissues usually is mediated by microbial
adhesins, which facilitate recognition of and binding to specific
receptors of host cells (35, 42, 44). Use of purified OMPs will
help identify endothelial binding sites. ICAM-1 accumulation
at the tips of the endothelial protrusions formed during bac-
terial engulfment was shown by Dehio et al. via confocal mi-
croscopy (18). In this context we propose ICAM-1 as a receptor
candidate for the 43-kDa OMP. For rhinovirus, NF-kB-medi-
ated induction of its own receptor ICAM-1 has been demon-
strated (41).
Data presented indicate that B. henselae triggered immedi-
ate signal transduction cascades in HUVEC. Bacterial attach-
ment was sufficient to initiate this endothelial response; uptake
appeared not to be required. NF-kB is an important regulatory
element in endothelial cell adhesion molecule expression (37,
45). Induction of E-selectin requires NF-kB binding to at least
three of the four positive regulatory domains in the E-selectin
FIG. 7. (a) OMP-induced endothelial adhesion molecule expression was NF-kB dependent and unrelated to LPS. Effects of OMPs (500 ng/ml)
on E-selectin and ICAM-1 expression were compared to those for untreated cells. When indicated, cells were pretreated with 5 or 25 mM CAPE
1 h before exposure to OMPs; this resulted in a dose-dependent reduction of adhesion molecule expression. When indicated, polymyxin B was
added to OMPs or LPS in a concentration of 50 mg/ml. Data are means 6 standard errors of the means of three separate experiments. (b) OMP
induced translocation of transcription factor NF-kB in HUVEC. An EMSA was performed as described in Materials and Methods. Nuclear
proteins were extracted 40 min p.i. TNF-a was used as a positive control. Note the weak NF-kB signal in LPS-exposed HUVEC compared to that
for OMP-treated cells. A representative gel (from three independent experiments) is shown.
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promoter region, a situation similar to that for the ICAM-1
promoter (16, 48). Our study, aimed at identifying the possible
intracellular signaling steps involved, indicated that NF-kB
activation and translocation occurred within 10 to 40 min after
B. henselae exposure to HUVEC. In addition, a specific NF-kB
inhibitor significantly blocked adhesion molecule expression
on the transcriptional level, proving the importance of NF-kB
in the early phase of Bartonella-induced endothelial cell acti-
vation. Moreover, enriched OMPs (500 ng/ml) induced NF-kB
activation and translocation, while LPS (S. enterica serovar
Abortus equi LPS; 50 mg/ml) had only a minor effect. Further
experiments must include B. henselae LPS, which unfortu-
nately has not been purified yet.
In vivo, endothelial cells appear to be a specific target of B.
henselae. In diseases such as BA and BPH bacteria are in
contact with the endothelium, thereby promoting endothelial
cell proliferation and angiogenesis (13). In this context our
observation of prolonged (up to 9 days) upregulation of endo-
thelial adhesion molecule expression might be relevant. Per-
manently adhering leukocytes and release of angiogenic fac-
tors possibly contribute to the vascular lesions described.
The interpretation of our study is limited to cultured human
large-vessel endothelial cells. For a detailed analysis of B.
henselae-related alterations of endothelial function in clinical
disorders it would be desirable to study human microvascular
endothelial cells of different organs, especially of lymph nodes
and dermal capillaries. The isolation and culture of these cells
in sufficient quantities, however, are difficult, and therefore the
applicability of the data presented to clinical disorders such as
cat scratch disease and BA must be verified in further studies.
In conclusion, infection of HUVEC with B. henselae resulted
in internalization and reproduction of bacteria without subse-
quent lysis of the host cell. Bacterial contact immediately led to
NF-kB-dependent upregulation of adhesion molecule expres-
sion and subsequently increased PMN rolling and adhesion.
The proinflammatory endothelial cell phenotype was repro-
duced by exposure of cells to purified Bartonella OMP. The
data presented suggest that B. henselae-induced endothelial
cell activation is an important event in the pathogenesis of
Bartonella-related diseases.
ACKNOWLEDGMENTS
This work was supported by the Deutsche Forschungsgemeinschaft.
We gratefully acknowledge the excellent technical assistance of
Heike Geisel. We thank the staff of the Delivery Services of the
hospitals Lich and Ehringshausen, as well as the Departments of Gy-
necology of Humboldt-Hospital, Berlin-Reinickendorf, and Waldkran-
kenhaus, Berlin-Spandau, for their help in collecting umbilical cords.
REFERENCES
1. Abbasi, S., and P. J. Chesney. 1995. Pulmonary manifestations of cat-scratch
disease; a case report and review of the literature. Pediatr. Infect. Dis. J.
14:547–548.
2. Anderson, B. E., and M. A. Neuman. 1997. Bartonella spp. as emerging
human pathogens. Clin. Microbiol. Rev. 10:203–219.
3. Arvand, M., C. Wendt, T. Regnath, R. Ullrich, and H. Hahn. 1998. Charac-
terization of Bartonella henselae isolated from bacillary angiomatosis lesions
in a human immunodeficiency virus-infected patient in Germany. Clin. In-
fect. Dis. 26:1296–1299.
4. Bass, J., J. M. Vincent, and D. A. Person. 1997. The expanding spectrum of
Bartonella infections. II. Cat-scratch disease. Pediatr. Infect. Dis. J. 16:163–
179.
5. Batterman, H. J., J. A. Peek, J. S. Loutit, S. Falkow, and L. S. Tompkins.
1995. Bartonella henselae and Bartonella quintana adherence to and entry
into cultured human epithelial cells. Infect. Immun. 63:4553–4556.
6. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye bind-
ing. Anal. Biochem. 72:248–254.
7. Breathnach, A. S., J. M. Hoare, and S. J. Eykyn. 1997. Culture-negative
endocarditis: contribution of Bartonella infections. Heart 77:474–476.
8. Brouqui, P., and D. Raoult. 1996. Bartonella quintana invades and multiplies
within endothelial cells in vitro and in vivo and forms intracellular blebs. Res.
Microbiol. 147:719–731.
9. Burgess, A. W., and B. E. Anderson. 1998. Outer membrane proteins of
Bartonella henselae and their interaction with human endothelial cells. Mi-
crob. Pathog. 25:157–164.
10. Burgess, A. W., J. Y. Paquet, J. J. Letesson, and B. E. Anderson. 2000.
Isolation, sequencing and expression of Bartonella henselae omp 43 and
predicted membrane topology of the deduced protein. Microb. Pathog. 29:
73–80.
11. Caniza, M. A., D. L. Granger, K. H. Wilson, M. K. Washington, D. L.
Kordick, D. P. Frush, and R. B. Blitchington. 1995. Bartonella henselae:
etiology of pulmonary nodules in a patient with depressed cell-mediated
immunity. Clin. Infect. Dis. 20:1505–1511.
12. Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion
molecules. Blood 84:2068–2101.
13. Chan, J. K., K. J. Lewin, C. M. Lombard, S. Teitelbaum, and R. F. Dorfman.
1991. Histopathology of bacillary angiomatosis of lymph node. Am. J. Surg.
Pathol. 15:430–437.
14. Chomczynski, P., and N. Sacchi. 1987. Single step method for RNA isolation
by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Bio-
chem. 162:156–159.
15. Chomel, B. B., R. W. Kasten, K. Floyd-Hawkins, B. Chi, K. Yamamoto, J.
Roberts-Wilson, A. Nikos-Gurfield, R. C. Abbott, N. C. Pedersen, and J. E.
Koehler. 1996. Experimental transmission of Bartonella henselae by the cat
flea. J. Clin. Microbiol. 34:1952–1956.
16. Collins, T., A. Williams, G. I. Johnston, J. Kim, R. Eddy, T. Shows, M. A.
Gimbrone, Jr., and M. P. Bevilacqua. 1991. Structure and chromosomal
location of the gene for endothelial-leukocyte adhesion molecule 1. J. Biol.
Chem. 266:2466–2473.
17. Conley, T., L. Slater, and K. Hamilton. 1994. Rochalimaea species stimulate
human endothelial cell proliferation and migration in vitro. J. Lab. Clin.
Med. 124:521–528.
18. Dehio, C., M. Meyer, J. Berger, H. Schwarz, and C. Lanz. 1997. Interaction
of Bartonella henselae with endothelial cells results in bacterial aggregation
on the cell surface and the subsequent engulfment and internalisation of the
bacterial aggregate by a unique structure, the invasome. J. Cell Sci. 110:
2141–2154.
19. Dehio, C. 1999. Interaction of Bartonella henselae with vascular endothelial
cells. Curr. Opin. Microbiol. 2:78–82.
20. Filip, C., G. Fletcher, J. L. Wulff, and C. F. Earhart. 1973. Solubilization of
the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-
lauryl sarcosinate. J. Bacteriol. 115:717–722.
21. Garcia, F. U., J. Wojta, K. N. Broadley, J. M. Davidson, and R. L. Hoover.
1990. Bartonella bacilliformis stimulates endothelial cells in vitro and is an-
giogenic in vivo. Am. J. Pathol. 136:1125–1135.
22. Giembycz, M. A., C. J. Corrigan, J. Seybold, R. Newton, and P. J. Barnes.
1996. Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human
CD41 and CD81 T-lymphocytes: role in regulating proliferation and the
synthesis of interleukin-2. Br. J. Pharmacol. 118:1945–1958.
23. Issekutz, A. C., D. Rowter, and T. A. Springer. 1999. Role of ICAM-1 and
ICAM-2 and alternate CD11/CD18 ligands in neutrophil transendothelial
migration. J. Leukoc. Biol. 65:117–126.
24. Jacobs, R. F., and G. E. Schutze. 1998. Bartonella henselae as a cause of
prolonged fever and fever of unknown origin in children. Clin. Infect. Dis.
26:80–84.
25. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Mimnick. 1973. Culture
of human endothelial cells derived from umbilical veins. Identification by
morphologic and immunologic criteria. J. Clin. Investig. 52:2745–2756.
26. Jonat, C., H. J. Rahmsdorf, K. K. Park, A. C. Cato, S. Gebel, H. Ponta, and
P. Herrlich. 1990. Antitumor promotion and antiinflammation: down-mod-
ulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189–
1204.
27. Koehler, J. E., C. A. Glaser, and J. W. Tappero. 1994. Rochalimaea henselae
infection. A new zoonosis with the domestic cat as reservoir. JAMA 271:
531–535.
28. Koehler, J. E., F. D. Quinn, T. G. Berger, P. E. LeBoit, and J. W. Tappero.
1992. Isolation of Rochalimaea species from cutaneous and osseous lesions
of bacillary angiomatosis. N. Engl. J. Med. 327:1625–1631.
29. Koehler, J. E., M. A. Sanchez, C. S. Garrido, M. J. Whitfeld, F. M. Chen,
T. G. Berger, M. C. Rodriguez-Barradas, P. E. LeBoit, and J. W. Tappero.
1997. Molecular epidemiology of Bartonella infections in patients with ba-
cillary angiomatosis-peliosis. N. Engl. J. Med. 337:1876–1883.
30. Kru¨ll, M., A. C. Klucken, F. N. Wuppermann, O. Fuhrmann, C. Magerl, J.
Seybold, S. Hippenstiel, J. H. Hegemann, C. A. Jantos, and N. Suttorp. 1999.
Signal transduction pathways activated in endothelial cells following infec-
tion with Chlamydia pneumoniae. J. Immunol. 162:4834–4841.
5096 FUHRMANN ET AL. INFECT. IMMUN.
Chapter 1
B-12
31. Kru¨ll, M., C. Dold, S. Hippenstiel, S. Rosseau, J. Lohmeyer, and N. Suttorp.
1996. Escherichia coli hemolysin and Staphylococcus aureus a-toxin potently
induce neutrophil adhesion to cultured human endothelial cells. J. Immunol.
157:4133–4140.
32. Lawrence, M. B., and T. Springer. 1991. Leucocytes roll on a selectin at
physiologic flow rates: distinction from and prerequisite for adhesion
through integrins. Cell 65:859–873.
33. Lewis, H., W. Kaszubska, J. F. DeLamarter, and J. Whelan. 1994. Cooper-
ativity between two NF-kB complexes, mediated by high-mobility-group
protein I (Y), is essential for cytokine-induced expression of the E-selectin
promoter. Mol. Cell. Biol. 14:5701–5709.
34. Ley, K., M. Allietta, D. C. Bullard, and S. Morgan. 1998. Importance of
E-selectin for firm leukocyte adhesion in vivo. Circ. Res. 83:287–294.
35. Lingwood, C. A. 1999. Glycolipid receptors for verotoxin and Helicobacter
pylori: role in pathology. Biochim. Biophys. Acta 1455:375–386.
36. Maeno, N., H. Oda, K. Yoshiie, M. R. Wahid, T. Fujimura, and S. Matay-
oshi. 1999. Live Bartonella henselae enhances endothelial cell proliferation
without direct contact. Microb. Pathog. 27:419–427.
37. Manning, A. M., and C. C. Chen. 1995. Transcriptional regulation of endo-
thelial cell adhesion molecules: a dominant role for NF-kB. Agents Actions
Suppl. 47:135–141.
38. Maurin, M., R. Birtles, and D. Raoult. 1997. Current knowledge of Bar-
tonella species. Eur. J. Clin. Microbiol. Infect. Dis. 16:487–506.
39. Minnick, M. F., S. J. Mitchell, and S. McAllister. 1996. Cell entry and the
pathogenesis of Bartonella infections. Trends Microbiol. 4:343–347.
40. Natarajan, K., S. Singh, T. R. Burke, Jr., D. Grunberger, and B. B. Aggarwal.
1996. Caffeic acid phenethyl ester is a potent and specific inhibitor of acti-
vation of nuclear transcription factor NF-kappa B. Proc. Natl. Acad. Sci.
USA 93:9090–9095.
41. Papi, A., and S. L. Johnston. 1999. Rhinovirus infection induces expression
of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased
NF-kappa B-mediated transcription. J. Biol. Chem. 274:9707–9720.
42. Prasadarao, N. V., C. A. Wass, J. Hacker, K. Jann, and K. S. Kim. 1993.
Adhesion of S-fimbriated Escherichia coli to brain glycolipids mediated by
sfaA gene-encoded protein of S-fimbriae. J. Biol. Chem. 268:10356–10363.
43. Reed, J. B., D. K. Scales, T. M. Wong, C. P. Lattuada, Jr., M. J. Dolan, and
I. R. Schwab. 1998. Bartonella henselae neuroretinitis in cat scratch disease.
Diagnosis, management, and sequelae. Ophthalmology 105:459–466.
44. Scheuerpflug, I., T. Rudel, R. Ryll, J. Pandit, and T. F. Meyer. 1999. Roles
of PilC and PilE proteins in pilus-mediated adherence of Neisseria gonor-
rhoeae and Neisseria meningitidis to human erythrocytes and endothelial and
epithelial cells. Infect. Immun. 67:834–843.
45. Schindler, U., and V. R. Baichwal. 1994. Three NF-kB binding sites in the
human E-selectin gene required for maximal tumor necrosis factor alpha-
induced expression. Mol. Cell. Biol. 14:5820–5831.
46. Schwarzer, N., R. No¨st, J. Seybold, S. K. Parida, O. Fuhrmann, M. Kru¨ll, R.
Schmidt, R. Newton, S. Hippenstiel, E. Domann, T. Chakraborty, and N.
Suttorp. 1998. Two distinct phospholipases C of Listeria monocytogenes in-
duce ceramide generation, nuclear factor-kB activation, and E-selectin ex-
pression in human endothelial cells. J. Immunol. 161:3010–3018.
47. Sriramarao, P., C. R. Norton, P. Borgstrom, R. G. DiScipio, B. A. Wolitzky,
and D. H. Broide. 1996. E-selectin preferentially supports neutrophil but not
eosinophil rolling under conditions of flow in vitro and in vivo. J. Immunol.
157:4672–4680.
48. Vorarberger, G., R. Scha¨fer, and C. Stratowa. 1991. Cloning of the human
gene for intercellular adhesion molecule 1 and analysis of its 59-regulatory
region: induction by cytokines and phorbol ester. J. Immunol. 147:2777–
2786.
49. Welch, D. F., D. M. Hensel, D. A. Pickett, V. H. San Joaquin, A. Robinson,
and L. N. Slater. 1993. Bacteremia due to Rochalimaea henselae in a child:
practical identification of isolates in the clinical laboratory. J. Clin. Micro-
biol. 31:2381–2386.
50. Whitley, M. Z., D. Thanos, M. A. Read, T. Maniatis, and T. Collins. 1994. A
striking similarity in the organization of the E-selectin and beta interferon
gene promoters. Mol. Cell. Biol. 14:6464–6475.
Editor: S. H. E. Kaufmann
VOL. 69, 2001 ADHESION MOLECULE EXPRESSION INDUCED BY B. HENSELAE 5097
Chapter 1
B-13
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 2 
Chapter 2 
The VirB type IV secretion system of Bartonella henselae mediates 
invasion, proinflammatory activation and anti-apoptotic protection 
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The Type IV secretion system (T4SS) VirB of Bartonella was recently identified 
as an essential pathogenicity factor, required to establish intraerythrocytic infection in 
the mammalian reservoir host (Schulein and Dehio, 2002). In this work, we 
investigated the role of the VirB T4SS of B. henselae during endothelial cell infection 
in the incidental human host, using HUVEC as an in vitro model.  
 First, we generated a B. henselae mutant lacking a functional VirB T4SS. A 
nonpolar inframe deletion mutant in virB4 (∆virB4) was constructed and 
complemented in trans with full-length virB4. The ∆virB4 mutant was tested for 
putative attenuation in the capacity to grow in co-culture with, invade into, or survive 
within endothelial cells compared to the wild-type strain. This was monitored by 
gentamicin-protection assays after HUVEC infection with either wild-type or the 
∆virB4 mutant. Thereby the ∆virB4 mutant did not show any attenuation. Next, the 
invasion process of the different B. henselae strains into HUVEC was analyzed by 
immunocytochemistry. Bacteria were internalized by the endocytotic pathway 
independently of the VirB T4SS. In contrast, invasome formation and the 
rearrangement of the actin cytoskeleton were restricted to strains harboring a 
functional VirB T4SS. The efficiency of invasome formation mediated by VirB 
increased with the multiplicity of infection. To test the ability of the different strains to 
activate a pro-inflammatory response after HUVEC infection (Fuhrmann et al., 2001), 
we quantified the activation of the nuclear transcription factor κB (NFκB), the 
expression of the surface adhesion molecule ICAM-1, and the release of the cytokine 
IL-8 during infection. All three markers of the pro-inflammatory pathway showed a 
strong response mediated by the VirB T4SS. However, a slight activation of the pro-
inflammatory pathway was also observed in a VirB-independent manner.  
B. henselae is able to protect HUVEC from apoptotic cell death (Kirby and 
Nekorchuk, 2002). To show inhibition of apoptosis by B. henselae during endothelial 
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cell infection, we monitored several apoptotic markers including executioner 
caspases -3/-7 activity, loss of membrane asymmetry, and DNA-fragmentation. 
Inhibition of apoptosis by B. henselae was strictly dependent on a functional VirB 
T4SS. Finally, we investigated the role of the VirB T4SS in B. henselae-stimulated 
HUVEC proliferation. During a 5-day proliferation assay, both wild-type and the ∆virB 
mutant induced initially HUVEC proliferation.  At later time points, the VirB T4SS 
mediated cytostatic and cytotoxic effects at high bacterial titers. In contrast, the ∆virB 
mutant induced a strong HUVEC proliferation, which was even more potent than that 
observed with vascular endothelial growth factor included as a positive control. We 
conclude that the potent mitogenic activity of B. henselae is VirB-independent and 
that the VirB-mediated cytotoxic effect interferes with the mitogenic activity of  
B. henselae in an infection-dose dependent manner. 
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Summary
 
Bartonella henselae
 
 is an arthropod-borne zoonotic
pathogen causing intraerythrocytic bacteraemia in
the feline reservoir host and a broad range of clinical
manifestations in incidentally infected humans.
Remarkably, 
 
B. henselae
 
 can specifically colonize the
human vascular endothelium, resulting in inflamma-
tion and the formation of vasoproliferative lesions
known as bacillary angiomatosis and bacillary pelio-
sis. Cultured human endothelial cells provide an 
 
in
vitro
 
 system to study this intimate interaction of
 
B. henselae
 
 with the vascular endothelium. However,
little is known about the bacterial virulence factors
required for this pathogenic process. Recently, we
identified the type IV secretion system (T4SS) VirB as
an essential pathogenicity factor in 
 
Bartonella
 
,
required to establish intraerythrocytic infection in
the mammalian reservoir. Here, we demonstrate that
the VirB T4SS also mediates most of the virulence
attributes associated with the interaction of
 
B. henselae
 
 during the interaction with human endot-
helial cells. These include: (i) massive rearrange-
ments of the actin cytoskeleton, resulting in the
formation of bacterial aggregates and their internal-
ization by the invasome structure; (ii) nuclear factor
 
k
 
B-dependent proinflammatory activation, leading to
cell adhesion molecule expression and chemokine
secretion, and (iii) inhibition of apoptotic cell death,
resulting in enhanced endothelial cell survival. More-
over, we show that the VirB system mediates cyto-
static and cytotoxic effects at high bacterial titres,
which interfere with a potent VirB-independent mito-
genic activity. We conclude that the VirB T4SS is a
major virulence determinant of 
 
B. henselae
 
, required
for targeting multiple endothelial cell functions
exploited by this vasculotropic pathogen.
Introduction
 
Bartonella henselae
 
 is a zoonotic pathogen of growing
medical importance. In the feline reservoir host, this
arthropod-borne bacterium causes intraerythrocytic
bacteraemia. Transmission to humans occurs by cat
scratch or bite or the bite of an infected cat flea.
Depending on the immune status of the infected individ-
ual, 
 
B. henselae
 
 can cause a variety of clinical manifes-
tations. Immunocompetent patients develop cat scratch
disease (a necrotizing lymphadenopathy with fever),
endocarditis or neuroretinitis. In immunocompromised
patients, 
 
B. henselae
 
 causes vasoproliferative lesions,
which result in the formation of tumours of the skin or inner
organs (bacillary angiomatosis) or blood-filled cysts in the
liver and spleen (bacillary peliosis) (Karem 
 
et al
 
., 2000).
Among all human pathogenic bacteria, this remarkable
capacity to trigger vasoproliferative tumour growth is
limited to 
 
Bartonella
 
 spp. (Dehio, 2003).
Within vasoproliferative lesions 
 
B. henselae
 
 is found in
close association with proliferating endothelial cells.
Clearance of infection by antibiotic treatment results in
complete regression of vascular lesions. These findings
suggest that 
 
B. henselae
 
 specifically colonizes the vascu-
lar endothelium and produces a mitogenic factor that acts
locally and temporarily. Primary human umbilical vein
endothelial cells (HUVEC) are used as 
 
in vitro
 
 system to
study this interaction with the vascular endothelium
(Dehio, 2001; 2003). 
 
Bartonella henselae
 
 invades and
colonizes HUVEC by two distinct routes, either as individ-
ual bacteria through a classical endocytotic pathway, or
as bacterial aggregates which are formed on the cell
surface, followed by their engulfment and internalization
via the invasome structure. Invasome-formation and inter-
nalization is an actin-dependent process resulting in mas-
sive cytoskeletal rearrangements (Dehio 
 
et al
 
., 1997).
Remarkably, 
 
B. henselae
 
 can stimulate the proliferation
and migration of HUVEC even without direct contact, sug-
gesting that bacteria secrete a vascular mitogen (Maeno
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et al
 
., 1999). Endogenous growth factors (e.g. vascular
endothelial cell growth factor, VEGF) released by
 
B. henselae
 
-infected macrophages 
 
in vitro
 
 may also con-
tribute to endothelial cell proliferation 
 
in vivo
 
 (Kempf 
 
et al
 
.,
2001; Resto-Ruiz 
 
et al
 
., 2002; Dehio, 2003). The proin-
flammatory activation described for 
 
B. henselae
 
-infected
endothelial cells (Fuhrmann 
 
et al
 
., 2001) could contribute
to the recruitment of macrophages and other inflamma-
tory cells competent for secretion of VEGF, which typically
infiltrate vasoproliferative lesions. The nuclear factor
 
k
 
B(NF-
 
k
 
B)-dependent proinflammatory response of
 
B. henselae
 
-infected HUVEC is characterized by cell sur-
face expression of cell adhesion molecules (i.e. ICAM-1
and E-selectin), which result in increased neutrophil
rolling and adherence (Fuhrmann 
 
et al
 
., 2001). Finally,
 
B. henselae
 
 protects HUVEC from apoptotic cell death as
shown by the suppression of caspase activation and DNA
fragmentation. The resulting increased endothelial cell
survival is considered to contribute to the formation of
vasoproliferative lesions 
 
in vivo
 
 (Kirby and Nekorchuk,
2002).
Recently, we have identified the VirB type IV secretion
system (T4SS) as an essential pathogenesis factor in the
related species 
 
B. tribocorum
 
 (Schulein and Dehio, 2002).
T4SS are multicomponent transporters of Gram-negative
bacteria with functions as diverse as the delivery of
effector proteins into eukaryotic target cells in pathogen-
esis or DNA transfer in bacterial conjugation (Christie,
2001). The highly conserved VirB T4SS of 
 
B. tribocorum
 
and 
 
B. henselae
 
 are encoded by operons of 10 genes
(
 
virB2-10
 
) (Padmalayam 
 
et al
 
., 2000; Schulein and Dehio,
2002). Unlike wild-type 
 
B. tribocorum
 
, mutants deleted for
 
virB4
 
 are unable to cause intraerythrocytic bacteraemia
(Schulein and Dehio, 2002), which is the hallmark of infec-
tion in the mammalian reservoir host (Schulein 
 
et al
 
.,
2001). Further analysis revealed that the VirB T4SS is
required at an early infection stage before the onset
of intraerythrocytic bacteraemia (Schulein and Dehio,
2002). Based on the observation that the 
 
virB
 
 operon of
 
B. henselae
 
 is induced during infection of endothelial cells
 
in vitro
 
 (Schmiederer 
 
et al
 
., 2001), we reasoned that the
VirB system may be involved in mediating endothelial
interaction in both the mammalian reservoir and the inci-
dental human host. Here, we used genetic analysis of the
VirB system of 
 
B. henselae
 
 in combination with cell
assays to study the role of this T4SS during HUVEC
infection. We demonstrate that most of the known physi-
ological changes associated with 
 
B. henselae
 
 infection of
HUVEC, i.e. actin remodelling, and the induction of a
proinflammatory and antiapoptotic response are depen-
dent on the VirB system. Moreover, we show that VirB
mediates cytostatic or even cytotoxic effects at high bac-
terial titres, which interfere with the VirB-independent
mitogenic activity of 
 
B. henselae
 
. Together, our data dem-
onstrate that the VirB T4SS represents a major virulence
determinant of 
 
Bartonella
 
 mediating subversion of multi-
ple vascular endothelial cell functions.
 
Results
 
Mutagenesis of the VirB T4SS of 
 
B. henselae
As a genetic basis for analysing the role of VirB in medi-
ating 
 
B. henselae
 
–HUVEC interaction, we constructed an
apolar in frame deletion in the 
 
virB4
 
 gene and comple-
mented the resulting 
 
D
 
virB4
 
 mutant with full-length 
 
virB4
in trans
 
 (
 
D
 
virB4
 
/p
 
virB4
 
). The isogenic wild-type, 
 
D
 
virB4
 
and 
 
D
 
virB4
 
/p
 
virB4
 
 strains were used for parallel infection
in cell assays described below.
 
Course of bacterial growth in endothelial cell co-culture, 
cell invasion, and intracellular survival of wild-type and 
 
D
 
virB4
 
 mutant bacteria
 
We first tested whether the 
 
D
 
virB4
 
 mutant is attenuated in
the capacity to grow in co-culture with, invade into, or
survive within endothelial cells. Therefore HUVEC were
infected with a multiplicity of infection (MOI) of 100 bacte-
ria per cell (MOI = 100) for 0 h, 6 h, 30 h, 54 h and 78 h.
To quantify the total number of cultivatable bacteria in
HUVEC co-culture, the infected cell monolayers were
lysed, and colony forming units (cfu) were determined by
plating of serial dilutions. Figure 1A shows a parallel
course of growth of wild-type and 
 
D
 
virB4
 
 mutant bacteria
over the entire time-course. The number of bacteria
changed little during the first 30 h of infection, but a strong
increase followed at later time points (54 h and 78 h). A
parallel experiment, in which gentamicin was used to kill
extracellular bacteria (gentamicin-protection assay),
determined the course of cell invasion (for time points 0 h,
6 h and 30 h) and intracellular survival (for time-points
30 h, 54 h and 78 h). Figure 1B, lower panel, shows a
similar number of intracellular wild-type and 
 
D
 
virB4
 
 mutant
bacteria at 6 h of infection. The number of intracellular
bacteria strongly increased at 30 h of infection, however,
with significantly more 
 
D
 
virB4
 
 mutant than wild-type bac-
teria. To follow the course of intracellular survival of bac-
teria after 30 h of infection, extracellular bacteria were
killed during a 2 h incubation period with gentamicin (30
to 32 h), followed by washing to remove gentamicin and
incubation with normal medium for the remaining period
of infection (total of 54 h or 78 h). The effectiveness of
gentamicin treatment for killing extracellular bacteria in
these samples is shown in the upper panel of Fig. 1B
(total number of bacteria at 54 h and 78 h). The lower
panel illustrates that wild-type and 
 
D
 
virB4
 
 mutant bacteria
show an equal drop in the number of cultivable intracellu-
lar organisms during one day (1.6-fold reduction at 54 h
versus 30 h), and a further drop till 78 h of infection.
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Taken together, quantification of cfu during HUVEC
infection did not provide any indication of attenuation of
the 
 
D
 
virB4
 
 mutant as compared to wild-type bacteria. The
course of growth in co-culture with HUVEC and of intra-
cellular survival was similar for both genotypes. Notably,
the 
 
D
 
virB4
 
 mutant displayed even an enhanced capacity
for cell invasion compared to wild-type bacteria.
 
VirB is required for invasome-mediated cell entry and the 
associated massive actin rearrangements
 
We next investigated whether VirB is required for bacterial
internalization into HUVEC by either of two described
pathways, via (i) endocytosis of individual bacteria or via
(ii) the invasome-mediated engulfment of large bacterial
aggregates formed on the cell surface (Dehio 
 
et al
 
., 1997).
Human umbilical vein endothelial cells infected for 48 h
were differentially stained for intra- and extracellular bac-
teria and for F-actin and examined by confocal microscopy
(Fig. 2). Bacteria of all isogenic strains were internalized
by conventional endocytosis as shown by intracellular
bacteria localizing to a perinuclear position (Fig. 2B–D,
bottom plane, red-coloured bacteria in the overlay). In
contrast, invasome structures containing a bacterial
aggregate (Fig. 2B and D, top plane) and the associated
ring-shaped actin rearrangements (Fig. 2B and D, bottom
plane) were exclusively triggered by wild-type and 
 
D
 
virB4
 
/
p
 
virB4
 
 bacteria. Infection with 
 
D
 
virB4
 
 did not result in any
obvious cytoskeletal rearrangement compared to the actin
cytoskeleton of uninfected cells (Fig. 2A and C). Quantifi-
cation of invasome-positive cells, infected with three dif-
ferent infection doses (MOI = 30, 100, and 300) of the
three isogenic strains revealed a strict dependency of
invasome formation on a functional VirB system (Table 1).
Invasome formation by the complemented mutant strain
 
D
 
virB4
 
/p
 
virB4
 
 was indistinguishable from wild-type at
higher infection doses, whereas phenotypic restoration
was reduced for the lower bacterial titres (i.e. MOI = 30,
Table 1).
Notably, the impairment of 
 
D
 
virB4
 
 mutant bacteria to
accumulate in an invasome structure resulted in increased
endocytic uptake into perinuclear localizing phagosomes
(Fig. 2B–D, bottom plane, red-coloured bacteria in the
overlay). Given the different time-frames of endocytosis
(minutes) and invasome-mediated invasion (up to one
day) (Dehio 
 
et al
 
., 1997), this finding may explain the
increased number of gentamicin-protected (intracellular)
 
D
 
virB4
 
 mutant versus wild-type bacteria at the 30 h time-
point of infection (Fig. 1C).
Taken together, we observed an absolute requirement
of VirB for invasome formation and the associated mas-
sive actin rearrangements.
 
VirB mediates an NF-
 
k
 
B-dependent proinflammatory 
response
 
We next analysed whether VirB mediates the proin-
flammatory response activated in 
 
B. henselae
 
-infected
 
Fig. 1.
 
Course of bacterial growth in endothelial cell co-culture, cell 
invasion and intracellular survival of wild-type and 
 
D
 
virB4
 
 bacteria. 
Human umbilical vein endothelial cells were infected with wild-type or 
 
D
 
virB4
 
 mutant bacteria. (A, B, upper panel) Total cfu or (B, lower 
panel) gentamicin-protected cfu (only intracellular bacteria) were 
determined after the indicated period of infection. (B) To follow the 
intracellular survival after 30 h of infection, extracellular bacteria were 
killed by gentamicin treatment for 2 h, followed by washing steps and 
further incubation in normal medium for the remaining time of the 
indicated infection period. Mean values 
 
±
 
 SD of triplicate samples are 
presented for one out of two similar experiments.
 
Table 1.
 
Quantification of invasome formation.
Strain
% invasome-positive cells 
 
±
 
 SD
MOI = 30 MOI = 100 MOI = 300
Wild-type 66 
 
± 
 
3 96 
 
± 
 
2 98 
 
± 
 
2
 
D
 
virB4
 
0 
 
± 
 
0 0 
 
± 
 
0 0 
 
± 
 
0
 
D
 
virB4/ pvirB4 26 ± 4 80 ± 3 95 ± 3
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HUVEC (Fuhrmann et al., 2001). As typical markers of an
NF-kB-dependent proinflammatory response, the cell sur-
face expression of ICAM-1 and the secretion of the
chemokine IL-8 into the culture medium were quantified.
Compared to uninfected cells, IL-8 secretion was elevated
by DvirB4 infection in a time-dependent (30 h and 54 h)
and infection-dose dependent manner (MOI = 30, 100 or
300) (Fig. 3A). Infection with wild-type displayed the same
time- and infection dose-dependency, whereas IL-8 levels
were always significantly increased relative to DvirB4. The
complemented mutant displayed partial phenotypic resto-
ration (Fig. 3A), as in results reported above for invasome
formation. Surface expression of ICAM-1 measured at
54 h of infection with a MOI = 100 (Fig. 3B) was in full
accordance with the data obtained for IL-8 secretion. Con-
sistent results were also obtained for the transcriptional
activity of NF-kB in HEK293T cells measured by a trans-
fected luciferase reporter plasmid after 30 h of infection
with a MOI = 100 (Fig. 3C).
Together, these data show that the strong NF-kB-
dependent proinflammatory response triggered by
B. henselae infection is mediated primarily by VirB,
whereas also VirB-independent processes contribute to
this response.
VirB mediates suppression of apoptosis
We next tested whether the VirB system mediates sup-
pression of apoptosis in B. henselae-infected HUVEC
(Kirby and Nekorchuk, 2002). We measured the activity of
executioner caspases-3 and -7 as early apoptotic markers
by using a specific fluorogenic substrate. The basal
Fig. 2. VirB mediates massive actin rearrangements resulting in invasome-mediated uptake of bacterial aggregates. Human umbilical vein 
endothelial cells were infected for 48 h (A) without bacteria (control) or with either (B) wild-type (C) DvirB4, or (D) DvirB4/pvirB4 bacteria. Cells 
were immunocytochemically stained for F-actin (upper left quadrant, green), extracellular bacteria (upper right quadrant, blue), and total bacteria 
(lower left quadrant, red). The overlay of all three channels is presented in the lower right quadrant, distinguishing extracellular bacteria (appearing 
in pink as a mixture of red and blue) from intracellular bacteria (appearing in red). Confocal pictures were taken (A–D) in a plane just above the 
cell substratum where actin stress fibres localize (bottom) or (B, D) in a parallel plane 3 mm above (top). The scale bar represents 10 mm.
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activity of these caspases in uninfected cells, which likely
accounts for a low level of spontaneous apoptosis, was
suppressed by infection with all three bacterial strains at
a MOI = 100 (Fig. 4A). Treatment with the apoptotic
inducer actinomycin D (Kirby and Nekorchuk, 2002)
resulted in an equal increase in caspase-3 and -7 activity
in cells which were either uninfected or infected with
DvirB4. In contrast, infection with wild-type or DvirB4/
pvirB4 resulted in a complete suppression of actinomycin
D-induced caspase activation (Fig. 4B). Suppression of
caspase activation by wild type, but not by the DvirB4
mutant, was consistently seen for the tested range of
infection doses (MOI = 30, 100 and 300, see Fig. 4C).
Consistent with the partial phenotypic restoration of the
complemented mutant DvirB4/pvirB4 reported above, this
strain suppressed caspase activation only at higher infec-
tion doses (MOI = 100 and 300, see Fig. 4C). The analy-
sis of loss of lipid membrane asymmetry (Fig. 4D) and
DNA-fragmentation (Fig. 4E) as late apoptotic markers
also demonstrated that wild-type and DvirB4/pvirB4, but
not DvirB4, efficiently suppress actinomycin D-induced
apoptosis.
We conclude that VirB is strictly required for the anti-
apoptotic activity of B. henselae on HUVEC.
VirB mediates cytostatic and cytotoxic effects at high 
bacterial titres, which interfere with HUVEC proliferation 
stimulated in response to a potent bacterial mitogen
Finally, we investigated whether VirB is involved in
B. henselae-stimulated HUVEC proliferation (Conley
et al., 1994; Maeno et al., 1999). During a 5-day prolifer-
ation assay in serum-containing culture medium deprived
for specific growth factors, the number of uninfected cells
dropped slightly (Fig. 5A and B), likely due to spontaneous
apoptosis. Unexpectedly, we observed that for all infection
doses tested (MOI = 10, 30 or 100) DvirB4 strongly stim-
ulated HUVEC proliferation, resulting in a ~threefold
increase in cell number already on day 3. On day 5 the
~eightfold increase in cell number even surpassed the
effect caused by the potent mitogen VEGF (Fig. 5A and
B). In contrast, infection with wild type or DvirB4/pvirB4 at
the lowest dose tested (MOI = 10) resulted in only a ~two-
fold increase in cell number on day 3 without further
increase till day 5. This indicates that VirB mediates a
cytostatic effect at the elevated bacterial titre reached in
the extended course of this co-cultivation experiment
(compare to Fig. 1A). The higher infection doses
(MOI = 30 or 100) also resulted in a ~twofold increase in
cell number on day 3, whereas cell numbers sharply
dropped at day 5, indicating that at very high bacterial
titres VirB can even mediate cytotoxicity (Fig. 5B). These
data clearly show: (i) that the potent mitogenic activity of
B. henselae is VirB-independent, reaching maximal activ-
ity already at a low infection dose (MOI = 10); (ii) that the
cytostatic and cytotoxic effects caused by B. henselae at
high titre are entirely dependent on VirB, and (iii) that the
VirB-mediated cytostatic/cytotoxic effects interfere with
the activity of the VirB-independent mitogen in an infection
dose-dependent manner.
Discussion
Vasoproliferative tumour lesions developed by patients
infected with B. henselae are the result of a remarkable
interaction between the pathogen and vascular endothe-
lial cells. The use of HUVEC as in vitro model allowed to
differentiate between four prominent changes of endothe-
lial cell function in response to B. henselae infection
(Dehio, 2003), which we have shown here to be all mod-
ulated by the T4SS VirB – the data are summarized sche-
Fig. 3. VirB mediates an NF-kB-dependent proinflammatory pheno-
type. (A, B) HUVEC or (C) HEK293T cells were infected for (A) 30 h 
or 54 h (B) 54 h or (C) 30 h without bacteria (control) or with either 
wild-type, DvirB4, or DvirB4/pvirB4 bacteria with (A) a MOI as speci-
fied (B) MOI = 300 or (C) MOI = 100.
A. IL-8 in the culture supernatants was quantified by ELISA.
B. Cell surface expression of ICAM-1 was determined by flow 
cytometry.
C. NF-kB activity was determined by luciferase activity expressed 
from a transfected NF-kB reporter plasmid. All assays were repeated 
at least three times. Mean values ± SD of triplicate samples are 
presented for one representative experiment.
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Fig. 4. VirB mediates protection of endothelial cells from apoptosis. (A–E) HUVEC were infected for 24 h without bacteria (control) or with wild-
type, DvirB4, or DvirB4/pvirB4 bacteria with an MOI = 100 if not specified differently. Cells were then incubated (B, C, D, right panel of E) with 
actinomycin D to trigger apoptosis or (A, left panel of E) without actinomycin D as control. (A, B) After the time-points indicated or (C–E) after 
12 h the assay was terminated and various markers of apoptosis were assayed. (A–C) Caspase-3 and -7 activities were measured with a specific 
fluorogenic peptide substrate. (D) The loss of membrane asymmetry was quantified by flow cytometry analysis of FITC-annexin V-stained cells. 
Counterstaining with PI allowed differentiation of necrotic cells (upper right quadrant of the dot plot) and apoptotic cells (lower right quadrant). 
The percentages of cells localizing to these quadrants are indicated. (E) DNA fragmentation was measured by ELISA. (A–C, E) Mean values ± 
SD of triplicate samples are presented for one representative out of three replica experiments. (E) Actinomycin D-treated samples differing 
statistically significantly from untreated control samples are marked by an asterisk (P < 0.05) or two asterisks (P < 0.01).
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matically in Fig. 6. (i) The massive cytoskeletal
rearrangements resulting in invasome-mediated uptake of
bacterial aggregates (Dehio et al., 1997) are entirely
dependent on VirB. This unique invasion process com-
petes with bacterial internalization by conventional
endocytosis (Dehio et al., 1997), therefore the DvirB4
mutant impaired in invasome-mediated invasion displayed
increased internalization by the classical endocytic path-
way. Internalization via the VirB-dependent invasome rep-
resents a novel paradigm for the invasion of bacteria into
host cells and may serve as a cellular colonization mech-
anism for endothelial cells associated with the formation
of vasoproliferative lesions (Dehio, 2003). (ii) The NF-kB-
dependent proinflammatory response (Fuhrmann et al.,
2001), considered to contribute indirectly to vasoprolifer-
ative growth (Kempf et al., 2001; Resto-Ruiz et al., 2002;
Dehio, 2003), is activated to a low level by VirB-
independent factors (e.g. LPS), whereas the majority of
this phenotype is clearly contributed by VirB. (iii) The inhi-
bition of apoptosis, which results in increased endothelial
cell survival and thereby directly contributes to vasoprolif-
erative tumour formation (Kirby and Nekorchuk, 2002), is
Fig. 5. VirB mediates cytostatic/cytotoxic effects at high bacterial titres, which interfere with HUVEC proliferation stimulated by a potent VirB-
independent bacterial mitogen. HUVEC in serum-containing medium deprived for specific growth factors were infected for 5 days without bacteria 
(control) or with either wild-type, DvirB4 or DvirB4/pvirB4 at the indicated MOI. VEGF (50 ng ml-1) was used as a positive control.
A. Digital pictures of phase-contrast microscopic fields are illustrated for day 1, 3 and 5 (MOI = 30 for bacterial infections).
B. Graph of the proliferation indices (= cell number on given day relative to day 0, mean ± SD of triplicate samples) for day 1, 3 and 5 is illustrated 
for one representative out of three replica experiments. Proliferation indices which differ statistically significantly from control (day 1) are marked 
by asterisks (one for P < 0.05, two for P < 0.01).
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strictly dependent on VirB. (iv) Mitogenic signalling result-
ing in endothelial cell proliferation (Dehio, 2003) was the
only known physiological change triggered by B. henselae
infection that we could not assign to VirB. However, VirB
turned out to interfere with this proliferative response in
an unexpected manner. Remarkably, DvirB4 elicited a pro-
liferative response at least as strong as that by the potent
mitogen VEGF. HUVEC proliferation was maximal already
at the lowest bacterial infection dose tested (MOI = 10),
whereas even the highest dose (MOI = 100) did not cause
any sign of cytotoxicity. In sharp contrast, both wild type
and DvirB4/pvirB4 caused cytostatic or even cytotoxic
effects in an infection dose-dependent manner, which
masked most of the potent mitogenic activity of
B. henselae. VirB-mediated cytotoxicity was only ob-
served for elevated bacterial titres reached rather late in
the course of a 5-day proliferation assay, which was per-
formed as a co-cultivation experiment as described before
(Conley et al., 1994; Maeno et al., 1999). Modification of
the assay conditions by either daily replacement of the
culture medium to remove an excess of bacteria or anti-
biotic killing of bacteria on day 2 abolished VirB-mediated
cytotoxicity and resulted in a similar proliferation response
elicited by all three isogenic strains (data not shown).
Whether VirB-mediated cytostatic and cytotoxic effects
represent an in vitro artifact because of elevated bacterial
titres or whether they have a physiological role in vivo (e.g.
to control an excessive proliferation response) needs to
be addressed further.
Collectively, our data demonstrate that the VirB T4SS
of B. henselae modulates several fundamentally important
endothelial cell functions in vitro, indicating that it repre-
sents a central virulence factor for establishing chronic
infection of the human vascular endothelium. Our previous
work in the B. tribocorum/rat model showed that VirB is
also required for establishing intraerythrocytic bacter-
aemia – the hallmark of Bartonella-infection in the mam-
malian reservoir (e.g. in the cat for B. henselae) (Schulein
and Dehio, 2002). In this case, VirB is essential for colo-
nizing a yet undefined primary niche in which the patho-
gen gains competence for the subsequent erythrocyte
infection process (Schulein and Dehio, 2002). Circum-
stantial evidence suggests that endothelial cells represent
a major constituent of this primary niche (Dehio, 2003).
Thus, it appears likely that the VirB system represents an
essential virulence determinant for vascular endothelial
cell infection both in mammalian reservoir hosts (i.e. for
establishing intraerythrocytic infection) and in incidentally
infected humans (i.e. for establishing the prominent vas-
cular pathologies). Together with surface expression of
VirB components, such as the immunogenic 17 kDa anti-
gen (Anderson et al., 1995; Padmalayam et al., 2000), this
T4SS system represents an essential surface structure for
pathogenicity and therefore a promising target for vaccine
development.
T4SS of other human pathogens have been recognized
to mediate important virulence features: the Cag system
of Helicobacter pylori stimulates proinflammatory activa-
tion and a motile phenotype of gastric epithelial cells, the
Dot/Icm system of Legionella pneumophila and the VirB
system of Brucella spp. are required for the establishment
of an intracellular replication niche in macrophages (Nagai
and Roy, 2003). However, none of these T4SS has been
associated with an equally wide range of physiological
changes in target cells as we have reported here for the
B. henselae VirB system in vascular endothelial cells.
Crucial for the molecular understanding of VirB function
will be the characterization of effector molecules translo-
cated by this T4SS into infected endothelial cells.
Whereas the VirB system shares striking sequence con-
servation with plasmid conjugal-transfer systems
(Schulein and Dehio, 2002), we have recently identified
several effector proteins translocated by this T4SS into
infected endothelial cells (unpublished data). The knowl-
edge of VirB-translocated effectors and their molecular
function in modifying endothelial cell processes related to
the cytoskeleton, inflammation, apoptosis, and prolifera-
tion would improve our understanding of the infection biol-
ogy of the vasculotropic pathogen B. henselae. Moreover,
these bacterial effectors could provide valuable tools for
the specific manipulation of endothelial cells, and may
allow to uncover novel aspects in vascular biology.
Experimental procedures
Bacterial strains and growth conditions
The bacterial strains and plasmids used in this study are
listed in Table 2. Escherichia coli NovaBlue was used for
cloning steps and the dap– E. coli strain b2150 for plasmid
mobilization to B. henselae (Dehio and Meyer, 1997). Escher-
ichia coli strains were grown at 37∞C overnight in Luria–
Fig. 6. Scheme of the role of the VirB T4SS in mediating B. henselae 
– vascular endothelial cell interaction.
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Bertani broth, supplemented with 50 mg l-1 kanamycin,
25 mg l-1 gentamicin, or 1 mM diaminopimelic acid. Bar-
tonella henselae ATCC 49882T (Regnery et al., 1992) and its
derivatives were grown for 3–7 days on Columbia agar con-
taining 5% defibrinated sheep blood (CBA agar) in a humid-
ified atmosphere with 5% CO2 at 35∞C. The spontaneous
streptomycin-resistant mutant RSE247 obtained by selection
of B. henselae ATCC 49882T on 100 mg l-1 streptomycin
served as wild-type strain. Kanamycin (50 mg l-1) or gentam-
icin (10 mg l-1) were added to select for transconjugants after
mating (Dehio and Meyer, 1997), and 0.5 mM IPTG and
100 mg l-1 streptomycin to select for loss of cointegrates of
the mutagenesis vector (Schulein and Dehio, 2002).
Generation of a VirB in frame deletion mutant and 
complementation in trans
DNA manipulations were carried out by standard procedures
(Sambrook et al., 1989). Plasmid pRS25 used for generating
a DvirB4 mutant was constructed as follows: the BamHI insert
of pRS14 (Schulein and Dehio, 2002) was replaced by a
1060 bp BamHI fragment of the virB locus containing a
2103 bp in frame deletion in virB4. This fragment was con-
structed by megaprime PCR from two PCR products. Product
1 of 0.56 kb was amplified with primers prRS07 and prRS08
and contained the first 123 bp of the virB4 gene and
upstream sequences. Product 2 of 0.50 kb was amplified with
primers prRS09 and prRS10 and contained the last 129 bp
of the virB4 gene and downstream sequences. Megapriming
and PCR amplification with primers prRS07 and prRS10
were performed as described (Schulein and Dehio, 2002).
pRS25 was used to generate the DvirB4 mutant RSE242
in the RSE247 wild-type background by a two-step gene
replacement procedure as recently described for B. trib-
ocorum (Schulein and Dehio, 2002). Polymerase chain reac-
tion with primers prRS285 and prRS286 priming in virB2 and
virB5, respectively, was used to confirm the chromosomal
deletion of virB4 in RSE242.
The virB4 complementation plasmid pvirB4 was con-
structed as follows: a 0.40 kb fragment containing the putative
virB promoter upstream of virB2 was amplified with primers
prRS198 and pRS199. This fragment was digested with ClaI,
filled-in, and ligated with the 4.8 kb vector backbone of plas-
mid pRS20 (Schulein and Dehio, 2002) after digestion with
XhoI and ClaI and fill-in, giving pRS100. A 2.39 kb PCR
fragment containing the complete virB4 gene was amplified
by primers prRS200 and pRS201, digested with XhoI, and
ligated with XhoI-digested pRS100, resulting in pvirB4. pvirB4
was conjugated into RSE242, resulting in the trans-comple-
mented mutant strain DvirB4/pvirB4 (RSE364). For details of
the oligonucleotides used see Table 3.
Table 2. Bacterial strains and plasmids used in this study.
Strain or plasmid Genotype or relevant characteristics Reference or source
B. henselae strains
ATCC 49882T ‘Houston-1’, isolated from a bacteraemic HIV-patient Regnery et al. (1992)
RSE242 DvirB4 mutant of RSE247 This work
RSE247 Spontaneous SmR strain of ATCC 49882T This work
RSE364 RSE242 containing pvirB4 This work
E. coli strains
b2150 F¢ lacZDM15 lacIq traD36 proA + B + thrB1004 pro thi strA hsdS lacZDM15 DdapA::erm
(ErmR) pir
(Dehio and Meyer, 1997)
NovaBlue endA1 hsdR17(r K12–m K12 +) supE44 thi-1 recA1 gyrA96 relA1 lac[F ¢ proA + B + 
lacIqZDM15::Tn10 (TcR)]
Novagen, Madison
Plasmids
pRS14 oriT, oriColE1, gfpmut2, lacIq, rpsL, KmR, mutagenesis vector for Schulein and Dehio (2002)
generating a DvirB4 in-frame deletion in B. tribocorum
pRS20 tra– mob+ GmR, expression vector for virB4 of B. tribocorum Schulein and Dehio (2002)
pRS25 Derivative of pRS14 used to generate a DvirB4 in frame deletion in B. henselae This work
pRS100 pRS20 containing a 0.4 kb fragment carrying the putative virB promoter of B. henselae This work 
pvirB4 Derivative of pRS100 containing full length virB4 of B. henselae This work
Table 3. Oligonucleotides used in cloning steps and verification of chromosomal deletion in B. henselae.
Name Sequencea Restriction site
prRS07 CGGGATCCCGTGTAGGTATTGGCTGGATGT BamHI
prRS08 TACACCTTCAACAACCATCAC
prRS09 TGATGGTTGTTGAAGGTGTAAATGATGAGATCGCCGTC
prRS10 CGGGATCCCGCTCTTCACGCAATTCTTCT BamHI
prRS198 TAGCATCGAT GGATCCGTTTCATTGCCCTTTCGTATT ClaI, BamHI
prRS199 AAGGATCGAT CTCGAGTTATCCTGGATATAGTGTCTGTCAT ClaI, XhoI
prRS200 AAGGCTCGAGGAGGAACTAAACAGGTGAAAC XhoI
prRS201 AAGGCTCGAGTCATTGATTTTCTCTCCTTTG XhoI
prRS285 TTGCTCTTCCATGACAGACACTATATCCAG
prRS286 TTGCTCTTCGTTAAAGTCGGACATCAGATTTC
a. Restriction endonuclease cleavage sites are underlined.
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Cell lines and cell culture
HUVEC were isolated as described (Dehio et al., 1997) and
cultured in EGM medium (PromoCell, Heidelberg, Germany).
The human embryonic kidney cell line HEK293T was cultured
in DMEM medium with Glutamax (Gibco, Carlsbad, CA) con-
taining 10% fetal calf serum (FCS, Life Technologies, Rock-
ville, MD). All cells were maintained at 37∞C in a humidified
atmosphere containing 5% CO2.
Infection assay
Unless otherwise indicated, HUVEC (passage 3–7) were
plated at a density of 2–3 ¥ 104 cells/cm2 in EBM medium
complemented with the ‘Supplement Pack’ except for gen-
tamicin and ampho B (PromoCell). The next day, cells were
washed twice with medium M199 with Earls salts (M199,
Gibco) supplemented with 10% FCS. Unless stated differently,
cells were infected with a MOI = 100 bacteria per cell (Kirby
and Nekorchuk, 2002) in M199/10% FCS and incubated
for the indicated time. If specified, 100 nM actinomycin D
(Sigma-Aldrich, St Louis, MO) was added to trigger apoptosis
as described before (Kirby and Nekorchuk, 2002).
Bacterial growth in HUVEC co-culture and gentamicin 
protection assay
Human umbilical vein endothelial cells seeded in 24-well
plates were infected with a MOI = 100 for the time indicated
and immediately centrifuged at 1200 g for 5 min to associate
bacteria with the cellular surface. To determine the total num-
ber of cultivatable bacteria, samples were directly lysed with
a final concentration of 1% saponin (Roth, Karlsruhe, Ger-
many) in PBS, followed by incubation for 15 min at 37∞C.
Serial dilutions of the cell lysates were plated on CSB-agar
and colony forming units (cfu) were determined. To determine
intracellular bacteria, an incubation with gentamicin sulphate
(125 mg ml-1 in culture medium) for 2 h at 37∞C and two
washing steps were added before lysis with 1% saponin. To
monitor intracellular survival, extracellular bacteria were killed
after 30 h of infection by incubation for 2 h with gentamicin
sulphate (125 mg ml-1 in M199/10% FCS), followed by two
washing steps and further incubation in fresh culture medium.
Immunocytochemistry and quantification of 
invasome-positive cells
Human umbilical vein endothelial cells were infected for
48 h, fixed, and stained for F-actin, extracellular, and total
bacteria as described (Dehio et al., 1997), except that
TRITC-phalloidine was used to label F-actin, and Cy2- and
Cy5-conjugated goat anti-rabbit antibodies (Dianova, Ham-
burg, Germany) to label extracellular and total bacteria
respectively. A Leica TCS NT confocal laser scanning
microscope equipped with an argon/krypton/HeNe mixed
gas laser (Leica Lasertechnik, Heidelberg, Germany) was
used for confocal microscopy.
To quantify invasome-positive cells, stained specimen were
examined under a Leica DM-IRBE inverted fluorescence
microscope using a 10 ¥ objective. Fifty cells for each of three
random microscopic fields were examined for the presence
of invasome structures based on the massive actin-rearrang-
ments and the associated bacterial aggregates and the mean
percentage of invasome-positive cells ± SD was calculated.
Determination of IL-8 secretion and ICAM-1 expression
Human umbilical vein endothelial cells seeded in 6-well
plates were infected with a MOI = 300 for the indicated time.
IL-8 in the culture supernatant was quantified by the human
IL-8 DuoSet ELISA kit (R and D Systems, Minneapolis, MN).
Adherent cells were harvested by mild trypsinization and
resuspended in PBS containing 3% FCS and stained for 1 h
at 4∞C with FITC-conjugated mouse anti-human ICAM-1
polyclonal antibodies (R and D Systems). Stained cells were
analysed with a FACSCalibur flow cytometer (Becton Dickin-
son, Franklin Lakes, NJ).
Caspase activity assay
After infection of HUVEC in 24-well plates for 24 h apoptosis
was induced for the indicated time. Subsequently, a fluoro-
genic assay with the caspase-3 and -7 substrate Ac-DEVD-
amc (Peptide Institute, Osaka, Japan) was carried out as
described (Vercammen et al., 1998). The release of fluores-
cent 7-amino-4-methylcoumarin (amc) was measured by flu-
orometry (excitation at 355 nm, and emission at 460 nm).
Annexin V assay
After infection of HUVEC for 24 h in 6-well plates apoptosis
was induced for 12 h. Cells were then collected by mild
trypsinization and briefly centrifuged together with the culture
supernatant. The cell pellet was washed, resuspended, and
stained with Annexin V Alexa Fluor 488 (Molecular Probes,
Eugene, OR). Propidium iodide (PI, 1 mg ml-1) was added to
counterstain necrotic cells and samples were then analysed
with a FACSCalibur flow cytometer (Becton Dickinson).
Cell death detection ELISA
After infection of HUVEC for 24 h in 6-well plates apoptosis
was induced for 12 h. Then, cells were lysed and the cyto-
plasmic histone-associated DNA oligonucleosome fragments
were quantified by a cell death detection ELISA (Roche Diag-
nostics, Indianapolis, IN).
Measurement of nuclear factor kB activity
HEK293T cells were seeded at 1 ¥ 104 cells/cm2 and on the
next day co-transfected via the calcium phosphate precipita-
tion method with the NF-kB reporter plasmid pconaLuc
(LMBP3248 from the LMBP collection, http://
www.dmb.rug.ac.be/Imbp), containing a luciferase gene
under control of a consensus binding site of NF-kB, and the
control plasmid pEFlacZ (Invitrogen). After 16 h of incubation,
the medium was replaced and cells were infected with a
MOI = 100. Thirty hours later cells were lysed with NP-40
buffer (Denecker et al., 2001) and NF-kB activity was deter-
mined by measuring the luciferase activity present in the cell
extracts by a luminescence reader in counts per second
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(Janssens et al., 2002). Luciferase values were normalized
for differences in transfection efficiency on the basis of b-
galactosidase activity in the same extracts.
Proliferation assay
Human umbilical vein endothelial cells were plated at
4 ¥ 103 cells/cm2 in 6-well plates and infected with different
MOI as indicated. For the following 5 days, the cell number
in each well was determined by capturing digital images
(MicroMAX camera from Princeton Instruments, Trenton,
NJ, with MetaMorph2 software) of three random micro-
scopic fields per well using the 10 ¥ phase-contrast objec-
tive of a Leica DM-IRBE inverted microscope. Cell numbers
were counted for each image and the mean and standard
deviation were calculated for the three microscopic fields
taken per well. The proliferation index was calculated by
dividing the cell number by the mean of the cell number
counted in the same well at the beginning of the experiment
(day 0).
Statistical analysis
All experiments were repeated at least three times with trip-
licate samples. Statistical significance was determined using
Student’s t-test.
Acknowledgements
We thank H. L. Saenz and C. J. Thompson for critical reading
of this manuscript. We are grateful to N. Devaux for excellent
technical assistance. The Bruderholzspital Basel is acknowl-
edged for providing human umbilical cords. This work was
supported by a grant from the Swiss National Science Foun-
dation (3100–061777.00/1) to C.D.
References
Regnery, R.L., Anderson, B.E., Clarridge, J.E., 3rd, Rod-
riguez-Barradas, M.C., Jones, D.C., and Carr, J.H. (1992)
Characterization of a novel Rochalimaea species, R.
henselae sp. nov., isolated from blood of a febrile, human
immunodeficiency virus-positive patient. J Clin Microbiol
30: 265–274.
Anderson, B., Lu, E., Jones, D., and Regnery, R. (1995)
Characterization of a 17-kilodalton antigen of Bartonella
henselae reactive with sera from patients with cat scratch
disease. J Clin Microbiol 33: 2358–2365.
Christie, P.J. (2001) Type IV secretion: intercellular transfer
of macromolecules by systems ancestrally related to con-
jugation machines. Mol Microbiol 40: 294–305.
Conley, T., Slater, L., and Hamilton, K. (1994) Rochalimaea
species stimulate human endothelial cell proliferation and
migration in vitro. J Laboratory Clin Med 124: 521–528.
Dehio, C. (2001) Bartonella interactions with endothelial cells
and erythrocytes. Trends Microbiol 9: 279–285.
Dehio, C. (2003) Recent progress in understanding
Bartonella-induced vascular proliferation. Curr Opin Micro-
biol 6: 61–65.
Dehio, C., and Meyer, M. (1997) Maintenance of broad-host-
range incompatibility group P and group Q plasmids and
transposition of Tn5 in Bartonella henselae following con-
jugal plasmid transfer from Escherichia coli. J Bacteriol
179: 538–540.
Dehio, C., Meyer, M., Berger, J., Schwarz, H., and Lanz, C.
(1997) Interaction of Bartonella henselae with endothelial
cells results in bacterial aggregation on the cell surface and
the subsequent engulfment and internalisation of the bac-
terial aggregate by a unique structure, the invasome. J Cell
Sci 110: 2141–2154.
Denecker, G., Declercq, W., Geuijen, C.A., Boland, A., Ben-
abdillah, R., van Gurp, M., et al. (2001) Yersinia entero-
colitica YopP-induced apoptosis of macrophages involves
the apoptotic signaling cascade upstream of bid. J Biol
Chem 276: 19706–19714.
Fuhrmann, O., Arvand, M., Gohler, A., Schmid, M., Krull, M.,
Hippenstiel, S., et al. (2001) Bartonella henselae induces
NF-kappaB-dependent upregulation of adhesion mole-
cules in cultured human endothelial cells: possible role of
outer membrane proteins as pathogenic factors. Infect
Immun 69: 5088–5097.
Janssens, S., Burns, K., Tschopp, J., and Beyaert, R. (2002)
Regulation of interleukin-1- and lipopolysaccharide-
induced NF-kappaB activation by alternative splicing of
MyD88. Curr Biol 12: 467–471.
Karem, K.L., Paddock, C.D., and Regnery, R.L. (2000) Bar-
tonella henselae, B. quintana, and B. bacilliformis: histori-
cal pathogens of emerging significance. Microbes Infect 2:
1193–1205.
Kempf, V.A., Volkmann, B., Schaller, M., Sander, C.A., Ali-
talo, K., Riess, T., and Autenrieth, I.B. (2001) Evidence of
a leading role for VEGF in Bartonella henselae-induced
endothelial cell proliferations. Cell Microbiol 3: 623–632.
Kirby, J.E., and Nekorchuk, D.M. (2002) Bartonella-
associated endothelial proliferation depends on inhibition
of apoptosis. Proc Natl Acad Sci USA 99: 4656–4661.
Maeno, N., Oda, H., Yoshiie, K., Wahid, M.R., Fujimura, T.,
and Matayoshi, S. (1999) Live Bartonella henselae
enhances endothelial cell proliferation without direct con-
tact. Microb Pathog 27: 419–427.
Nagai, H., and Roy, C.R. (2003) Show me the substrates:
modulation of host cell function by type IV secretion sys-
tems. Cell Microbiol 5: 373–383.
Padmalayam, I., Karem, K., Baumstark, B., and Massung, R.
(2000) The gene encoding the 17-kDa antigen of Bar-
tonella henselae is located within a cluster of genes homol-
ogous to the virB virulence operon. DNA Cell Biol 19: 377–
382.
Resto-Ruiz, S.I., Schmiederer, M., Sweger, D., Newton, C.,
Klein, T.W., Friedman, H., and Anderson, B.E. (2002)
Induction of a potential paracrine angiogenic loop between
human THP-1 macrophages and human microvascular
endothelial cells during Bartonella henselae infection.
Infect Immun 70: 4564–4570.
Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecu-
lar Cloning. A Laboratory Manual, 2nd edn. Cold Spring
Harbor, NY: Cold Spring Harbour Laboratory Press.
Schmiederer, M., Arcenas, R., Widen, R., Valkov, N., and
Anderson, B. (2001) Intracellular induction of the Bar-
tonella henselae virB operon by human endothelial cells.
Infect Immun 69: 6495–6502.
Chapter 2
C-13
92 M. C. Schmid et al.
© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 81–92
Schulein, R., and Dehio, C. (2002) The VirB/VirD4 type IV
secretion system of Bartonella is essential for establish-
ing intraerythrocytic infection. Mol Microbiol 46: 1053–
1067.
Schulein, R., Seubert, A., Gille, C., Lanz, C., Hansmann, Y.,
Piemont, Y., and Dehio, C. (2001) Invasion and persistent
intracellular colonization of erythrocytes. A unique parasitic
strategy of the emerging pathogen Bartonella. J Exp Med
193: 1077–1086.
Vercammen, D., Brouckaert, G., Denecker, G., Van de Craen,
M., Declercq, W., Fiers, W., and Vandenabeele, P. (1998)
Dual signaling of the Fas receptor: initiation of both apop-
totic and necrotic cell death pathways. J Exp Med 188:
919–930.
Chapter 2
C-14
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 3 
Chapter 3 
A bipartite signal mediates the transfer of type IV secretion 
substrates of Bartonella henselae into human cells 
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The VirB type IV secretion system (T4SS) of Bartonella henselae mediates 
subversion of endothelial cell function upon bacterial infection (Schmid et al., 2004). 
In this report, multiple protein substrates of the VirB T4SS were identified and shown 
to mediate all known VirB-dependent cellular changes. In addition, we found a 
bipartite signal conserved in all the substrates, which enables translocation via the 
VirB T4SS into the host cell. By sequencing downstream of the virB locus (virB2-
virB11), we identified a region encoding a putative T4SS coupling protein (virD4) and 
seven assumed translocated effector proteins (∆bepA-G). Together, the 
virB/virD4/bep locus represents a novel pathogenicity island (PAI) encoding 18 
proteins with functions related to the type IV secretion. To asses the contribution of 
VirD4 and the BepA-G to VirB-mediated subversion of host cell function, two 
nonpolar deletion mutants (∆bepA-G and ∆virD4) were generated. Deletion of  
bepA-G or virD4 abolished all previously described VirB-dependent cellular 
phenotypes. These include (i) massive rearrangement of the actin cytoskeleton 
during invasome formation, (ii) anti-apoptotic protection of endothelial cells,  
(iii) activation of a pro-inflammatory response, and (iv) cytostatic/cytotoxic effects 
upon high infection doses.  
To demonstrate translocation of one of the newly identified Bep substrates into 
HUVEC, we monitored the phosphorylation of putative tyrosine–phosphorylation 
motifs found in BepD. Phosphorylation by a host cell tyrosine kinase upon infection 
with B. henselae was only observed for bacteria harboring a functional VirB/VirD4 
T4SS. Next, we delimited the BepD translocation signal using a Cre-recombinase 
reporter assay for translocation (CRAFT) by flow cytometry. Several different  
BepD-Cre fusion proteins were constructed and analyzed in the CRAFT assay. The 
183 aa C-terminus of BepD was efficiently translocated in a VirB/VirD4-dependent 
manner. The data revealed a bipartite translocation signal at the C-terminus, which 
D-1 
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we defined as Bep intracellular delivery (BID) domain and a short positively charged 
tail sequence. This VirB/VirD4 T4SS translocation signal was found to be conserved 
among all seven Beps, and translocation could be demonstrated for BepB, C, D,  
and F. Moreover, a Hidden-Markov model generated from the alignment of all BID 
domains allowed us to identify several conjugative relaxases of α-proteobacterial 
origin which carry such a bipartite translocation signal. Using CRAFT, we exemplary 
confirmed for the relaxase AvhB/TraG, which is part of the T4SS-related conjugation 
system of Agrobacterium tumefaciens, that its bipartite signal is still able to direct 
VirB/VirD4-dependent protein transfer from B. henselae into HUVEC. 
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∆bepB-G deletion mutant, I generated the substrate-free ∆bepA-G mutant of  
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host cell function by the Bartonella effector proteins, i.e. the determination of 
caspase-3/-7 activity (Fig. 1D), cytokine IL-8 secretion (Fig. 1E), and monitoring of 
the cytotoxic/cytostatic effect (Fig. 1F).  
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Bacterial type IV secretion (T4S) systems mediate the transfer of
macromolecular substrates into various target cells, e.g., the con-
jugative transfer of DNA into bacteria or the transfer of virulence
proteins into eukaryotic host cells. The T4S apparatus VirB of the
vascular tumor-inducing pathogen Bartonella henselae causes sub-
version of human endothelial cell (HEC) function. Here we report
the identification of multiple protein substrates of VirB, which,
upon translocation into HEC, mediate all known VirB-dependent
cellular changes. These Bartonella-translocated effector proteins
(Beps) A–G are encoded together with the VirB system and the T4S
coupling protein VirD4 on a Bartonella-specific pathogenicity is-
land. The Beps display a modular architecture, suggesting an
evolution by extensive domain duplication and reshuffling. The C
terminus of each Bep harbors at least one copy of the Bep-
intracellular delivery domain and a short positively charged tail
sequence. This biparte C terminus constitutes a transfer signal that
is sufficient to mediate VirBVirD4-dependent intracellular delivery
of reporter protein fusions. The Bep-intracellular delivery domain
is also present in conjugative relaxases of bacterial conjugation
systems. We exemplarily show that the C terminus of such a
conjugative relaxase mediates protein transfer through the Bar-
tonella henselae VirBVirD4 system into HEC. Conjugative relax-
ases may thus represent the evolutionary origin of the here
defined T4S signal for protein transfer into human cells.
conjugative relaxase  effector protein  endothelial cell  protein
translocation  antiapoptosis
Bacterial type IV secretion (T4S) systems are versatile trans-porters ancestrally related to bacterial conjugation ma-
chines. Present-day functions of T4S systems include (i) DNA
transfer into bacterial or plant cells by cell-to-cell contact, (ii)
protein delivery into mammalian or plant cells by cell-to-cell
contact, (iii) DNA release to or uptake from the extracellular
milieu, and (iv) release of multisubunit protein toxins to the
extracellular milieu (1, 2). The prototypic T4S system for in-
terkingdom substrate transfer is the VirB apparatus (encoded by
virB1–virB11) and associated T4S coupling protein VirD4 of the
phytopathogen Agrobacterium tumefaciens (At). This VirB
VirD4 T4S system mediates transfer of all components of the so
called T-DNA complex, which is composed of protein substrates
(VirD2 and VirE2) and single-stranded DNA (T-DNA), into
plant cells (3). Intracellular delivery of solely protein substrates
subverting host cell function (effector proteins) is considered to
represent the primary function of T4S systems in human patho-
genic bacteria (2). Examples include the Cag system of the gastric
pathogen Helicobacter pylori (Hp), which translocates the CagA
effector protein into gastric epithelial cells (4), and the DotIcm
system of the Legionnaires disease agent Legionella pneumophila
(Lp), which translocates multiple effector proteins into infected
macrophages (5, 6). Although reporter protein fusions with
subdomains of T4S substrates of At VirBVirD4 or Lp DotIcm
have indicated the requirement of C-terminal sequences for
interkingdom protein transfer (5, 7, 8), no conserved T4S signal
has been defined yet (1, 2).
Bartonella henselae (Bh) is a zoonotic pathogen causing a
broad range of clinical manifestations in humans, including
cat-scratch disease, bacillary angiomatosis-peliosis, bacteremia
with fever, and neuroretinitis. Bacillary angiomatosis-peliosis is
characterized by the formation of vasoproliferative tumors,
which result from bacterial colonization and activation of human
endothelial cell (HEC) (9). VirB, a T4S system closely related to
conjugative DNA-transfer systems of -proteobacterial plasmids
(10), is a major virulence determinant of Bh for subversion of
HEC function. VirB-dependent changes of HEC include (i)
massive cytoskeletal rearrangements resulting in cell-surface
aggregation and uptake of large bacterial aggregates by a defined
structure termed the invasome; (ii) induction of a proinflam-
matory phenotype by activation of NF-B, resulting in surface
expression of the cell adhesion molecules ICAM-1 and E-
selectin and secretion of the proinflammatory cytokine IL-8; (iii)
increased cell survival by inhibition of early and late events of
apoptosis (caspase activation and DNA fragmentation, respec-
tively); and (iv) cytostatic or even cytotoxic effects at high
infection doses, which interfers with a potent VirB-independent
mitogenic activity of Bh (11).
Here, we report the identification of the genes encoding the
T4S coupling protein VirD4 and seven putative effector proteins
[Bartonella-translocated effector proteins (Beps) A–G]. We pro-
vide evidence that VirD4 and at least one of the effector proteins
mediates all VirB-dependent phenotypes in HEC. Furthermore,
we exemplarily show BepD to be translocated into HEC in a
VirBVirD4-dependent manner. Based on sequence homology
between all seven Beps, we functionally define the signal for
VirBVirD4-dependent protein transfer and propose its evolu-
tionary origin from conjugative relaxases of bacterial conjuga-
tion systems.
Materials and Methods
Bacterial Strains, Cell Lines, and Growth Conditions. Bh and Esche-
richia coli strains were grown as described in ref. 11, and At C58
was grown on plates containing Luria–Bertani medium plus agar
at 28°C overnight. Table 1, which is published as supporting
information on the PNAS web site, lists all the strains used in this
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: T4S, type IV secretion; Bep, Bartonella-translocated effector protein; Hp,
Helicobacter pylori; Lp, Legionella pneumophila; At, Agrobacterium tumefaciens; Bh,
Bartonella henselae; HEC, human endothelial cell; HUVEC, human umbilical vein endothe-
lial cell; NLS, nuclear localization signal; CRAFT, Cre recombinase reporter assay for trans-
location; PAI, pathogenicity island; gpc, GFP-positive cells; BID, Bep intracellular delivery.
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study. Human umbilical vein endothelial cells (HUVEC) were
isolated and cultured as described in ref. 12. The endothelial cell
line Ea.hy926 resulting from a fusion of HUVEC and the lung
carcinoma cell line A549 were cultured as reported in ref. 13.
DNA Sequencing and Plasmid Construction. Sequencing of the bep
region of BhATCC 49882T was performed from a cosmid library
by using a primer walking strategy, starting with primers used for
the sequencing of virD4 ofBartonella tribocorum (10). Details are
described in Supporting Materials and Methods and Table 2,
which are published as supporting information on the PNAS web
site. The resulting sequence has been deposited in GenBank
under accession no. AJ556988. The nuclear localization signal
(NLS)–Cre–Bep fusion protein-expressing vectors (pRS49–
pRS124), the Cre-sensor vector (pRS56), and the BepD expres-
sion vector (pPG104) were constructed bymultiple cloning steps.
Sequences of oligonucleotides (Table 2), sources of gene cas-
settes, and further details of cloning steps are given in Supporting
Materials and Methods. Briefly, for the expression of NLS–Cre–
Bep fusion proteins in the bacteria, we first constructed pRS40,
which contains the coding sequence for an NLS–Cre fusion
protein under the control of the taclac promoter. Sequences of
interest of the bep genes were amplified from genomic DNA and
cloned into the region encoding the C terminus of the NLS–Cre
gene in pRS40, providing vectors for inducible expression of
NLS–Cre–Bep fusion proteins (pRS49–pRS124). pRS56 was
constructed for generation of cell line Ea.hy926pRS56-c#B1,
and it contains the successive arrangement of a loxH site, a
neomycin phosphotransferase (neo) gene followed by a termi-
nator, a loxP site, and an egfp gene encoding GFP. To express
FLAG-tagged BepD, we first constructed a vector containing
the coding sequence for the FLAG tag following the starting
methionine (MDYKDDDDK) under the control of the taclac
promoter (pPG100). bepD was amplified from genomic DNA
and cloned downstream of the FLAG tag in pPG100, which
yielded pPG104.
Construction of In-Frame Deletions and Complementation of the
Deletion Mutants. In-frame deletion mutants of Bh RSE247 were
generated by a two-step gene replacement procedure as de-
scribed in refs. 10 and 11. The virD4 mutant contains an
in-frame deletion of 1.63 kb in virD4. The bepB–G strain carries
a 14.33-kb chromosomal deletion resulting in a 51-bp cryptic
ORF composed of a 5 sequence of bepB and a 3 sequence of
bepG. To construct the bepA–G strain, a 1.49 kb in-frame
deletion in bepA was introduced into the bepB–G strain, which
resulted in a remaining 144-bp cryptic ORF composed of 5 and
3 sequences of bepA. Further details are provided in Supporting
Materials and Methods.
Fig. 1. The Beps mediate VirBVirD4-dependent invasion, antiapoptotic protection, proinflammatory activation, and control of proliferation of HEC. (A)
Structure of the virBvirD4bep locus encoding the VirB components (VirB2–VirB11), the T4S coupling protein (VirD4), and seven putative effector proteins
(BepA–G). (B) Domain structure of BepA–G. Yellow boxes represent tyrosine-containing sequence repeats resembling tyrosine-phosphorylation motifs (indicated
by Y). (C) VirB4VirD4Bep proteins are required for mediating characteristic actin rearrangements, which result in uptake of Bh aggregates by means of
invasomes. HUVEC infected with the indicatedBh strains were stained for F-actin. (Scale bar, 10m.) (D) VirB4VirD4Bep proteins are required for antiapoptosis.
Caspase-37 activity of HUVEC was measured after infection with the indicated Bh strains for 24 h, followed by induction of apoptosis by actinomycin D for the
indicated times. (E) VirBVirD4Bep proteins are required for NF-B-dependent proinflammatory activation. HUVEC were infected for the indicated time with
the indicatedBh strains, followed by quantification of IL-8 in the culture medium. (F) VirB4VirD4Bep proteins are required for controllingBh-stimulated HUVEC
proliferation. HUVEC infected with the indicated Bh strains were counted at the indicated time points, and proliferation indices were calculated. (D–F) Triplicate
samples  standard deviation.
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Caspase Activity, IL-8 Secretion, and Proliferation. The infection of
HEC and the determination of caspase-3 and caspase-7 activity
[multiplicity of infection (moi)  100], secretion of IL-8 (moi 
300), and cell proliferation (moi  30) were carried out as
described in ref. 11.
Immunocytochemical Stainings and Immunoprecipitation.HECwere
infected with Bh strains, stained for F-actin, total bacteria, and
extracellular bacteria or anti-FLAG M2. To assess the tyrosine
phosphorylation of BepD upon translocation by the T4S system,
Ea.hy926 cells were infected with Bh strains expressing FLAG-
tagged BepD. Cells were subsequently lysed, and the FLAG-
tagged BepD was immunoprecipitated with anti-FLAG agarose
and probed with antiphosphotyrosine antibody in a Western
blot. Experimental details are described in Supporting Materials
and Methods.
Cre Recombinase Reporter Assay for Translocation (CRAFT). CRAFT
(7, 8) was used to monitor the translocation of NLS–Cre–Bep
fusion proteins from Bh into Ea.hy926 cells stably transfected
with pRS56 (clone Ea.hy926pRS56-c#B1). After transport to
the nucleus, the fusion protein recombines two lox sites in
pRS56, thereby excising neo and the terminator, which resulted
in expression of eGFP. Briefly, Ea.hy926pRS56-c#B1 were
infected with Bh strains harboring plasmids containing NLS–
Cre–Bep fusions, trypsinized after 120 h, and analyzed by flow
cytometry. To monitor the stability of NLS–Cre–Bep fusions in
Bh, steady-state protein levels in total lysates of bacteria grown
on isopropyl -D-thiogalactoside-containing medium were de-
termined by immunoblotting with anti-Cre antibodies. Experi-
mental details are described in Supporting Materials and Methods.
Bioinformatic Analysis. The putative C-terminal transfer domains
of Bh BepA–G were aligned by CLUSTALW. The alignment was
further edited manually, and a hidden Markov model was built
thereof. By using this model, we queried the UniProt database
(14) as described in SupportingMaterials andMethods. Sequences
of interest were aligned, and a neighbor-joining tree was gen-
erated as described in Supporting Materials and Methods.
Results
Bh Carries a Pathogenicity Island (PAI) Encoding the VirBVirD4 T4S
System and Seven Putative Protein Substrates.Assuming functional
clustering of the operon encoding the previously described VirB
apparatus (virB2–virB11) (15) with genes encoding further T4S-
related functions, we sequenced 23,294 base pairs that were
downstream of virB11 (Fig. 1A) (GenBank accession no.
AJ556988). Among the 10 genes encoded by this region, only the
distal mviN and trpS are present in the chromosome of related
-proteobacteria, suggesting that these genes belong to the
ancestral core genome (16). A cryptic prophage integrase gene
upstream of mviN indicates that the flanking region may have
been acquired by horizontal gene transfer (16). Based on criteria
defined by Hacker et al. (17), the virB operon and the eight
downstream-located genes may constitute a PAI. The second
gene downstream of virB11 encodes the T4S coupling protein
VirD4. The remaining seven genes of the PAI code for putative
VirBVirD4-translocated effector proteins, which we termed
BepA–G. Sequence analysis revealed a modular domain struc-
ture for BepA–G (Fig. 1B). BepA–C are homologues carrying an
N-terminal filamentation induced by cAMP (Fic) domain, which
is implicated in bacterial cell division (18) and is conserved in
many bacterial species (Fig. 1B and Fig. 5, which is published as
supporting information on the PNAS web site). The N-terminal
regions of BepD–F contain repeated tyrosine-containing pep-
tide sequences that resemble tyrosine-phosphorylation motifs
(e.g., EPLYA, Fig. 1B and Fig. 6, which is published as support-
ing information on the PNAS web site). Strikingly, all Beps share
at least one copy of a domain of 140 aa in their C-terminal
region (Fig. 1B and Fig. 7, which is published as supporting
information on the PNAS web site). This domain was suspected
to be involved in Bep translocation and was thus designated the
Bep intracellular delivery (BID) domain. In addition to the BID
domain, the C termini of BepA–G contain short unconserved
tail sequences rich in positively charged residues, each carrying
a net positive charge (Table 3, which is published as supporting
information on the PNAS web site).
All Known VirB-Dependent Cellular Phenotypes of HEC Require VirD4
and at Least One of the Putative Effector Proteins BepA–G. To test
whether VirD4 and BepA–G contribute to VirB-mediated
virulence, we generated nonpolar in-frame deletion mutants
(virD4 and bepA–G, the latter mutant being constructed by
sequential deletion of bepB–G and bepA) and compared them
with the isogenic virB4 mutant and wild-type strain with
respect to known VirB-dependent phenotypes of Bh-infected
HEC (11). Opposed to wild type, all three deletion mutants
were deficient for triggering (i) the formation of the charac-
teristic F-actin rearrangements associated with invasome-
mediated invasion (Fig. 1C and Table 4, which is published as
supporting information on the PNAS web site), (ii) the inhi-
bition of apoptotic cell death triggered by actinomycin D as
measured by caspase-37 activity (Fig. 1D), (iii) the activation
of an NF-B-dependent proinf lammatory response deter-
mined by quantification of secreted IL-8 in the culture medium
(Fig. 1E), and (iv) cytostaticcytotoxic effects interfering with
the VirB-independent mitogenic activity of Bh as measured by
cell counting (Fig. 1F). We conclude that all known VirB-
mediated phenotypes of HEC require the T4S coupling protein
Fig. 2. BepD becomes tyrosine-phosphorylated after VirB4-dependent
translocation into HEC. (A) VirB4-dependent translocation of BepD into HEC
results in tyrosine phosphorylation and a coincident reduction in electro-
phoretic mobility. Total protein extracts of Ea.hy926 cells uninfected (lane 1)
or infected with virB4 (lane 2), wild type (lane 3), virB4pPG104 (lane 5), or
wild typepPG104 were prepared. FLAG-BepD encoded by pPG104 was im-
munoprecipitated with anti-FLAG antibodies, separated by SDSPAGE, and
immunoblotted with anti-FLAG (Left) or anti-phosphotyrosine antibodies
(Right). (B and C) Immunocytochemical detection of FLAG-BepD after VirB
VirD4-mediated translocation into HEC. Ea.hy926 cells were infected with
wild-type (B) or the virB4 mutant (C), each harboring pPG104. Specimens
were immunocytochemically stained for the FLAG epitope (green), F-actin
(red), and bacteria (blue). (Scale bar, 10 m.)
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VirD4 and at least one of the putative effector proteins
BepA–G. Moreover, these data suggest that most likely all
genes encoded by the virBvirD4bep PAI of Bh have functions
related to T4S.
BepD Is Translocated into HEC in a VirB-Dependent Manner.Next, we
tested whether BepD, one of the three putative substrates for
host cell tyrosine kinases among the Beps (Fig. 1B), becomes
tyrosine-phosphorylated during infection of HEC. Phosphory-
lation by host cell tyrosine kinases was previously used to
demonstrate translocation of bacterial proteins into human cells
(19). We show that FLAG-epitope-tagged BepD becomes ty-
rosine-phosphorylated during HEC infection when expressed in
wild type but not in the virB4 mutant (Fig. 2A Right). Tyrosine
phosphorylation coincided with a prominent shift in electro-
phoretic mobility (Fig. 2A Left), suggesting additional protein
modification. Immunocytochemistry revealed a VirB4-
dependent punctuate staining pattern of FLAG-BepD in the
host cell cytoplasm (Fig. 2 B and C). Together, these data
demonstrate VirB-dependent translocation of BepD into HEC.
Fig. 3. The C-terminal translocation signal of Beps mediates VirBVirD4-dependent protein transfer into HEC. Protein transfer was determined by CRAFT. The
Cre-tester cell line Ea.hy926pRS56-c#B1 was infected with the indicated Bh strains expressing different NLS–Cre fusion proteins (plasmid names are indicated
in blue inA–E or black in F). The region of a given Bep fused to the C terminus of NLS–Cre is specified by the respective first and last amino acids (except for pRS96,
which expresses only NLS–Cre). Percentages of GFP-positive cells as determined by FACS analysis are indicated in red. (A) NLS–Cre fused to the C-terminal 183
aa of BepD translocates efficiently into HEC in a VirBVirD4-dependent manner. Dot blots of forward scatter (FSC) and GFP fluorescence (FL-1) are shown for
the indicated Bh strains. (B) Relative translocation efficiency mediated by the BID domain of BepB, BepC, and BepF. (C) The signal for VirBVirD4-dependent
translocation into HEC is bipartite, composed of the BID domain and an adjacent unconserved C-terminal tail. (D) Creation of an efficient bipartite translocation
signal by fusing a BID domain of BepF and the C-terminal tail of BepD. (E) The C terminus of the relaxase TraA of At plasmid pATC58 contains a BID domain and
mediates efficient protein transfer from Bh into HEC. (F) Steady-state NLS–Cre fusion protein levels in Bh grown on isopropyl -D-thiogalactoside-containing
medium.
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Delineation of the Bipartite T4S Signal of the Beps. To delimit the
BepD translocation signal and to demonstrate translocation of
other Beps, we adapted CRAFT, a reporter assay originally
designed to detect translocation of bacterial effector proteins
into plant cells (8) (Fig. 3A and Fig. 8, which is published as
supporting information on the PNAS web site). After infection
of the Cre-tester cell line Eahy.926pRS56-c#B1 with Bh strains
expressing NLS–Cre–recombinase fusion proteins, the percent-
age of GFP-positive cells (gpc) as determined by FACS analysis
was used as a relative measure for the efficiency of protein
transfer from Bh into HEC. Expression of an NLS–Cre–
recombinase fusion protein in wild-type Bh resulted in 0.0% gpc
and was thus negative in this assay (Fig. 3A, pRS96). In contrast,
NLS–Cre fused to the C-terminal 183 aa of BepD (BID domain
plus a short positively charged tail sequence, pRS51) was effi-
ciently translocated from wild-type (11.8% gpc) and bepA–G
(3.0% gpc), whereas no translocation occurred from virB4 or
virD4 strains (0.0% gpc) (Fig. 3 A and F). Hence, this heter-
ologous fusion protein was translocated in a VirB4VirD4-
dependent, and essentially Bep-independent, manner. Similar as
for BepD, NLS–Cre fusions to the BID domain-containing C
terminus of BepB, BepC, and BepF were translocated into HEC,
albeit at lower frequency (Fig. 3 B and F). Taken together, we
provide evidence for a functional T4S signal in the C terminus
of four Bep proteins (BepB, BepC, BepD, and BepF).
To further delimit the T4S signal contained in the 183-aa
C-terminal fragment of BepD, we performed a deletion analysis
(Fig. 3C and F). C-terminal deletion of 20 aa of the short positively
charged C-terminal tail sequence almost completely abolished
translocation (0.1% gpc). Stepwise deletion of the BID domain
from theN terminus resulted in a gradual reduction of translocation
efficiency. Together, these data suggest a bipartite translocation
signal at the C terminus, composed of a BID domain and a short
positively charged tail sequence. As illustrated in Fig. 3D, this
notion was supported by the success in creating an efficient trans-
location signal (1.9% gpc) via fusion of a translocation-inefficient
BID domain of BepF (0.1% gpc) with the translocation-deficient
positively charged tail of BepD (0.0% gpc). Notably, all NLS–Cre–
Bep fusion proteins analyzed by CRAFT displayed comparable
steady-state protein levels in bacteria (Fig. 3F), indicating that the
low translocation efficiency observed for several fusion proteins
does not result from protein instability but rather reflects the
absence of an appropriate T4S signal.
Identification of BID Domains in Conjugative Relaxases and Demon-
stration of Their Function As T4S Signal for the Bh VirBVirD4 System.
To search for other proteins containing a BID domain, we
queried the UniProt database with a hidden Markov model (20)
generated from an alignment of all BID domains of BepA–G
(Fig. 7 and Table 5, which is published as supporting information
on the PNAS web site). Among the 40 top hits are 27 hits within
putative T4S substrates. These hits include BepA–G of Bh and
their homologues in Bartonella quintana, annotated as hypothet-
ical proteins in the recently published genome sequences (16), as
well as Fic-1, which is a BepA homologue in Bartonella triboco-
rum (10). The other hits in putative T4S substrates are all in
relaxases of conjugative plasmids found in various -proteobac-
teria. The plasmid-borne conjugation systems associated with
these conjugative relaxases are closely related to each other as
well as to the Bh VirBVirD4 system (10), as indicated by
clustering in one clade of a phylogenetic tree for VirD4TraG-
like T4S coupling proteins (Fig. 4, cluster A). Interestingly, no
BID domain was found in protein substrates of agrobacterial
T-DNA transfer systems (VirBVirD4), which cluster in a
separate clade of the VirD4TraG phylogram (Fig. 4, cluster B),
or in the T4S substrates of Lp or Hp. For the AvhBTraG
conjugation system of At plasmid pAtC58 (21), we show that the
C terminus of its relaxase harbors a BID domain and a positively
charged tail sequence, which efficiently directs VirBVirD4-
dependent protein transfer from Bh into HEC (Fig. 3E,
pRS114), whereas the positively charged tail alone did not result
in detectable transfer activity (Fig. 3E, pRS115). These data
suggest that the Bh VirBVirD4Bep protein transfer system
evolved rather recently from one of the wide-spread conjugative
plasmid-transfer systems in -proteobacteria and that the bipar-
tite transfer signals in the substrates of these T4S systems are
functionally interchangeable.
Discussion
In this study, we characterized a PAI encoding presumably all
proteins related to the function of a pathogenesis-related T4S
system in Bh. In addition to the previously described T4S
apparatus VirB (VirB2–VirB11) (11, 15), this PAI encodes the
T4S coupling protein, VirD4, and seven T4S substrates termed
BepA–G. Deletion of either virD4 or the complete set of bep
genes (bepA–G) resulted in a similar phenotype as that described
for deletion of virB4 (11); i.e., these mutants are deficient for
subverting multiple HEC functions related to the cytoskeleton
and to inflammation, apoptosis, and proliferation. The essential
role of VirD4 for mediating VirB-dependent host cellular
changes is consistent with the proposed function as T4S coupling
protein, representing the interface between the T4S apparatus
and the translocated substrates (1). The loss of all known
VirBVirD4-dependent HEC changes in the bepA–G mutant
indicates that BepA–G may comprise the complete set of
VirBVirD4-translocated effector proteins. Preliminary data
Fig. 4. The coupling proteins (VirD4TraG) of T4S systems containing a BID
domain in their protein substrate(s) form a distinct phylogenetic cluster. This
cluster is formed by Bartonella VirBVirD4 systems and -proteobacterial
conjugative DNA transfer systems (cluster A) and does not contain agrobac-
terial T-DNA transfer systems (cluster B). VirD4TraG protein sequences were
extracted from the Uniprot database and then aligned and diagrammed as an
unrooted neighbor-joining radial tree. T4S systems containing a BID domain
in one of their substrate(s) are marked in bold (compare with Table 5). The
following sequences (with corresponding accession numbers) are included.
At: plasmid pAT (Q8UKJ4), pTiC58 (Q44346 and P18594), pTiA6NC (Q44360
and P09817), pRi1724 (Q9F5E3 and Q9F585), pTi15955 (Q8VLK3), and
pTiAB273 (Q8VT85); Agrobacterium rhizogenes: pRiA4b (Q93UY7 and
P13464); Bh (Q6G2A8); Bartonella quintana (Q6FYV9); Bartonella tribocorum
(Q8GJ55); Escherichia coli: pKM101 (Q46706) and R388 (Q04230); Hp
(Q75XB9); Lp (Q9RLR2); Oligotropha carboxydovorans (Q6LB53); Rhizobium
etli: p42d (Q8KL68);Rhizobiummeliloti: pSymA (Q92ZI3); andRhizobium spp.:
pNGR234a (P55421).
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from our laboratory suggest that the specific contribution of
individual Beps to the complex VirBVirD4-dependent pheno-
typic changes of HEC can be assessed by their expression, either
alone or in combination, in the effector-free bepA–G mutant
background (M.C.S., P.G., and C.D., unpublished data).
The recently published comparative genome analysis of Bh
and Bartonella quintana revealed that the virBvirD4bep PAI
characterized herein is present in both Bartonella genomes but
not in any other published genome sequence. However, in
contrast to the highly conserved virBvirD4 loci, the bep loci
display a high degree of plasticity, including signatures of gene
duplication and degradation (data not shown) as well as intra-
genic domain duplication and intragenic or intergenic domain
reshuffling (Fig. 1B). As a result, the domain structure of the
Beps is highly modular. The N termini of BepA–C are composed
of a domain (Fic) conserved in many bacterial species that is
considered to be involved in cell division (18). The N termini of
BepD–F contain short repeated peptide sequences containing
conserved putative tyrosine phosphorylation motifs (i.e.,
EPLYA) similar to the EPIYA motif of the CagA effector
protein of Hp known to be phosphorlyated by human Src-family
kinases (4, 22). Consistently, we show BepD to become tyrosine-
phosphorylated upon T4S-dependent transfer into HEC. Taken
together, the N termini of the Beps are highly divergent and may
primarily serve effector functions within HEC. In the C-terminal
region of all Beps, we could define at least one copy of a 142-aa
domain called BID. An unconserved, positively charged tail
sequence at the C terminus and the proximal BID domain was
shown here to represent a bipartite T4S signal that mediates
VirBVirD4-dependent protein transfer into HEC. This finding
is in agreement with a requirement of C-terminal sequences for
interkingdom transfer of T4S substrates of At and Lp (5, 7, 8).
A hidden Markov model of the BID domain alignment from
Bh allowed us to search for other proteins containing a similar
domain. A large proportion of the top hits were indeed within
putative T4S substrates, including all Bep homologues of bar-
tonellae as well as the conjugative relaxases of plasmid-borne
bacterial conjugation systems present in various -proteobacte-
ria. Conjugative relaxases direct the transfer of plasmid DNA by
first cleaving and covalently attaching to one DNA strand,
followed by transport of the resulting protein–DNA conjugate by
the plasmid-encoded T4S system (23). In this process, the
specific interaction between the relaxase and the T4S coupling
protein is thought to initiate the transport through the mem-
brane-spanning T4S channel (24). The BID domain has likely
evolved in the relaxases of -proteobacterial conjugation systems
before horizontal transfer occurred into a progenitor of Bar-
tonella. A phylogenetic analysis of the T4S coupling proteins
(VirD4TraG) of representative T4S systems indeed revealed
that the coupling proteins of T4S systems with a BID domain in
their substrate(s) form a distinct cluster. This finding suggests
coevolution of the coupling protein and the T4S signal, which is
consistent with the finding that coupling proteins and T4S
substrates physically interact (24–26). The absence of a BID
domain in the substrates of other T4S systems (e.g., of the
agrobacterial VirBVirD4 system, the Hp Cag system, and the
Lp DotIcm system) suggests that a different signal mediates
protein transfer by these T4S systems.
We show that the BID domain and short positively charged
C-terminal tail of the conjugative relaxase (TraA) of the At
pAtC58 conjugation system AvhBTraG is functional for medi-
ating VirBVirD4-dependent protein transfer from Bh into
HEC. The T4S signals of these related T4S systems involved
either in interbacterial DNA transfer or interkingdom protein
transfer are thus interchangeable. This finding makes it tempting
to speculate that conjugative relaxases are also transported by
the Bh VirBVirD4 system into HEC when they are covalently
attached to their single-stranded DNA substrate, similar to the
interkingdom DNA transfer by the At VirBVirD4 system into
plant cells. T4S-mediated DNA transfer from virulence-
attenuated Bh in human cells could have important applications
for gene therapy and vaccination and should thus be an inter-
esting subject for future investigations.
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The antiapoptotic activity of Bartonella henselae during endothelial cell 
infection is dependent on a functional VirB/VirD4 T4SS (Schmid et al., 2004). In this 
study, the Bartonella effector protein A (BepA) was identified as a VirB/VirD4-
translocated substrate that mediates the inhibition of apoptosis in HUVEC. To 
demonstrate this, a nonpolar ∆bepA mutant was constructed, which no longer 
showed the known anti-apoptotic effect. We were able to restore this phenotype by 
complementation in trans. BepA homologues of different Bartonella species were 
cloned into complementation plasmids and their ability to inhibit apoptosis was 
monitored by caspase-3/-7 assays. Thereby, only BepA homologues from Bartonella 
species known to induce angioproliferative tumor formation were able to protect 
endothelial cells from apoptosis. To demonstrate translocation of the two putative 
effector proteins BepA from B. henselae and B. quintana into HUVEC, we used the 
calmodulin-dependent adenylate cyclase (cya)-reporter assay. Translocation of the 
anti-apoptotic BepA from B. henselae and B. quintana into the host cell was confined 
to the C-terminus and was dependent on a functional VirB/VirD4 T4SS.  
To delineate the functional domain of BepA required to inhibit apoptosis, we 
constructed different GFP-BepA fusion proteins. These fusion proteins were 
ectopically expressed in HUVEC and the apoptotic cell population was then 
determined. We identified a 140 aa domain of BepA, which is sufficient to inhibit 
apoptosis in HUVEC. This domain corresponds to the conserved BID domain of 
BepA. Next, we investigated the subcellular localization of BepA in the host cell. 
Different GFP-BepA fusion constructs were expressed in HUVEC and samples were 
analyzed by immunocytochemistry. We found that BepA associates to the 
cytoplasmic membrane of the host cell. Interestingly, only anti-apoptotic GFP-BepA 
fusion constructs associated to the membrane. 
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To enlighten the mechanism of inhibition of apoptosis by BepA, we 
incorporated microarray data obtained for the transcriptome of HUVEC infected with 
wild-type versus the ∆virB4 mutant. These revealed a VirB-dependent upregulation 
of NFκB and the cAMP/CREM/CREB regulon in infected endothelial cells. We tested 
whether these pathways were specifically activated by anti-apoptotic BepA 
homologues. The NFκB pathway did not show any specific activation by anti-
apoptotic homologues of BepA. However, the upregulation of cAMP-regulated gene 
expression and the increased intracellular cAMP level correlated with the property of 
BepA to inhibit apoptosis. As artificially elevated cAMP levels protected endothelial 
cells from apoptosis, these data indicate that BepA mediates anti-apoptosis of 
endothelial cells by heightening cAMP levels by a plasma membrane-associated 
mechanism. Furthermore, expression of BepA in endothelial cells resulted in a 
significantly increased resistance to cytotoxic T-lymphocytes mediated cell death. 
Our results indicate that BepA, a novel T4S effector protein, plays a crucial role 
during the formation of vascular tumors.  
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Abstract  
The modulation of host cell apoptosis by bacterial pathogens is of critical importance 
for the outcome of the infection process. The capacity of Bartonella henselae (Bh) and 
Bartonella quintana (Bq) to cause vascular tumor formation in immunocompromized patients 
is linked to the inhibition of vascular endothelial cell (EC) apoptosis. Here, we show that 
translocation of BepA, a type IV secretion (T4S) substrate is necessary and sufficient to 
inhibit EC apoptosis. Ectopic expression in EC allowed mapping the anti-apoptotic activity of 
BepA to the BID domain, which as part of the signal for T4S is conserved in other T4S 
substrates. The anti-apoptotic activity appeared to be limited to BepA orthologs of Bh and Bq 
and correlated with (i) protein localization to the host cell plasma membrane, (ii) elevated 
levels of intracellular cAMP, and (iii) increased expression of cAMP-responsive genes. The 
pharmacological elevation of cAMP levels protected EC from apoptosis, indicating that BepA 
mediates anti-apoptosis by heightening cAMP levels by a plasma membrane-associated 
mechanism. Finally, we demonstrate that BepA mediates a marked protection of EC against 
cell death triggered by CTL, suggesting a physiological context in which the anti-apoptotic 
activity of BepA contributes to tumor formation in the chronically infected vascular 
endothelium.   
 
Word count: 200 
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Introduction 
Bacterial pathogens have developed various strategies to subvert host cell functions to 
their benefit. Especially intracellular bacteria adapted mechanisms to modulate the apoptotic 
pathway of their host cells (1). The resulting induction or inhibition of apoptosis is often 
crucial for a successful infection of the host. Pathogen-induced apoptosis can serve to 
eliminate key immune cells or to evade other host defenses (1). Several bacteria elicit an 
inflammatory process by inducing a specific form of apoptotic cell death, which at the place 
of infection leads to the disruption of tissue barriers and thus may secure efficient microbial 
spread in the host (2, 3). In contrast, inhibition of apoptosis may be essential for intracellular 
pathogens to establish chronic infection. Pathogen-triggered anti-apoptosis of infected host 
cells facilitates a slow microbial replication process and enables persistence in the infected 
host. For example, the obligate intracellular pathogen Chlamydia pneumoniae degrades by an 
unknown effector mechanism pro-apoptotic BH-3 host cell proteins (4). Rickettsia rickettsii 
protects invaded host cells from apoptosis by activating an NFκB-dependent survival pathway 
(5). For many human pathogens, the activation and inhibition of the apoptotic machinery of 
the infected host cell thus has a central role during the infection process (1).  
The bacterial effectors known to modulate apoptosis are mostly pro-apoptotic. The 
only described anti-apoptotic effector is the outer membrane protein PorB of Neisseria 
meningitis (6). PorB has been shown to interact with mitochondria, where it is thought to 
block apoptosis by preventing mitochondrial depolarization and cytochrome C release. 
Interestingly, opposite effects were reported for the PorB ortholog of Neisseria gonorrhoea, 
which provokes a pro-apoptotic effect upon interaction with mitochondria (7, 8).  
Bartonellae are facultative intracellular pathogens associated with the formation of 
vasoproliferative tumors in humans (e.g. bacillary angiomatosis, bacillary peliosis, and 
verruga peruana) (9). These vascular lesions consist of an increased number of EC, which are 
colonized by extracellular and intracellular bacteria. Although at least nine Bartonella species 
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are known to infect humans, vascular proliferation is mainly caused by the species Bh, Bq, 
and B. bacilliformis (9). Upon EC infection in vitro, Bh and Bq are able to stimulate 
proliferation and inhibition of apoptosis (9-11). The anti-apoptotic activity of bartonellae is 
considered to contribute synergistically to an unrelated mitogenic activity and results in the 
formation of vascular tumors (10, 11).  
In Bh, inhibition of apoptosis is dependent on a functional VirB/VirD4 system (12, 
13). This T4S system is a major virulence determinant for Bartonella-EC interaction (12-14). 
T4S systems are versatile transporters ancestrally related to bacterial conjugation machines. 
Different human pathogens have recruited such conjugation machineries to inject 
macromolecular effectors across the bacterial and host cell membranes directly into the host 
cell cytosol, where they alter various cellular processes (15). Bh carries a pathogenicity island 
(PAI) that encodes next to the virB/virD4 locus seven putative T4S substrates, the Bartonella-
translocated effector proteins Bh_BepA-G (13). Deletion of the PAI-regions encoding bepA-G 
abolished the anti-apoptotic activity and all other VirB/VirD4-dependent EC phenotypes (13). 
However, the contribution of individual Bh_Beps to anti-apoptosis and the other cellular 
phenotypes is unknown. All seven Bh_Beps carry in their C-terminus at least one conserved 
region, defined as BID (Bep intracellular delivery) domain (13). The positively-charged 
C-terminal tail sequence together with the proximal BID domain constitute a bipartite signal 
for T4S. Based on a Cre-Recombinase Assay for Translocation (CRAfT), this T4S signal was 
shown to be functional for VirB/VirD4-dependent transfer of four different Bh_Beps (i.e. 
Bh_BepB, Bh_BepC, Bh_BepD, and Bh_BepF) (13). Evidence for translocation of Bh_BepA, 
Bh_BepE, and Bh_BepG is still missing.  
Bh_BepA, Bh_BepB and Bh_BepC are paralogous proteins. A Bh_BepA ortholog is 
found in the animal pathogen Bartonella tribocorum (Bt) (16). Remarkably, all BepA 
homologs encode in their N-terminal part a conserved FIC (filamentation induced by cAMP) 
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domain, which was proposed to be involved in bacterial cell division (17), while the putative 
effector function within human cells is unknown.  
In this paper, we identified BepA as anti-apoptotic effector of the vasoproliferative 
bartonellae Bh and Bq. We show that this effector is translocated by the VirB/VirD4 system 
into EC. Further, we show that the anti-apoptotic activity is confined to the BID domain of 
Bh_BepA, which also mediates localization to the EC plasma membrane. We demonstrate that 
Bh_BepA provokes an elevation of intracellular cAMP and the upregulation of cAMP-
responsive genes, suggesting that plasma membrane-associated Bh_BepA triggers cAMP 
production and signaling, resulting in the abrogation of apoptotic processes. Accordingly, we 
were able to mimic the anti-apoptotic effect of BepA by artificially increasing the intracellular 
cAMP level in EC. Finally, we demonstrate that expression of BepA during endothelial cell 
infection results in resistance against CTL-mediated cell death. 
E-7 
Chapter 4 
Results 
Bh_BepA mediates anti-apoptosis in EC.  
The anti-apoptotic activity of Bh on human umbilical vein endothelial cells (HUVEC) 
requires a functional VirB/VirD4 system and at least one of the putatively secreted effectors 
Bh_BepA-G (12, 13). To identify the effector(s) required for inhibition of apoptosis, we 
expressed them individually in the substrate-free Bh_∆bepA-G mutant and assayed for anti-
apoptotic activity. To this end, HUVEC were infected with the different Bh strains and 
apoptosis was induced by exposure to actinomycin D (actD). Morphological examination 
(Figure 1A) and measuring of caspase-3/-7 activity (Figure 1B) was used to monitor 
apoptosis. Bh_∆bepA-G did not display anti-apoptotic activity (13). Strikingly, the expression 
of Bh_BepA (by plasmid pBh_BepA) restored the anti-apoptotic activity to wild-type level 
(Figure 1), whereas no other Bh_Bep interfered with actD-triggered apoptosis (data not 
shown). Consistently, strain Bh_∆bepA carrying an in-frame deletion of bepA did not protect 
HUVEC from apoptosis, whereas complementation of this mutant with pBh_BepA restored 
the anti-apoptotic activity. To test for functionality of the VirB/VirD4 system in the 
Bh_∆bepA mutant we monitored the T4S-dependent process of invasome formation (12, 18), 
and furthermore quantified the translocation efficiency of a reporter substrate (encoded by 
pRS51) using CRAfT (13). Both assays confirmed that the VirB/VirD4 T4S system is 
functional in the Bh_∆bepA strain (data not shown). 
Taken together, these results provide evidence that Bh requires the putative T4S 
substrate Bh_BepA to protect HUVEC from apoptosis.  
 
Bh_BepA is a VirB/VirD4 substrate translocated into EC.  
CRAfT was used to demonstrate functionality of most of the C-terminal bipartite T4S signals 
of Bh_Beps (13), while this assay was negative for the putative T4S substrate Bh_BepA (data 
not shown). Here, we adapted the calmodulin-dependent adenylate cyclase (cya) reporter 
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assay (19, 20) as alternative to test for translocation of Bh_BepA into HUVEC. Translocation 
of a Cya-reporter fusion is demonstrated by the increase in the intracellular cAMP level. An 
N-terminal FLAG-tag epitope was fused to Cya to allow determining the stability of fusion 
proteins by immunoblot analysis (Figure 2A,C). As positive control, the T4S signal of 
Bh_BepD (Bh_BepD352-534) (13) was fused to the FLAG-Cya reporter (pFLAG-Cya-
Bh_BepD352-534). To test for translocation of Bh_BepA, either full-length protein (Bh_BepA1-
544), or the C-terminal domain harboring the putative T4S signal (Bh_BepA305-544) was fused 
to FLAG-Cya. These reporter constructs were expressed either in Bh wild-type or in the 
∆virB4 mutant lacking a functional VirB/VirD4 system. HUVEC infected with wild-type 
expressing FLAG-Cya did not display any significant increase of the cAMP level as 
compared to wild-type without the pFLAG-Cya plasmid. In contrast, FLAG-Cya fused to 
either Bh_BepD352-534, Bh_BepA1-544, or Bh_BepA305-544 resulted in an approximately 10-fold 
increase of intracellular cAMP levels in HUVEC (Figure 2B). This effect was dependent on a 
functional VirB/VirD4 system. In summary, we show that BepA is a VirB/VirD4 substrate 
that harbors a C-terminal T4S signal.  
 
The BID domain of Bh_BepA is sufficient to inhibit apoptosis. 
Next we determined whether ectopic expression of Bh_BepA in HUVEC is sufficient 
to mediate anti-apoptosis. N-terminal GFP-fusions to full-length Bh_BepA or fragments 
thereof were constructed in an appropriate eukaryotic expression vector. As control we 
included the expression vector pGFP encoding just GFP (Figure 3A). Twenty-four hours after 
transfection of HUVEC with the different GFP-fusion constructs, cells were either exposed to 
actD (apoptosis induction) or left untreated (non-induced control) for another 12 h. Then, cells 
were stained with AnnexinV and propidium iodide (PI) and the proportion of apoptotic cells 
(AnnexinV positive, PI negative) among the GFP-positive cell population was quantified by 
flow cytometry. 
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HUVEC transfected with pGFP and treated with actD displayed an apoptotic rate of 
13%. Fusion of full-length Bh_BepA to the C-terminus of GFP (pGFP-Bh_BepA1-544) reduced 
the apoptotic population almost 4-fold to a level similar to the non-induced control. The same 
anti-apoptotic activity was observed when only the C-terminal bipartite T4S signal of 
Bh_BepA was fused, thus missing the first 304 N-terminal aa encoding the FIC domain 
(pGFP-Bh_BepA305-544). In contrast, fusion of the FIC domain (pGFP-Bh_BepA1-304) did not 
result in inhibition of apoptosis. Further analysis showed that fusion of the BID domain (142 
aa) to GFP (pGFP-Bh_BepA305-446) was sufficient to inhibit apoptosis, whereas fusion of the 
positively charged C-tail plus only part of the BID domain (pGFP-Bh_BepA403-544) did not 
result in anti-apoptosis (Figure 4B). Expression of the latter construct rather had a pro-
apoptotic effect, indicated by the increased apoptotic cell population in the untreated sample. 
Taken together, these data demonstrate that ectopic expression of the BID domain as part of 
the bipartite T4S signal of Bh_BepA in EC is sufficient to mediate protection against 
apoptosis.  
 
Anti-apoptotic Bh_BepA constructs associate with the plasma membrane. 
To test for the subcellular localization of Bh_BepA in EC, the generated GFP fusions 
(Figure 3A) were ectopically expressed in HUVEC for 30 h, followed by 
immunocytochemical staining for the surface marker αv-integrin. Samples were analyzed by 
confocal microscopy by taking images in the xy-plane. To better distinguish between 
cytoplasmic and membrane-associated localization, we also captured images in a xz-plane at 
sections with increased cytoplasmic volume close to the nucleus (indicated in Figure 3C by 
dashed lines). Ectopically expressed GFP localized to the cytoplasm of HUVEC, whereas the 
GFP-Bh_BepA1-544 fusion localized to the plasma membrane (Figure 3C). Interestingly, all 
fusion proteins with anti-apoptotic activity localized to the plasma membrane, while those 
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which did not confer protection localized to the cytoplasm. These findings indicate that 
association to the plasma membrane is critical for the anti-apoptotic activity of Bh_BepA.  
 
Only BepA orthologs from vasoproliferative Bartonella species display anti-apoptotic 
activity. 
To assess whether anti-apoptosis is a general feature of BepA homologs, we tested the 
orthologs encoded by other Bartonella species for this activity. In the public databases, 
orthologous sequences to Bh_BepA are available for Bq (NC_005955) and Bt (CAD37389). 
Bq was previously shown to cause vascular tumor formation, while Bt was never associated 
with vascular lesions (9). In the genome sequence of Bq the bepA gene is annotated as a 
pseudogene (21). Closer inspection of the sequence revealed that due to an internal stop codon 
and a downstream located start codon in frame this bepA locus is split into two ORFs 
(Bq_bepA1, Bq_bepA2). Bq_bepA1 encodes a FIC domain, and Bq_bepA2 encodes a BID 
domain and the positively charged C-terminal tail, the latter representing a putative T4S 
signal. Comparison of the amino acid sequences of Bq_BepA1 and Bq_BepA2 to Bh_BepA 
revealed high similarity (59% and 63%, respectively). We cloned Bt_bepA and Bq_bepA2 into 
expression plasmids, which were introduced into Bh_∆bepA-G (Figure 4A). As controls we 
included the paralogs Bh_bepB and Bh_bepC, which in the initial screening of Bh_Beps were 
found to lack anti-apoptotic activity (Figure 4A and data not shown). HUVEC were infected 
for 24 h with the different isogenic strains, and subsequently apoptosis was induced by actD. 
Of the tested BepA homologs, only Bh_BepA and Bq_BepA2 inhibited actD-triggered 
caspase-3/-7 activation (Figure 4B). These findings revealed that Bq_bepA2 encodes an anti-
apoptotic effector. To assign Bq_BepA2 as a novel T4S substrate, we demonstrated 
translocation of a FLAG-Cya-BepA2 fusion from Bh into HUVEC by the Cya-reporter assay 
(data not shown). These results show that the anti-apoptotic activity of BepA is conserved 
among two human pathogens with vasoproliferative capacity (Bh and Bq), but not in Bt which 
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has not been associated with vasoproliferation. Moreover, these data confirm the localization 
of the anti-apoptotic activity to the C-terminal region of BepA composing a functional T4S 
signal (13).  
 
Inhibition of apoptosis correlates with an increased intracellular cAMP level. 
To identify potential survival pathways mediated by anti-apoptotic BepA, we analysed 
Affymetrix GeneChip data obtained for the transcriptome of HUVEC infected with Bh wild-
type versus the ∆virB4 mutant impaired in T4S (M. Dehio, M. Schmid, M. Quebatte and C. 
Dehio, unpublished data). These data revealed a T4S-dependent upregulation of the NFκB and 
cAMP-dependent CREM/CREB regulons in HUVEC. Both signaling pathways were 
described to mediate, among other functions, the protection against apoptosis (22-24). 
We tested whether these pathways were activated by anti-apoptotic BepA homologs. 
We monitored activation of the NFκB pathway in infected HUVEC by measuring the release 
of IL-8. Bh wild-type triggered an increased IL-8 release compared to Bh_∆bepA-G or the 
uninfected control. In contrast, none of the BepA homologs expressed in Bh_∆bepA-G 
induced increased IL-8 secretion (Figure 5A). This finding indicates that activation of the 
NFκB pathway by wild-type is independent of the survival mechanism triggered by anti-
apoptotic BepA homologs. Activation of the cAMP-dependent CREM/CREB pathway was 
assayed by quantitative real-time PCR of two cAMP-inducible genes, namely pde4B and crem 
(25, 26). Only strains translocating anti-apoptotic BepA homologs were found to induce the 
expression of these genes in a statistically significantly manner (Figure 5B). By quantifying 
intracellular cAMP upon infection of HUVEC by the various isogenic Bh strains, we further 
demonstrated that anti-apoptotic BepA homologs significantly increase the intracellular 
cAMP level (Figure 5C). 
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A rise in intracellular cAMP results in protection of EC against apoptosis. 
 As translocation of anti-apoptotic BepA homologs resulted in a rise of the intracellular  
cAMP level, we further studied the role of cAMP in anti-apoptosis. The intracellular cAMP 
level is regulated by adenylate cyclases (AC) generating cAMP, and phosphodiesterases 
(PDE) degrading cAMP (27, 28). To trigger a physiological rise of the cAMP level in EC, we 
activated AC with forskolin and in parallel inhibited cAMP degradation by adding the PDE-
inhibiting drug 3-isobityl-1-methylxanthine (IBMX) (29, 30). HUVEC were infected with the 
substrate-free Bh_∆bepA-G strain and with the BepA-expressing strain Bh_∆bepA-
G/pBh_BepA in the absence and presence of forskolin/IBMX. Apoptosis was induced by 
exposure to actD and monitored by measuring caspase-3/-7 activity. By adding 
forskolin/IBMX we were able to reduce caspase-3/-7 activity in uninfected HUVEC and cells 
infected with the Bh_∆bepA-G strain to a similar level as found in cells infected with 
Bh_∆bepA-G/pBh_BepA. Interestingly, the addition of forskolin/IBMX did not have an 
additive protection-effect in Bh_∆bepA-G/pBh_BepA infected HUVEC (Fig. 6A).  The same 
results were obtained by adding the cell-permeable cAMP analog dibutyryl cAMP to the 
culture medium (Fig. 6B). From these data we conclude, that a moderately increased 
intracellular cAMP level, as triggered by Bh_BepA, is sufficient to protect EC against 
apoptosis. 
 
The role of Bh_BepA in evading CTL-mediated cell death. 
 During colonization of the human endothelium, intracellular Bh are hidden from 
antibody and complement-mediated immune responses (9). However, the infected EC may be 
killed by CTL (31). To study the role of Bh_BepA in this context, we used PHA-activated 
CTL for triggering apoptosis of Bh infected EC (32). To specifically measure the rate of EC 
apoptosis without interference by apoptotic CTL, we pre-labeled the EC population with the 
fluorogenic dye CSFE. Pre-labeled HUVEC were infected with Bh_∆bepA-G or with 
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Bh_∆bepA-G/pBh_BepA. Twenty-four hours after infection, CTL were added in an E/T cell 
ratio of 13:1. At different time points morphological examination and AnnexinV/PI staining 
was performed to quantify the amount of surviving (AnnexinV negative, PI negative) and 
early-apoptotic or dead HUVEC (AnnexinV positive, PI negative and positive) (Fig. 7A/B).  
Starting with a confluent monolayer with adherent CTL, considerable differences in 
remaining HUVEC numbers were observed during the course of CTL exposure in the various 
conditions tested (Fig. 7A). In the early time points (2 h and 6 h), uninfected HUVEC were 
more susceptible to CTL-mediated cell death than pre-infected cells. Importantly, in pre-
infected HUVEC the translocation of Bh_BepA provoked a marked increase in resistance to 
CTL-mediated cell death. After 6 h CTL-exposure the monolayer pre-infected with 
Bh_∆bepA-G was heavily disrupted and remaining HUVEC were found in patches. In 
Bh_∆bepA-G/pBh_BepA pre-infected HUVEC the grade of disruption of the monolayer was 
strongly diminished. This Bh_BepA-dependent increase in EC resistance to CTL-mediated 
cell death was even more pronounced during prolonged CTL exposure time. After 48 h 
exposure to CTL, the persistence of a HUVEC monolayer was strictly dependent on the 
presence of Bh_BepA. 
The same results were obtained by quantifying the surviving and dead HUVEC 
populations by AnnexinV/PI staining. Uninfected HUVEC revealed a rapid decrease of the 
surviving cell population in the presence of CTL (Fig. 7B), as indicated by 7% surviving cells 
and 80% dead cells after 6 h exposure to CTL. The percentage of surviving HUVEC was 
dependent on the presence of bacteria, however, during all stages of incubation with CTL, the 
presence of Bh_BepA caused increased HUVEC survival and strongly reduced the dead cell 
population compared to the substrate-free Bh_∆bepA-G strain. After 48 h of HUVEC 
exposure to CTL, Bh_BepA caused the persistence of 30% of HUVEC, while survival of 
uninfected or Bh_∆bepA-G infected HUVEC declined to 1% and 5%, respectively (Fig. 7C). 
E-14 
Chapter 4 
These data indicate that translocated Bh_BepA effectively protects the chronically 
infected vascular endothelium against CTL-mediated cell death. 
 
Ectopic expression of Bh_BepA reduces CTL-mediated cell death. 
 To test whether Bh_BepA alone is sufficient to mediate increased resistance to CTL-
triggered EC death, we ectopically expressed the anti-apoptotic pGFP-Bh_BepA1-544 construct 
in HUVEC (Fig.3A). pGFP served as a negative control. Twenty-four h after transfection, 
CTL were added to the HUVEC monolayer in an E/T cell ratio of 4:1 or 13:1. Upon 22 h of 
incubation, bright field pictures were taken, followed by AnnexinV/PI staining to measure the 
surviving rate of GFP-positive cells by flow cytometry. While in the absence of CTL the 
monolayer of pGFP and pGFP-Bh_BepA1-544 transfected cells stayed intact (Fig. 8A), the 
addition of CTL decreased the surviving cell population in an E/T cell-dependent manner. 
This CTL-mediated cell death was significantly reduced by expression of pGFP-Bh_BepA1-544 
for both E/T cell ratios tested. 
From these data, we conclude that ectopic expression of Bh_BepA in HUVEC is 
sufficient to provoke increased resistance against CTL-mediated cell death.  
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Discussion 
The modulation of host cell apoptosis is a recurrent theme in bacterial pathogenesis (1). 
Research in this area focused initially on the pro-apoptotic mechanisms triggered by 
pathogens that typically cause acute infections (e.g. Shigella, Salmonella, and Yersinia 
species). Some pro-apoptotic effectors and the targeted cellular pathways have been studied in 
molecular detail (33, 34). More recently, pathogen-triggered anti-apoptosis was recognized as 
an important virulence trait of bacteria that predominately cause chronic infection (e.g. 
Bartonella, Brucella, Chlamydia, Helicobacter, Mycobacterium, and Rickettsia species) and 
thus require to protect their cellular habitats by suppressing host-triggered apoptosis (35). 
However, the bacterial effectors and to a large extent also the cellular pathways involved in 
mediating pathogen-induced anti-apoptosis remained poorly defined. In the case of Bh and 
Bq, the formation of vascular tumors in immunocompromized patients was shown to be linked 
to the inhibition of apoptosis of infected EC (10). In this report we identified the anti-
apoptotic factor of these vasoproliferative bartonellae. Deletion of the Bh_bepA gene resulted 
in the complete loss of the anti-apoptotic activity of Bh, while expression of Bh_bepA in trans 
restored the activity to wild-type level. Bh_BepA was previously described as putative 
substrate of the T4S system VirB/VirD4 (13). In this report, we used the Cya-reporter assay to 
demonstrate that Bh_BepA is indeed translocated into EC in a T4S-dependent manner. 
Bh_BepA is thus a genuine T4S effector that inhibits apoptosis upon translocation into 
HUVEC. It is worth to note, that we have been unable to show translocation of Bh_BepA by 
CRAfT, an assay that we previously used to demonstrate translocation of several other 
Bh_Beps (13). Nuclear import of the Cre-reporter protein fusion is a prerequisite for a positive 
read-out by CRAfT (13), suggesting that the negative read-out obtained for Bh_BepA fusions 
could result from protein recruitment to an intracellular localization that interferes with 
nuclear import. Indeed, ectopic expression of full-length Bh_BepA fused to GFP revealed a 
prominent localization of the fusion protein to the plasma membrane, in contrast to the 
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cytosolic localization of GFP alone. Unlike ectopically expressed GFP, the GPF-Bh_BepA 
fusion also conferred protection against EC apoptosis. These data demonstrate that Bh_BepA 
is not only required, but also sufficient for inhibiting EC apoptosis, and that this anti-apoptotic 
effector localizes to the plasma membrane. Moreover, ectopic expression of various parts of 
Bh_BepA fused to GFP revealed a strict correlation of the capacity to mediate anti-apoptosis 
with localization to the plasma membrane (opposed to the cytoplasmic localization of fusions 
that did not cause anti-apoptosis). This finding indicates that plasma membrane targeting may 
be important for the anti-apoptotic activity of Bh_BepA. 
In search for the cellular pathway by which Bh_BepA mediates anti-apoptosis in EC, 
we first tested whether an NFκB-dependent survival pathway is involved. The anti-apoptotic 
activity of Rickettsia rickettsii in EC was reported to depend on  NFκB activation (5), and we 
have previously shown that Bh activates NFκB in a VirB/VirD4 and Bep-dependent manner 
(13). Here, we demonstrated that Bh_BepA alone does not trigger the NFκB-dependent 
secretion of IL-8, even so it fully protects against apoptosis. Thus, NFκB does not seem 
critical for Bh_BepA-mediated anti-apoptosis. Affymetrix genechip experiments indicated 
that Bh also triggers a cAMP-signalling pathway in a T4S-dependent manner (M. Dehio, M. 
Schmid, M. Quebatte and C. Dehio, unpublished data). Here, we have shown that the anti-
apoptotic activity of Bh_BepA in HUVEC correlated with the elevation of the intracellular 
cAMP level and resulted in the upregulation of cAMP-stimulated gene expression. Recently, 
it emerged that the regulation of apoptosis is an important facet of cAMP signal transduction 
(30, 36-38). Moderately elevated cAMP levels were reported to protect several cell types 
against apoptosis, while the survival mechanisms differed from cell type to cell type and were 
considered to require the activation of PKA, ERK, MAPK, or a GEF-signaling pathways, 
which subsequently resulted in the expression of anti-apoptotic genes (23, 36, 37, 39-44). In 
our system, the specific downstream signaling pathway mediating cAMP-dependent anti-
apoptotis remains elusive, because efforts to block putatively involved signaling molecules 
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(i.e. PKA) failed due to apparent cytotoxic effects of effective inhibitor concentrations during 
the extended time-frame of the apoptosis assay.  
Importantly, a physiological rise in the intracellular cAMP level was reported to fully 
protect EC against apoptosis (45). Consistently, we observed that increased cAMP levels as a 
result of the combined action of the AC-activating drug forskolin and the PDE-inhibiting drug 
IBMX resulted in a complete suppression of actD-induced apoptosis in HUVEC (Fig. 6). 
Forskolin/IBMX-treated cells displayed a similar increase in the expression of cAMP-
regulated genes as observed upon infection with anti-apoptotic Bh strains. Cyclic AMP is 
produced in eukaryotic cells by the family of membrane anchored AC. AC are activated by 
heterotrimeric G proteins that are regulated by G protein-coupled receptors (46). Since the 
anti-apoptotic activity of Bh_BepA in HUVEC is strictly associated with the plasma 
membrane localization of this effector (Fig. 3), concomitant with an increase in the cAMP 
level (Fig. 5), we propose that Bh_BepA may trigger anti-apoptosis by interacting either with 
AC directly, or with plasma membrane-associated heterotrimeric G proteins or G protein-
coupled receptors that regulate AC activity.  
Ectopic expression of GFP-fusions with different parts of Bh_BepA confined the anti-
apoptotic activity to a region of 142 aa, which corresponds to the BID domain. This conserved 
domain was previously shown to be present in a least one copy in all Beps of Bh and Bq (13, 
14, 21). The BID domain plus the C-terminal positively charged tail sequence of the Beps 
were shown to constitute a bipartite translocation signal for T4S (13). Interestingly, in contrast 
to the BID domain of Bh_BepA, the conserved BID domains of the paralogs Bh_BepB and  
Bh_BepC have not be associated with anti-apoptosis. This indicates that subsequent to the 
expansion of this paralogous protein family by gene duplication, the BID domain of Bh_BepA 
acquired in addition to its crucial function in mediating T4S the capacity to mediate anti-
apoptosis. How this rather short domain may mediate these unrelated activities is presently 
unknown. It may be speculated that the BID domain represents a basic fold that mediates a 
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protein-protein interaction with the T4S machinery that is crucial for protein translocation, 
and that in Bh_BepA this basic fold is adapted to also mediate specific interaction with the 
plasma membrane-associated cAMP-generating signaling cascade of EC. Each of the paralogs 
Bh_BepA, Bh_BepB and Bh_BepC carries in the N-terminal region one copy of the FIC 
domain. While this conserved domain of unknown function might be important for the 
effector function of Bh_BepB and Bh_BepC, our results demonstrated that the FIC domain is 
dispensable for the anti-apoptotic activity of Bh_BepA. Interestingly, an internal stop codon 
and downstream located start codon within the bepA ortholog of Bq is splitting this locus into 
two separate ORFs (Bq_bepA1 and Bq_bepA2). Bq_BepA1 consists of the FIC domain but 
lacks a T4S signal, and thus can not be translocated into EC. In contrast, Bq_BepA2 consists 
only of the T4S signal, which we have shown to mediate both T4S-dependent translocation, as 
well as anti-apoptosis in EC. It thus appears plausible that the functional diversification of 
BepA into an anti-apoptotic effector occurred in the common ancestor of these closely species 
Bh and Bq (21), and that following speciation the acquisition of mutations resulted in the 
elimination of the dispensable N-terminal FIC domain in Bq. 
Interestingly, unlike Bh_BepA and Bq_BepA2, the BepA ortholog of Bt did not 
mediate any anti-apoptotic activity, nor any measurable activation of the cAMP pathway. This 
observation is in agreement with the previously reported finding that among the bartonellae 
the anti-apoptotic activity is limited to the vasoproliferative species Bh and Bq (10).  
To asses if the here identified anti-apoptotic activity of Bh_BepA might be able to 
protect the cellular habitat of Bh during the infection process, we used a co-culture system of 
HUVEC with human CTL. CTL execute cell-mediated immunity (CMI), a physiological 
mechanism involved in the elimination of Bh infection (9, 12, 47). CMI particularly serves as 
a defense mechanism against microbes that survive and replicate inside infected host cells. 
Upon recognition of MHC class I displaying microbial peptides, CTL are activated to kill 
their target cells by the release of perforin and granzymes (31, 48). Perforin forms pores in the 
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target cell membrane and assists the delivery of pan-caspase activating granzymes into the 
cytoplasm of the target cell (44, 49, 50). In our study, we used a CTL clone, which is 
pharmacologically activated by PHA and kills HUVEC in a perforin-dependent manner, 
primarily by triggering granzyme-dependent apoptosis (50, 51). In this experimental context, 
the release of cytotoxic effector proteins by this CTL clone is independent of the MHC class 
I-restricted presentation of microbial peptides (32). Hence, we can exclude differences in 
peptide-presentation and CTL activation between different Bh stains. Bh_BepA mediated 
increased resistance to CTL-dependent cell death, indicating that the biological function of 
Bh_BepA expression in vivo might be to protect the integrity of its colonized cellular niche. 
Interestingly, Bh_BepA could not prevent EC death completely in this CTL co-culture system, 
suggesting that Bh_BepA might inhibit the apoptotic pathway mediated by granzymes, while 
apoptosis-independent killing mechanisms such as perforin-mediated lyses are unaffected.  
Via the ectopic expression of Bh_BepA in HUVEC we further showed a protective 
effect of this bacterial effector against CTL-mediated cell death in the absence of bacterial 
infection (Fig. 8). These data confirm the cytoprotective effect of Bh_BepA observed during 
infection assays and allowed us to exclude any interference of Bh_BepA with CTL-activity by 
effector-translocation into CTL (Fig. 8B). 
The Bh_BepA-mediated resistance of EC to CTL-dependent cell death points towards 
an important role of BepA in escaping CMI and thus in protecting the integrity of the 
chronically infected vasculature, which represents a prerequisite for vascular proliferation. 
The establishment of an animal model for Bartonella-triggered vasoproliferation now appears 
an urgent need to study the precise contribution of BepA-mediated anti-apoptosis in the 
process of vascular tumor formation. 
In summary, the anti-apoptotic T4S effectors Bh_BepA and Bq_BepA2 characterized 
in this study represent striking examples for the evolution of new pathogenic traits in bacteria. 
The delineation of their anti-apoptotic activity to the conserved BID domain and its proposed 
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role to maintain the cellular habitat by mediating anti-apoptosis via specific interaction with 
the plasma membrane-associated cAMP-generating signaling cascade of EC should pave the 
way for future studies to elucidate the molecular and structural basis of Bartonella-mediated 
anti-apoptosis in the vascular endothelium and the role of this pathological process in 
vasoproliferative tumor growth. 
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Materials and methods 
Bacterial strains and Growth Conditions. The bacterial strains used in this study are listed 
in Table 1 of the Online Supplemental Material. Bartonella spp. were grown on Columbia 
agar plates containing 5% defibrinated sheep blood (CBA plates) at 35°C and 5% CO2 for 2-4 
days. Strain RSE247, a spontaneous streptomycin-resistant strain of ATCC 49882T (12) 
served as wild-type in this study. When indicated, media were supplemented with 30 µg/ml 
kanamycin, 100 µg/ml streptomycin, 12.5 µg/ml gentamicin, and/or 500 µM isopropyl β-D-
thiogalactosidase (IPTG). E. coli strains were cultivated in Luria-Bertani liquid medium (LB) 
or after addition of agar on plates (LA) at 37°C overnight. When indicated, media were 
supplemented with 50 µg/ml kanamycin, 200 µg/ml ampicillin, 25 µg/ml gentamicin, 500 µM 
IPTG, and/or 1 mM diaminopimelic acid (DAP).  
 
DNA-Manipulation 
Plasmids used in this study are listed in Table 1 of the Online Supplemental Material. Primers 
are listed in Supplementary Material Table 2. 
Construction of In-Frame Deletions and Complementation of the Deletion Mutants. pMS5 
used for creating the ∆bepA  mutant was already described before (13). The use of pMS5 for 
gene-replacement in RSE247 resulted in the ∆bepA mutant MSE154.  
Plasmids for complementation of Bh_∆bepA mutant and Bh_∆bepA-G mutant. For 
constructing vectors expressing N-terminal FLAG-tagged Bep proteins, the plasmid pPG100 
was used. The fragments were generated by PCR-amplification from chromosomal DNA of 
RSE247 (Bh) and Bt, respectively, using oligonucleotide primers prPG92/93, prPG95/129, 
prPG97/130, or pMS27/28 were inserted by the flanking NdeI-site into the corresponding site 
of  pPG100, resulting in pPG101 (encoding Bh_BepA), pMS006 (encoding Bh_BepB), 
pMS007 (encoding Bh_BepC), and pMS011 (encoding Bt_BepA).  
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To construct plasmid pMS100, carrying a multiple cloning site, prGS01 and prGS02 
were annealed together and the resulting 45 bp fragment was inserted into pPG100 using the 
NdeI-site. Using oligonucleotide primers pMS102 and prMS103, a fragment of 0.85 kb was 
amplified using chromosomal DNA of Bq as template. Using SalI/XmaI-sites this fragment 
was inserted into the corresponding site of pMS100, giving rise to pMS106. 
Plasmid pMS105 was constructed as follows. Using flanking SalI/XmaI- sites, the 1.65 
kb PCR-fragment generated by prMS37/38 (chromosomal DNA of RSE247 serves as a 
template) was inserted into the corresponding sites in pRS40, yielding pMS13. Using flanking 
SalI/XmaI- sites the 1.65 fragment was shuttled into pMS100 using the corresponding sites.  
Using oligonucleotide primer prRS167/180 and prRS187/188, fragments of 0.73 kb 
size were amplified using chromosomal DNA of RSE247 and of Bt respectively as template. 
Using flanking SalI/XmaI-sites, the fragments were inserted into the corresponding site of 
pRS40, giving rise to pRS48 and RS55, respectively.  
C-terminal sequences of the different Bep-proteins were shuttled into pMS100 using 
the flanking SalI/XmaI-sites. The plasmids resulting from this step are given below, as well as 
the range of aa of a given Bep protein fused to the N-terminal FLAG: pMS100-A (shuttled 
from pRS48, aa 305-544 of BepA), pMS100-B (shuttled from pRS49, aa 303-542 of BepB), 
pMS100-C (shuttled from pRS50, aa 292-532), and pMS100-D (shuttled from pRS51, aa 352-
534 of BepD). 
Plasmid for expression of Cya-Bep-fusion proteins. To construct pMS400, the calmodulin-
dependent adenylate cyclase of pMS111 was PCR-amplified with oligonucleotide primers 
prMS78/90 introducing a start and a stop codon to the resulting cya fragment. Using flanking 
NdeI/XmaI-sites, the 1.23 kb fragment was inserted in the corresponding sites of pMS100. 
Plasmid pMS401 was derived by insertion of a 1.2 kb NdeI/StuI-fragment of pMS400, which 
includes the cya-gene without stop codon, into the corresponding sites of pMS100-A. The 
NdeI/StuI-fragment of pMS400 was further inserted in the corresponding site of pMS100-D 
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and pMS105, giving rise to pMS404 and pMS405, respectively. To construct pMS406, 
Bq_BepA2 was PCR-amplified from chromosomal DNA of Bq with oligonucleotide primers 
prMS103/104. Using flanking PmeI/XmaI-sites, the 0.86 kb fragment was inserted in the 
StuI/XmaI-sites of pMS400. 
Plasmids for ectopic expression  of GFP-BepA-fusion proteins. To construct eGFP-Bep fusion 
proteins (see Figure 4A), pWAY21 (Molecular Motion Montana Labs), a CMV driven EGFP 
for C-terminal fusion, was used as basic vector. The plasmids resulting from this step and the 
used oligonucleotide primers (with incorporated XmaI/XbaI-sites used for cloning to the 
corresponding sites of pWAY21) are given below, as well as the range of aa of a given Bep 
protein fused to eGFP: pMS21 (primers prMS68/69, aa 1-544 of Bh_BepA); prMS22 (primer 
prMS76/77, aa 302-542 of Bh_BepB); pMS23 (primers prMS83/69, aa 305-544 of 
Bh_BepA); pMS24 (primers prMS83/84, aa 305-446 of Bh_BepA); pMS25 (primers 
prMS74/69, aa 403-544 of Bh_BepA); pMS26 (primers prMS68/75, aa 1-304 of Bh_BepA); 
pMS27 (primers prMS105/106, aa 1-277 of Bq_BepA2). 
The integrity of all constructs was confirmed by sequence analysis and western 
blotting using anti FLAG M2 antibodies (SIGMA, Saint Louis, USA). 
 
Cell Lines and Cell Culture. Human umbilical vein endothelial cells (HUVEC) were 
isolated as described (18). HUVEC and the human embryonic kidney cell line HEK293T were 
cultured as described before (12). The stable transfected endothelial cell line 
Ea.hy296/pRS56-c#B1 was cultured as reported (13).  
 
Infection Assay. HUVEC (passage 3-7) plated as described before (12). Unless stated 
differently, cells were infected with a multiplicity of infection (MOI) 300 bacteria per cell 
(10) in M199/10% FCS/500 µM IPTG and incubated for the indicated time. If specified, 100 
nM actD (Sigma Aldrich) was added to trigger apoptosis as described before (10, 12). 
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Transfection Assay. Huvec were transfected using Amaxa nucleofection technologyTM 
(Amaxa, Koeln, Germany) following the manufactures guidelines for HUVEC transfection. 
After transfection cells were seeded onto cover-slips into 24-well plates or 6 well plates for 
subsequent immunocytochemistry or AnnexinV assay, respectively. 
 
Caspase Activity Assay. The infection of HUVEC and the determination of caspase-3/-7 
activity (MOI=300) were carried out as described (12). 
 
Calmodulin Dependent Adenylate Cyclase Assay. cAMP was assayed after 20h contact 
between bacteria (MOI=300) and HUVEC in 24-well plates. HUVEC were washed one time 
in pre-warmed PBS and lysed in denaturizing conditions as described previously (19). cAMP 
was assayed by a EIA system (Biotrak, Amersham). Total cell proteins were assayed by the 
method of Bradford (52)(Bradford Reagent, SIGMA). 
 
Cre-Recombinase Reporter Assay for Translocation (CRAfT). The infection of the stable 
transfected Ea.hy926/pRS56-c#B1cell line and the quantification of GFP positive cells 
(positive events in %) by flow cytometry was carried out as described (13). 
  
Immunoblot Analysis. To monitor the steady-state level of Cya-fusion proteins, bacteria 
were grown on isopropyl β-D-thiogalactosidase-containing medium for 2 days. Cells were 
harvested and proceed as described previously (13), excepting as primary antibody anti FLAG 
M2 (Sigma, Saint Louis, USA) was used.  
The stability of the different GFP-fusion protein used for ectopic expression in 
HUVEC was monitored after transient transfection of HEK293T cells. Cells were transfected 
by Fugene6 (Roche, Switzerland) following the manufactures instructions. After 24 h 
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expression cells were washed twice with PBS and harvested in 100ul sample buffer. Samples 
were then further proceed as described before (13) and probed with anti-GFP (Roche, 
Switzerland) antibody. 
 
AnnexinV Assay. 24 h after transfection of HUVEC apoptosis was induced for 12 h. Cells 
were then collected by mild trypsinization and briefly centrifuged together with the culture 
supernatant. The cell pellet was washed, resuspended, and stained with AnnexinV APC 
(Alexis, Switzerland). Propidium iodide (PI, 1ug/ml) was added to counterstain necrotic cells 
and sample were then analyzed with a FACSCalibur flow cytometer (Becton Dickinson). 
Prior to determine the apoptotic population, transfected cells were gated by their positive GFP 
signal. 
 
Transfection and Immunocytochemistry. HUVEC were transfected for 30 h with different 
GFP-Bep fusion constructs, fixed with 3.7% paraformaldehyde, and immunocytochemically 
stained against αv-integrin (Merck). Specimens were analyzed by confocal microscopy as 
described (12). 
 
Determination of IL-8 Secretion. The infection (MOI=300) of HUVEC and the 
determination of IL-8 secretions by IL-8 DuoSet ELISA kit (R and D Systems, Minneapolis, 
MN) was performed as described before (12). 
 
Determination of Intracellular cAMP Level. After infection (MOI=150) of HUVEC for 30 
h in 24-well plates, cells were washed with pre-warmed PBS and lysed. Intracellular cAMP 
level was determined by the EIA system (Biotrak, Amersham) as described by the 
manufacture. 
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Real time PCR. To quantify the activation of the cAMP pathway, total cellular RNA was 
isolated at 54 h after infection as described above. RNA manipulation and real time PCR was 
performed as previously described (53) using primers listed in Table II.   
 
Effects of Exogenous cAMP and cAMP-elevating Agents. HUVEC were infected in the 
absence or presence of either forskolin (Sigma-Aldrich) and 3-isobityl-1-methylxanthine 
(IBMX) (Sigma-Aldrich) or dibutyryl cAMP (Sigma-Aldrich) for 24 h with the indicated Bh 
strains (MOI = 300) or left uninfected (control). Apoptosis was induced and caspase-3 and -7 
activities were monitored as described above. 
 
CTL Assay upon Infection. Confluent HUVEC monolayers were labeled with 5uM 
carboxyfluorescein diacetate, succinimidyl ester (CFSE, Molecular Probes) in M199 without 
FCS according to the manufactures protocol. Cells were then infected with indicated Bh 
strains (MOI=300) or left uninfected in M199/ 10% FCS/ 500uM IPTG during 24 h. CTL  
clones were generated as described previously (51).  CTL were washed twice by 
centrifugation and were added in a ratio of E/T cell of 13:1 in replacing the infection medium 
with CTL-assay medium (M199, 2%FCS, 5mM HEPES, 2mM Glutamine, 500µM IPTG). 
Plates were centrifuged to bring the cells in contact followed by adding phytohemagglutinin 
PHA (Sigma Aldrich) in a final concentration of 1µg/ml . Cells were washed with prewarmed 
PBS (excepted time point 0h) prior transmission light pictures were taken at indicated time 
points by a Leica DM IL microscope equipped  with a Leica DFC 280 camera and Leica 
Image Manager 50 software. To quantify the surviving and dead cell rate, we used 
AnnexinV/PI staining and flow cytometry (described above). Prior to determine the surviving 
and dead cell populations, CFSE-positive cells were gated by their positive GFP signal. 
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CTL Assay upon Transfection. HUVEC were transfected for 24 h with indicated GFP-
fusion constructs. CTL were added in an E/T cell ratio of 4:1 and 13:1. Cells were brought in 
contact by centrifugation and PHA was added (1µg/ml). After 22 h incubation, pictures were 
taken and surviving cells were quantified by AnnexinV/PI staining as described above. Prior 
to determine the surviving cell populations using flow cytometry, GFP-positive cells were 
gated by their positive GFP signal. 
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Figure legends 
 
Figure 1. Bh_BepA meditates inhibition of apoptosis in EC.  
(A, B) HUVEC were infected for 24 h with the indicated Bh strains (MOI=300) or left 
uninfected for this period (control). If not indicated differently, apoptosis was then triggered 
by the addition of actD. 12 h later (A) morphological changes were visualized by recording 
phase contrast images (bar = 40 µm), and (B) caspase-3/-7 activities were determined with a 
specific fluorogenic peptide substrate. Arrowheads indicate apoptotic cells displaying 
membrane blebbing. All strains were tested a minimum of three times in triplicate samples. 
 
Figure 2. Bh_BepA is a genuine VirB/VirD4 T4S substrate that is translocated into EC. 
(A) The bars indicate the parts of Bh_BepA or Bh_BepD, which were fused to calmodulin-
dependent adenylate cyclase (cya). These reporter fusions were used to monitor translocation 
via the VirB/VirD4 system. All construct contain an N-terminal FLAG epitope for 
immunological detection of the encoded fusion protein. (B) Quantification of the amount of 
intracellular cAMP in HUVEC infected for 20 h with the indicated bacterial strains 
(MOI=300). Isogenic strains with a functional (wild-type) or non-functional (∆virB4) 
VirB/VirD4 T4S systems were used to express the different cya-reporter constructs. Mean and 
SD are shown for one representative out of three independent replica experiments. (C) 
Steady-state FLAG-Cya fusion protein levels of the indicated Bh strains grown on IPTG-
containing medium. 
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Figure 3. Delineation and subcellular localization of the region of Bh_BepA required for 
inhibition of apoptosis. 
(A) Schematic presentation of N-terminal GFP-fusions to parts of Bh_BepA. (B) 
Determination of apoptosis following ectopic expression of the constructs illustrated in (A). 
GFP-BepA fusion proteins were ectopically expressed in HUVEC for 24 h, followed by 12 h 
incubation in the presence or absence of actD as indicated. The loss of membrane asymmetry 
in transfected cells (GFP-positive) was then quantified by flow cytometric analysis of APC-
AnnexinV and PI stained cells, allowing to distinguish apoptotic (AnnexinV positive, PI 
negative) and necrotic cells (AnnexinV positive, PI positive). The means and SD of three 
independent replica experiments are shown. The P values were determined by using an 
unpaired Student’s t-test. (C) The GFP-Bh_BepA fusion proteins illustrated in (A) were 
ectopically expressed for 30 h in HUVEC. Cells were immunochemically stained for the cell 
surface marker αv-integrin. Confocal pictures were taken for GFP (green channel) and αv-
integrin (red channel) in the xy-plane (upper image, overlay both channels, bar = 10 µm), and 
at the dashed stroke line in the xy-plane also in the xz-plane (lower images, single channels 
and overlay channels) 
 
Figure 4. Comparison of the anti-apoptotic activities of BepA homologs. (A) Domain 
structure of Bh_BepA, its paralogs Bh_BepB and Bh_BepC, and the orthologs Bt_BepA and 
Bq_BepA1/2. These homologs contain conserved FIC and BID domains in their N-terminal 
and C-terminal regions, respectively, except for the ortholog Bq_BepA, which due to an 
internal stop codon is split between these domains into two separate ORFs. (B) Anti-apoptotic 
activity of BepA homologs. HUVEC were infected with the indicated Bh strains for 24 h, 
followed by apoptotic induction with actD for 12 h. Caspase-3/-7 activities were then 
determined with a specific fluorogenic peptide substrate. Mean and SD are illustrated for one 
representative out of three independent experiments. 
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Figure 5. Anti-apoptotic BepA homologs mediate an increase in intracellular cAMP and 
an upregulation of cAMP response genes. HUVEC were infected with the indicated Bh 
strains. (A) IL-8 was determined in culture supernatants after infection for 54 h with an 
MOI=300. (B) Expression of the cAMP-responsive genes pde4B and crem was determined by 
quantitative real-time PCR after infection for 54 h with an MOI=300. (C) Intracellular cAMP 
levels were determined after infection for 30 h with a MOI=150. The means and SD of three 
independent replica experiments are presented. (B, C) Samples marked with an asterisk 
(P<0.05) differ statistically significantly from Bh_∆bepA-G by using an unpaired Student’s t-
test. 
 
Figure 6. A pharmacologically increased cAMP level in EC mimics the anti-apoptotic 
effect of Bh_BepA. HUVEC were infected for 24 h with the indicated Bh strains or left 
uninfected (control) in the absence or presence of either (A) forskolin (1 µM) and IBMX 
(10 µM) or (B) dibutyryl cAMP (Db cAMP, 1 mM). If indicated, apoptosis was then induced 
with actD. Caspase-3/-7 activities were determined 9 h later. All strains were tested in 
triplicates for a minimum of three times. 
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Figure 7. Bh_BepA protects EC against CTL-mediated cell death. Confluent HUVEC 
monolayers were infected with the indicated bacterial strains for 24 h or left uninfected 
(control). (A) CTL were added in a E/T cell ratio of 13:1 for the indicated period and after 
washing the disruption of the HUVEC monolayer was monitored by phase contrast 
transmission light microscopy (size bar = 50 µm). (B) Dotplots of surviving and dead cell 
populations at indicated time points upon AnnexinV/PI staining and flow cytometry analysis. 
Percentage (mean) of surviving and dead cells (dashed boxes) are presented. (C) Summary 
graph representing HUVEC cell survival during CTL co-culture as quantified by 
AnnexinV/PI staining. The mean and SD of one of three independent experiment performed 
in triplicates is shown.  
 
Figure 8. Ectopic expression of Bh_BepA in EC mediates cytoprotection against CTL-
mediated cell death. HUVEC expressing GFP or GFP-Bh_BepA1-544 were incubated with 
CTL for 22 h at different E/T cell ratios, or left untreated (control). (A) Cells were washed and 
phase contrast microscopic images were taken (size bar = 50 µm). (B) Quantification of the 
surviving cell proportion by AnnexinV/PI staining and flow cytometry analysis. P values 
were determined by using an unpaired Student’s t-test. The mean and SD of one out of two 
independent assays performed in duplicates is shown. 
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Online Supplemental Material 
 
Table I: Bacterial strains and plasmids used in this study 
Strain or plasmid Genotype or relevant characteristics Reference or source 
B. henselae  strains  
ATCC 49882 T ‘Houston-1’, isolated from a bacteremic HIV-patient (1) 
MSE150 ∆bepA-G mutant of RSE247 (2)  
MSE154 ∆bepA mutant of RSE247 This work 
MSE156 MSE150 containing pPG101 This work 
MSE159 MSE150 containing pMS007 Ths work 
MSE162 MSE150 containing pRS51 (2) 
MSE164 MSE154 containing pRS51 This work 
MSE166 MSE154 containing pPG101 This work 
MSE167 MSE150 containing pMS006 This work 
MSE175 MSE150 containing pMS011 This work 
MSE218 MSE150 containing pMS100-A This work 
MSE220 MSE150 containing pMS100-D This work 
MSE226 MSE150 containing pMS100-B This work 
MSE228 MSE150 containing pMS100-C This work 
MSE240 MSE150 containing pMS102 This work 
MSE242 MSE150 containing pMS104 This work 
MSE249 RSE247 containing pMS400 This work 
MSE251 RSE247 containing pMS401 This work 
MSE253 RSE247 containing pMS404 This work 
MSE255 RSE242 containing pMS400 This work 
MSE257 RSE242 containing pMS401 This work 
MSE259 RSE242 containing pMS404 This work 
MSE269 MSE150 containing pMS106 This work 
MSE273 RSE247 containing pMS406 This work 
MSE275 RSE242 containing pMS406 This work 
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MSE277 RSE247 containing pMS405 This work 
MSE279 RSE242 containing pMS405 This work 
RSE232  RSE242 containing pRS51 (2) 
RSE242  ∆virB4 mutant of RSE247 (3) 
RSE247  Spontaneous Smr strain of ATCC 49882 T,   
 serving as wild-type (3) 
RSE308 RSE247 containing pRS51 (2) 
B. quintana strain 
VR 358  (4) 
B. tribocorum strain 
IBS 506T  (5) 
E. coli strains   
β2150 F' lacZDM15 lacIq traD36 proA+B+ thrB1004 pro (6)  
  thi strA hsdS lacZ∆M15 ∆dapA::erm (ErmR) pir  
NovaBlue endA1 hsdR17(r K12–m K12+) supE44 thi-1 recA1 Novagen, Madison 
 gyrA96 relA1 lac[F’ proA+B+ lacIqZ∆M15::Tn10 (TcR)]  
Plasmids   
pPG100 E. coli- Bartonella spp. shuttle vector,  
 encoding a short FLAG epitope  (2) 
pPG101 Derivative of pPG100, encoding FLAG::Bh_BepA  This work  
pRS40 Cre-vector encoding NLS::Cre (2) 
pRS48 Cre-vector containing NLS::Cre::Bh_BepA (aa 305-544) This work 
pRS49 Cre-vector encoding NLS::Cre:: Bh_BepB (aa 303-542) (2) 
pRS50 Cre-vector encoding NLS::Cre:: Bh_BepC (aa 292-532) (2) 
pRS51 Cre-vector encoding NLS::Cre:: Bh_BepD (aa 352-534) (2) 
pRS55 Cre-vector encoding NLS::Cre:: Bt_BepA (aa 326-568) This work 
pMS005 Mutagenesis vector for generating a  
 ∆bepA  in-frame deletion in B. henselae (2) 
pMS006 Derivative of pPG100, encoding FLAG::Bh_BepB  This work 
pMS007 Derivative of pPG100, encoding FLAG::Bh_BepC  This work 
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pMS013 Cre vector containing::Bh_BepA (aa 1-544) This work 
pMS011 Derivate of pPG100, encoding FLAG::Bt_BepA This work 
pMS100 Insertion of a multiple cloning site into pPG100 This work 
pMS106 Derivate of pMS100, encoding FLAG::Bq_BepA2  This work 
pMS100-A Derivate of pMS100, encoding FLAG::Bh_BepA (aa  305-542) This work 
pMS100-B Derivate of pMS100, encoding FLAG::Bh_BepB (aa 303-542) This work 
pMS100-C Derivate of pMS100, encoding FLAG::Bh_BepC (aa 292-542) This work 
pMS100-D Derivate of pMS100, encoding FLAG::Bh_BepD (aa 352-534) This work 
pMS105 Insertion of Bh_BepA into pMS100 This work 
pMS111 containing the hybrid yopE-cyaA gene (7) 
pMS400 pMS100 containing a 1.23 kb PCR fragment carrying the cya  This work 
 of  Bordetella pertussis (amplified from pMS111-Cornelis) 
pMS401 Cya vector encodning Bh_BepA (aa 305-542) This work 
pMS404 Cya vector encoding Bh_BepD (aa 252-534) This work 
pMS405 Cya vector encoding Bh_BepA This work 
pMS406 Cya vector encoding Bq_BepA2 This work 
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Table II: Oligonucleotide primers used in this study 
Name Sequence a Restriction site 
prCREMfw ATCGCCCGGAAGTTTGC 
prCREMrv CAGCTCTCGTTTGCGTGTTG 
prGAPDHfw  GAAGGTGAAGGTCGGAGTC 
prGAPDHrv  GAAGATGGT GATGGGATTTC  
prGS001 TATGAAGGCCTCGAGTCGACCGCGGCCGCATCGATGACCCGGG  
 (NdeI/StuI/XhoI/SalI/SacII/NotI/ClaI/XmaI) 
prGS002 TACCCGGGTCATCGATGCGGCCGCGGTCGACTCGAGGCCTTCA 
 (XmaI/ClaI/NotI/SacII/SalI/XhoI/StuI/NdeI) 
prMS027  CGGGAATTCCATATGCAAAAGGGAATATTTCACT  NdeI 
prMS028  CGGGAATTCCATATGTTAGCTGGCTATAGCGAGTA  NdeI 
prMS037 ACGCGTCGACCTCCAAAGGCAAAAGCAAAAACG  SalI 
prMS038  TCCCCCCGGGTTAGCTAGCCATGGCAAGC XmaI 
prMS068 TCCCCCCGGGATGCCAAAGGCAAAAGCAAAAA XmaI 
prMS069 CTAGTCTAGATTAGCTAGCCATGGCAAGC XbaI 
prMS074  TCCCCCCGGGAAGCATGTTGCACTCCTCA XmaI 
prMS075   CTAGTCTAGATTATTCGGCTTTTGGAGCTGTAA  XbaI 
prMS076 TCCCCCCGGG GAGCTTGAAAACACGCTCAT XmaI 
prMS077 CTAGTCTAGATTAGCTGGCAATAGCAAGCG XbaI 
prMS078  GGAATTCCATATGCAGCAATCGCATCAGGCTG NdeI 
prMS083 TCCCCCCGGGGAATTAAAAAAAACACTCATCCC XmaI 
prMS084 CTAGTCTAGATTAACTTGGCATAGGGACCTCTT XbaI 
prMS090 TCCCCCCGGGTTACGAGGCCTGGCGTTCCACTGCGCCCA XmaI/StuI 
prMS102  ACGCGTCGACCGATGAGCCATATGAAAAATATCAAA SalI 
prMS103  TCCCCCCGGGTTAGCAAACTATTTTAGCTTGC XmaI 
prMS104  AGCTTTGTTTAAACGATGAGCCATATGAAAAATATCAAA PmeI 
prPG92 GGAATTCCATATGCCAAAGGCAAAAGCAAAAA  NdeI 
prPG93  GGAATTCCATATGTTAGCTAGCCATGGCAAGC    NdeI 
prPG095   GGAATTCCATATGTTAGCTGGCAATAGCAAGCG NdeI 
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prPG097    GGAATTCCATATGTTAGTTGGTAAGAGCCCTTG NdeI 
prPG129 GGAATTCCATATGCCAAAAGCAAAAGCAAAAAA  NdeI 
prPG130   GGAATTCCATATGTTAGAGCATAATTATCTGTA NdeI 
prRS167 TCCCCCCGGGTTAGCTAGCCATGGCAAGC XmaI 
prRS180 ATGGTGTCGAAAGAATTAAAAAAAACACTCATCC SalI 
prRS187 ATGGTGTCGACAAGAGTTAAAAAATATTCTCATTC SalI 
prRS188  TCCCCCCGGGTTAGCTGGCTATAGCGAGTA XmaI 
 
a Restriction endonuclease cleavage sites are underlined  
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Bartonella-endothelial cell interaction 
Bartonella species are vasculotropic bacterial pathogens responsible for 
clinical manifestations including trench fever, Carrion’s disease, cat-scratch disease, 
and bacillary angiomatosis-peliosis. The endothelium is proposed to be the primary 
niche for bartonellae upon transmission via an arthropod vector (Dehio, 2001). 
Bartonella are able to adhere to and invade endothelial cells (EC). In humans, the 
colonization of the endothelium by the three Bartonella species B. henselae, 
 B. quintana, and B. bacilliformis, is associated with vascular tumor formation (Dehio, 
2004). The property of bartonellae to stimulate the proliferation of human EC is 
unique among bacterial pathogens. EC are lining the inside of our blood vessels and 
are in close interaction with smooth muscle cells and pericytes.  The blood vessel is 
finally embedded in an extracellular matrix composed of different rigid protein 
structures. This tight interaction of all components provides the required stability for 
the blood vessel (Folkman, 1995). The process of forming new vessels out of existing 
ones is called angiogenesis. The vasculature is usually quiescent in the adult, and 
endothelial cells are among the longest-lived cells outside the nervous system. The 
few adult tissues that do require ongoing “normal” angiogenesis include the female 
reproduction organs, organs that undergo physiological growth, and injured tissue 
(Hanahan and Folkman, 1996). Induction of “pathological” angiogenesis is often 
observed during tumor formation. To contribute to an angiogenic process, the 
normally quiescent EC require a specific stimulus to proliferate.  
Considering their localization, EC play an important role during an 
inflammatory response (Johnson-Leger and Imhof, 2003). By expressing different 
adhesion molecules and chemokines, they control the transmigration of immune cells 
to the site of infection. The first published report of my PhD thesis is related to this 
pro-inflammatory activation of EC: “B. henselae induces NFkB-dependent 
upregulation of adhesion molecules in cultured endothelial cells: possible 
roles of outer membrane proteins as pathogenic factors” (Chapter 1, p. B-1). In 
this work, we provide evidence, that B. henselae-EC interaction results in an 
induction of a pro-inflammatory response of the host cell. Upon B. henselae infection 
the normally quiescent EC started to express several genes involved in a pro-
inflammatory process. This included the expression of the adhesion molecules  
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E-selectin and ICAM-1, which are known to mediate the adherence, rolling, and 
transmigration of leukocytes in vivo.  The pro-inflammatory response was regulated 
by the activation of the NF-κB pathway by B. henselae. To biochemically characterize 
the bacterial stimulus mediating this pro-inflammatory response, B. henselae was 
subfractionated. We were able to restrict the observed pro-inflammatory response to 
the outer membrane protein fraction of B. henselae. Further, we excluded the 
involvement of bacterial lipopolysaccharide (LPS) in the observed inflammation.  
LPS, also called endotoxin, is a potent inducer of a local and systemic inflammation. 
By binding to toll-like receptor 4 (TLR4), LPS induces a strong pro-inflammatory 
response in EC (Faure et al., 2001; Miller et al., 2005). In our study, the activation of 
EC by B. henselae was determined to be of proteinaceous origin, independent of the 
LPS, because adding the common LPS inhibitor polymyxin B to the outer membrane 
fraction did not show any effect.  Our findings were finally confirmed by the recently 
solved LPS structure of B. henselae by Zähringer and co-workers (Zahringer et al., 
2004). They gave evidence that the endotoxic activity of purified LPS from  
B. henselae is 103- to 104-times lower compared to enterobacterial LPS. These 
results strongly support our previous conclusions, that indeed bacterial proteins 
rather than LPS mediate the pro-inflammatory response of the endotoxin-sensitive 
EC. In summary, our study provides evidence that the pro-inflammatory activation of 
EC by B. henselae is mediated by bacterial proteins. The low endotoxic activity of B. 
henselae and the specific induction of a pro-inflammatory response by bacterial 
proteins might indicate an evolved characteristic feature of a highly adapted 
vasculotropic pathogen. 
 
Role of the VirB type IV secretion system in subversion of EC function 
Different pathogenic bacteria have adapted conjugation systems to translocate 
effector proteins into the cytosol of host cells. During bacterial infection, these 
injection machineries, also called type IV secretion systems (T4SS), represent major 
virulence factors (Cascales and Christie, 2003). B. henselae harbors two T4SS, the 
Trw and the VirB T4SS, classified by their evolutionary origin. In the study “The VirB 
T4SS of B. henselae mediates invasion, pro-inflammatory activation, and anti-
apoptotic protection of endothelial cells” (Chapter 2, p. C-1), we were driven by 
the interest to reveal the role of the VirB T4SS during endothelial cell interaction. 
Different aspects of the subversion of EC through Bartonella infection were already 
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described in literature, like (i) the massive rearrangement of the actin cytoskeleton, 
resulting in the formation of the so-called  invasome (Dehio et al., 1997), (ii) the 
induction of a pro-inflammatory response (Fuhrmann et al., 2001), (iii) the protection 
against apoptosis (Kirby and Nekorchuk, 2002), and (iv) a mitogenic activation 
(Maeno et al., 1999). To specify the contribution of the VirB T4SS during EC-
interaction, we first abrogated the functioning of the VirB T4SS of B. henselae by a 
nonpolar deletion of the virB4 gene. Then, we established several cell-assays to 
dissect the different influences of the VirB T4SS during EC infection. Using wild-type 
bacteria, a ∆virB4 inframe mutant, and a trans-complemented ∆virB4 mutant, we 
were able to dissect and classify the B. henselae-EC interactions. The majority of the 
analyzed phenotypes were dependent on a functional VirB T4SS. Beside the 
mitogenic activity of B. henselae, all known characteristics were found to be mediated 
by the VirB T4SS. Other bacterial pathogens are also known to use their T4SS for 
subversion of host cell function. For example the translocation of CagA via the VirB-
related Cag T4SS of the gastric pathogen Helicobacter pylori induces elongation and 
spreading of host cells (Segal et al., 1999). However, such a variety of T4SS-
dependent phenotypes as observed upon B. henselae infection was never described 
for any other T4SS. As inactivation of the translocation machinery resulted in the loss 
of a wide array of phenotypes, we suggested that several yet unknown T4SS 
substrates could be translocated into the host cell, where they could act in an 
individual or synergistic manner. 
Taken together, by determining VirB T4SS-dependent cellular processes in 
EC, we revealed various aspects of bacteria-host cell interaction which may play a 
crucial role during pathogenesis. During this study, we further established cell-biology 
assays which facilitate our future Bartonella research to monitor the differential 
behavior of genetically modified bacteria during EC infection. 
 
Show me the type IV  substrates 
The subversion of EC function by the VirB T4SS described in chapter 2 was 
proposed to be mediated by yet unidentified translocated effector proteins. Our report 
“A bipartite signal mediates the transfer of T4SS substrates of B. henselae into 
human cells” (Chapter 3, p. D-1) describes the discovery of these putative VirB 
T4SS effector proteins in B. henselae. By sequencing downstream of the virB locus, 
the genes encoding the type IV secretion coupling protein VirD4 and seven putative 
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Bartonella effector proteins (Bep) were identified. The nonpolar deletion of the genes 
encoding these putative Beps abolished the ability of B. henselae to trigger host cell 
phenotypes, which were previously described to be mediated by the VirB T4SS 
(Chapter 2, p. C-1). These findings confirmed our assumption that the observed 
subversion of host cell function is mediated by putative effector proteins. A so-called 
Bep intracellular delivery (BID) domain, conserved in all Beps, was further 
characterized by a Cre-recombinase reporter assay for translocation (CRAFT). We 
identified a VirB/VirD4-dependent bipartite translocation signal, composed of the 
conserved BID domain and a short positively charged tail sequence. Interestingly, the 
VirB/VirD4 T4SS of B. henselae shares high homology to bacterial conjugation 
systems, which mediate the transfer of DNA into recipient cells. We could provide 
evidence, that a bipartite translocation signal of a relaxase of the conjugation 
machinery AvhB/TraG of Agrobacterium tumefaciens still mediates translocation by 
the VirB/VirD4 T4SS of B. henselae. This allows the speculation that the VirB/VirD4 
T4SS could also have retained the capacity of transferring DNA. 
To summarize, the identification of translocated effector proteins was an 
exciting step towards a molecular understanding of host cell subversion by B. 
henselae. Next, we were ambitious to further investigate the here identified bacterial 
effectors to characterize their individual functions in host cell subversion. 
 
The anti-apoptotic factor 
One of the VirB/VirD4-dependent processes described in chapter 2 and 3 is 
the protection of EC from apoptotic cell death. This anti-apoptotic activity of B. 
henselae is proposed to contribute to the mitogenic activity resulting in enhanced 
vasculoproliferative tumor formation (Kirby, 2004; Kirby and Nekorchuk, 2002). In the 
report “The BID domain of the translocated effector protein BepA of B. henselae 
is sufficient to protect endothelial cells from apoptosis” (Chapter 4, p. E-1), we 
identified BepA as the anti-apoptotic factor of B. henselae. A nonpolar deletion of 
bepA resulted in the loss of the anti-apoptotic activity of B. henselae. Because 
translocation of BepA could not been shown by the CRAFT assay (Chapter 3,  
p. D-1), we adapted a calmodulin-dependent adenylate cylclase (cya) reporter assay 
to demonstrate BepA-translocation by the VirB/VirD4 T4SS. This defined BepA as a 
novel VirB/VirD4 T4SS substrate and as the first Bartonella effector protein with an 
assigned function in host cells. Moreover, it represents the first identified secreted 
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substrate of a type III or type IV secretion system known to mediate an anti-apoptotic 
activity (Synopsis, p. A-1). Strikingly, the anti-apoptotic activity of BepA was found 
exclusively among Bartonella species associated with bacillary angiomatosis. BepA 
of the human pathogen B. quintana showed even a more pronounced anti-apoptotic 
effect than the orthologue of the zoonotic species B. henselae. Genome comparison 
of these two pathogens showed that B. quintana, which is highly adapted to humans, 
evolved from B. henselae by reductive evolution (Alsmark et al., 2004). The 
increased efficiency of BepA of B. quintana to protect EC from apoptotic cells death 
might indicate the importance of the anti-apoptotic activity of Bartonella during human 
infection. We have to consider that the formation of angioproliferative lesions, 
including new vessel sprouting, is a tightly controlled mechanism, in which several 
mechanisms are acting in a orchestral order (Bergers and Benjamin, 2003). 
Additionally, stimulation of EC proliferation is not sufficient to trigger vascular tube 
formation in a three-dimensional matrix (Kirby, 2004). The central question is to 
define the contribution of the anti-apoptotic activity of BepA to the process of vascular 
tumor formation induced by B. henselae. There is an emerging need for an 
appropriate animal model to study bacillary angiomatosis in vivo and to unravel the 
putative synergistic effects of the mitogenic and anti-apoptotic activity of B. henselae 
during the formation of vasculoproliferative lesions. Beside the putative involvement 
of BepA during tumor formation, the here identified anti-apoptotic bacterial factor 
might be useful for biotechnical applications, or might represent a valuable tool to 
specifically manipulate EC. 
To summarize, my PhD thesis project aimed at characterizing Bartonella-EC 
interactions. The core work of this thesis consists of two major findings. First, the role 
of the VirB T4SS in mediating most of the EC changes observed during bacterial 
infection, like invasion, pro-inflammatory activation, and anti-apoptotic protection of 
EC. Second, the discovery of BepA as a novel VirB/VirD4 T4SS substrate, protecting 
EC from apoptosis. 
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